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Abstract
Dihydrolipoamide dehydrogenase (E3) is structurally and functionally 
related to the group of enzymes known as the pyridine nucleotide-disulphide 
oxidoreductases. It is a homodimer with a Mr of approx. 2 x 50 000, each subunit 
containing one non-covalently bound FAD molecule and a redox active disulphide. 
The importance of E3 lies in its function as an integral component of the 2-oxoacid 
dehydrogenase complexes and the glycine decarboxylase complex.
In mammals and some prokaryotes, a common E3 enzyme forms part of all 
the complexes; however, in recent years a variety of complex specific isoforms 
have been isolated from certain prokaryotes. Additionally, E3 enzymes which are 
not associated with 2-oxoacid dehydrogenase complexes have been discovered 
suggesting an as yet unknown function. Most plants investigated to date contain 
two organelle specific isoforms of E3; one found in mitochondria and the other in 
chloroplasts. In pea, a single E3 enzyme complements the activities of all the 
complexes in mitochondria. The discovery in this laboratory of three novel 
isoforms of E3 in the mitochondria of potato tubers and subsequently barley leaves 
suggests a possible physiological role in which each functions preferentially or 
exclusively with one of the multienzyme complexes. The isoforms (a 2, exp and 
p2) appear to arise as a result of the various combinations of two closely related 
polypeptides. A modified procedure for purification of the potato tuber E3 
isoforms enabled the isolation of sufficient protein for the determination of their 
precise molecular masses. By electrospray mass spectrometry it was found that the 
a  polypeptide had a Mr of 49 446 compared to 49 561 for the P polypeptide. 
Although the a  polypeptide was the smaller form, it migrated more slowly than the 
P polypeptide through SDS-PAGE.
Reconstitution assays analysed the possible complex specific roles of the E3 
mitochondrial isoforms from potato tubers. Bovine heart OGDC was employed 
due to the inherent problems in the purification of the complexes from plants. All 
three isoforms were unable to promote the activity of OGDC stripped of its native
E3 component; however competitive binding assays demonstrated that they 
interacted weakly with the E1/E2 subcomplex of OGDC. Preferential binding of 
one or more isoforms to the subcomplex was not shown and valid conclusions 
could not be drawn. Of interest was the comparison of reconstitution ability of a 
variety of E3s. Bovine mucosal and porcine heart E3 were found to give poor 
reconstitution with bovine heart E1/E2 subcomplex (15-20%) and yeast E3 did not 
promote any complex activity although they exhibited tight binding. In spite of the 
high sequence conservation between these E3s, subtle differences in catalytic and/or 
binding orientations between bovine heart E1/E2 and E3 fi'om different species are 
evident. Similar results were obtained with PDC by other researchers.
Cloning the possible genes for the a  and p polypeptides was caixied out as 
a means to establishing the physiological roles of the isoforms. All the clones 
obtained by amplification of cDNA from potato leaf RNA and screening a potato 
leaf cDNA library had identity with the p polypeptide by their deduced amino acid 
sequences and predicted values. This represented only the second E3 to be 
cloned from plants. The open reading frame consisted of 1512 bp encoding a 
protein with 470 residues and a 34 residue leader sequence. Expression of a 
cDNA, truncated at the 5' end, produced insoluble protein. This was possibly due 
to the absence of the N-terminal region causing incorrect folding and lack of FAD 
binding.
The relationship of the a  polypeptide to the p polypeptide remains to be 
established; however, they are expected to have a high degree of sequence identity. 
The suggestion that the isoforms have distinct properties would imply that the a  
polypeptide is a distinct gene product. However, the similarities between the 
polypeptides at the N-terminus, Mr values and their strong cross reaction to yeast 
E3 antisera would suggest that the two forms have arisen as a result of alternate 
splicing or an in-frame deletion of one internal amino acid by another event. A 
post-translational modification involving the addition of a chemical group was 
eliminated as the cDNA encoding the larger polypeptide (p) had been cloned.
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Chapter 1 
Introduction
1.1 Dihydrolipoamide Dehydrogenase
Dihydrolipoamide dehydrogenase (E3) belongs to the pyridine nucleotide- 
disulphide oxidoreductase group of enzymes comprising glutathione reductase, 
mercuric reductase and trypanothione reductase (Carothers et al, 1989). These 
enzymes are homodimers containing one flavin adenine dinucleotide (FAD) and a 
redox active disulphide per subunit. The importance of E3 lies in its function as a 
component of the family of 2-oxoacid dehydrogenase complexes and the related 
glycine decarboxylase where it reoxidises the lipoamide group, transferring 
reducing equivalents onto NAD+ via its FAD cofactor. E3 will be discussed more 
fully in section 1.3.4. This chapter will begin with an update on the current 
knowledge of the mammalian and bacterial complexes and their component 
enzymes since they have been investigated more thoroughly than plant complexes.
1 .2  The 2-Oxoacid Dehydrogenase Complexes
E3 is the flavoprotein component of the ubiquitous family of 2-oxoacid 
dehydrogenase complexes comprising the pyruvate dehydrogenase complex (PDC), 
2-oxoglutarate dehydrogenase complex (OGDC) and branched-chain 2-oxoacid 
dehydrogenase complex (BCDC). Each mammalian complex is located within the 
mitochondrial matrix, probably loosely associated with the mitochondrial inner 
membrane. This family of enzymes has been studied extensively in bacteria and 
mammals because they are model examples of multienzyme complexes, which are 
defined as self-assembling aggregates of non-covalently interacting proteins, 
catalysing successive steps in a metabolic pathway. (Perham, 1991, Reed, 1974). 
Interesting questions arise concerning the assembly of the complexes and the 
mechanisms for channelling substrates and intermediates between multiple active 
sites.
Of prime importance is the key regulatory position in central metabolism of 
the complexes in catalysing essentially irreversible reactions (Yeaman, 1986). A
scheme of the metabolic interaction of the complexes is represented in Fig. 1.1. 
PDC oxidatively decarboxylates pyruvate to acetyl CoA, committing the entry of 
carbohydrate into the TCA cycle for subsequent oxidation, with the concomitant 
generation of ATP. It also has a role in supplying acetyl CoA for a range of 
biosynthetic pathways. OGDC is a component of the TCA cycle converting 2~ 
oxoglutarate to succinyl CoA and controls the flux of carbon atoms around the latter 
stages o f the cycle. Additionally, OGDC supplies succinyl CoA for the 
biosynthesis of porphyrins (in mammalian cells), lysine and methionine. BCDC is 
the only complex with a broad substrate specificity, catalysing the committed step in 
the degi'adation of branched-chain amino acids leucine, isoleucine and valine. It is 
also involved in the catabolism of methionine and threonine. In mammals BCDC 
has nutritional signficance in controlling the levels of branched-chain amino acids, 
converting excesses into acyl CoA derivatives and thereby recycling carbon atoms 
back into central metabolism.
1 . 2 . 1  Enzyme Reaction
Each complex is composed of multiple copies of three component enzymes 
termed E l, E2 and E3. E l is a substrate specific 2-oxoacid dehydrogenase which 
has thiamine diphosphate (ThDP) as an essential cofactor. E2 is a complex specific 
dihydrolipoamide acyltransferase possessing a covalently attached lipoic acid 
cofactor, and E3 is the FAD-containing dihydrolipoamide dehydrogenase. These 
three enzymes utilise the same reaction mechanism in each complex to catalyse the 
co-ordinated oxidative decarboxylation of their respective 2-oxoacid substrates, 
releasing CO2 and generating the relevant acyl CoA (Fig. 1.2). E l catalyses the 
overall rate-limiting step in the reaction: the decarboxylation of the 2-oxoacid 
substrate with the formation of a hydroxyacyl-ThDP intermediate (reaction 1). The 
E l enzyme then catalyses the reductive acylation of the S^-thiols of the lipoamide 
cofactor, covalently bound to the lipoyl domains of the oligomeric E2 enzyme to 
form an S^-acyllipoamide intermediate (reaction 2). The acyl group is transferred at 
the E2 active site to the CoA acceptor (reaction 3), leaving the lipoic
Branched Chain 
Amino Acids
Glucose
BCDC 
Acyl CoAs
„  TPyruvate
IPDCI
}Glycolysis
j■ Acetyl CoA 
Oxaloacetate 2-oxoglutarate
PÜÜO'Succinyl-CoA
Citric
Acid
Cycle
Fig. 1.1: Location of the 2-oxoacid dehydrogenase complexes in central 
metabolism
PDC, pyruvate dehydrogenase complex; OGDC, 2-oxoglutarate dehydrogenase 
complex; BCDC, Branched-chain 2-oxoacid dehydrogenase complex. Broken lines 
indicate that several steps are involved.
.CoA-SH
O
R-C-COOH
CO2
-C=ThD
S-CoALip-SH
Lip-(
FAD
Lip-S2
o
NADH
FAD■SHHS
RC CO2H + CoASH + NAD+ — ► RC~S CoA + CO2 + NADH + H+
Fig. 1.2: Reaction scheme for the oxidative decarboxylation of the 2-oxoacids by 
respective 2-oxoacid dehydrogenase complexes
E l, 2-Oxoacid Dehydrogenase; E2, Dihydrolipoamide Acyltransferase; E3, Dihydro­
lipoamide Dehydrogenase; TPP, Thiamine pyrophosphate; Lip, Lipoic acid; R = CH3
(for pyruvate), COOH-CH2-CH2 (for 2-oxoglutarate) and (CH3)2CHCH2 (for 2-
ketoisocaproic acid derived from leucine).
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acid in the reduced state. This cofactor is re-oxidised by the FAD-containing E3 
component (reaction 4) which in turn becomes re-oxidised by NAD+ as the final 
electron acceptor (reaction 5). The E3 component, carrying out the same reaction 
might be expected to be an identical enzyme in all three complexes but this is not 
always the case and will be discussed later in this chapter.
1 . 2 . 2  Quaternary Structure
The 2-oxoacid dehydrogenases have Mr values of several million (5-10 
xlO"b) and are seen as particles of 30-40 nm in the electron microscope (Henderson 
et aL, 1979; Oliver & Reed, 1982), being larger than ribosomes. The oligomeric 
E2 component forms a central, structural core around which multiple copies of E l 
and E3 are bound tightly, but non-covalently. It was apparent by electron 
microscopy that the relationship of the E2 subunits formed two types of distinct 
polyhedral morphology: the cube and the pentagonal dodecahedron. The cubic 
morphology is formed by 24 copies of E2 arranged with octahedial symmetry and 
the dodecahedron by 60 E2 copies arranged with icosahedral symmetry (Fig. 1.3). 
Table 1.1 provides a summary of the E2 morphology found in complexes from 
different species. Structural determination of the cubic core of Azotobacter 
vinelandii suggested that the building blocks were eight trimers of E2, forming a 
hollow cavity, connected to the outside by large channels (Mattevi et al., 1992b).
The E l of mammalian PDC, BCDC and bacterial (gram-positive) PDC are 
tetramers consisting of two copies of two non-identical subunits, a  and p, whereas 
in mammalian OGDC and bacterial (gram-negative) OGDC and PDC, E l exists as a 
homodimer. For example, bovine heait PDC has about 30 E l heterotetramers 
(0C2P2) and 6 E3 homodimers which are thought to bind near the 30 edges and to 
the 12 faces of the pentagonal dodecahedron E2 core, respectively (Reed & 
Hackert, 1990; Wu & Reed, 1984). E. coll PDC has 12 E l homodimers arranged 
on the 12 edges of the cube-like E2 core and 6 E3 dimers organised in the 6 faces.
AFig 1.3: Interpretative models of the quaternary structure of dihydrolipoamide 
acyltransferase (E2)
A) Model of those acyltransferases consisting of 24 subunits arranged in groups 
of 3 about the 8 vertices of a cube.
B) Model of the 24-subunit acyltransferases illustrating the proposed domain 
structure. Each of the 24 acyltransferase subunits is represented by one sphere 
and its attached ellipsoid. The spheres represent the compact, inner core domains, 
and the ellipsoids represent the extended lipoyl domain.
C) Model of those acyltransferases consisting of 60 subunits arranged in groups 
of three about the 20 vertices of a pentagonal dodecahedron.
D) Model of the 60-subunit acyltransferases illustrating the proposed domain 
structure. The figure is viewed down a 2-fold axis of symmetry.
Reproduced from Reed et al. (1989).
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An additional component, termed protein X is found tightly associated with 
the E2 cores of mammalian and yeast PDC (De Marcucci & Lindsay, 1985; Jilka et 
al., 1986), but has not been identified in any other 2-oxoacid dehydrogenase 
complexes (e.g. OGDC and BCDC). It does not appear to have an essential role in 
catalysis but is thought to involve binding of the E3 to the E2 core (Gopalkrishnan 
et a l,  1989). Protein X was thought to be present in 6 copies in the bovine kidney 
PDC (Jilka et aL, 1986), however, Maeng et al. (1994) provided evidence for 12 
copies of protein X attached to 12 E3 homodimers in Saccharomyces cerevisiae. 
The presence of 12 copies of X was also recently established in bovine heart PDC 
by Sanderson et al. (1996a), which is consistent with one X subunit with each face 
of the E2 pentagonal dodecahedron. Cross-linking data of the lipoyl domains from 
bovine heart PDC tentatively suggested that 6 protein X dimers bind 6 dimers of 
E3. In addition, bovine heart PDC possesses a tightly bound kinase (1-3 
molecules/complex in bovine kidney PDC) and a loosely associated phosphatase, 
requiring Ca^+ ions (approx. 5 molecules/ complex, Yeaman, 1989).
1.3  Constituent Enzymes of the 2-Oxoacid Dehydrogenase 
Complexes
1 . 3 . 1  2-Oxoacicl Dehydrogenase (E l)
'E l catalyses the irreversible and rate-limiting step in the oxidative-' 
decai'boxylation of the 2-oxoacids and thus determines the kinetic parameters of the 
reaction. It is the main regulatory centre of the complexes via dephosphorylation 
(activation) and phosphorylation (inactivation) cycles of the E l a  component, 
involving a specific phosphatase and a kinase (Linn et al., 1969).
The E l can be divided into three groups: E l from OGDC, E l from PDC of 
Gram-negative bacteria and E l from eukaryotic PDC and BCDC. Sequence 
homologies between these groups are minimal or non-existent, and even E l 
enzymes from OGDC and PDC from the same organisms (e.g E. coli) are quite
dissimilar (Daiiinson et al., 1984). In contrast, the E2 components of both 
complexes have striking homologies. The E l of bacterial and mammalian OGDC 
and bacterial PDC exist as homodimers (110 000 kDa/polypeptide). However, the 
E l components of mammalian PDC and BCDC are heterotetramers (CC2^2) 
consisting of two copies of two non-identical subunits termed a  (41 kDa) and |3 (36 
kDa) (Reed, 1974; Perham, 1996). The j3 subunit anchors E l to the subunit 
binding domain of E2.
A common ThDP binding sequence motif exists in E l a  which was found 
by comparisons with other ThDP requiring enzymes, including pyruvate 
decarboxylase and pyruvate oxidase and transketolase (Hawkins et a i, 1989). The 
characterisation of individually expressed E l a  and El(3 subunits have shown that 
both are required for catalytic activity and coenzyme binding (Korotchkina et al., 
1995; Jeng et al., 1994; see Korotchkina et al., 1996, for review). Robinson and 
Chun (1993) proposed that the mode of ThDP binding by human E l was similar to 
that of the three ThDP-requiring enzymes named above. The mechanism of ThDP 
binding by these three enzymes has been determined by analysis of their crystal 
structures, which confirms that the conserved ThDP binding structure is a common 
feature. They are all composed of identical subunits (2 for TK; 4 for PD and 
POX). Two different domains are required to bind the coenzyme, one binding the 
pyrophosphate group and the other the pyrimidine ring. Each subunit contains both 
domains, however ThDP is bound in a cleft between subunits so that the 
pyrophosphate domain belongs to one subunit and the pyrimidine domain to the 
other subunit. The function of the ThDP binding motif found by Hawkins et al. 
(1989) is to bind the pyrophosphate moiety.
1 . 3 . 2  Dihydrolipoamide Acyltransferase (E2)
The E2 component fulfils a number of essential roles in the 2-oxoacid 
dehydrogenases: 1) it forms the symmetrical core around which multiple copies of 
E l and E3 are co-ordinated, 2) it functions as an acyltransferase, catalysing the
formation of the acyl-CoA product, 3) it provides the attachment site for the lipoic 
acid cofactor which interacts with the E l and E3 active sites (Yeaman, 1989).
1 . 3 . 2 . 1  Domain Structure of E2
Limited proteolysis studies, mainly of the E2 from E. coli PDC and OGDC,
Irevealed the complex, functional domain structure of this component (Bleile et aL,
1979; Packman & Perham, 1986) and confirmation was provided when Stephens 
et al. (1983) and Spencer et al. (1984) obtained the gene sequences of the E2 
enzymes from E. coli PDC {aceF) and OGDC (^wcB), respectively (Fig. 1.4). The 
N-terminal half of E. coli PDC E2 consists of three, highly homologous lipoyl 
domains of about 80 amino acids each. A structurally distinct domain of about 50 
ammo acids (peripheral subunit-binding domain) follows the lipoyl domains and is 
involved in the binding of E3 (Packman & Perham, 1986). Removal of these 
domains by trypsin, leaves a large (29kDa), catalytic domain at the C-terminal end 
which promotes the acyltransferase reaction, is involved in E l binding and 
aggregates to form the core of the complex. The E2 polypeptide of OGDC is highly 
homologous with that of PDC E2 but has only one lipoyl domain. The independent 
units making up E2 are connected by flexible hinge regions, rich in alanine, proline 
and charged amino acids. Proteolytic cleavage sites for trypsin and Staphylococcus 
aureus V8 pro tease are clustered in these polypeptide segments, defining the limits 
of the domains and facilitating their purification from each other.
Comparisons of E2 amino acids sequences from a variety of organisms 
found that they presented the same segmented structures and were highly 
homologous (Guest et aL, 1989; Fig. 1.4), The degree of sequence conservation in 
the peripheral subunit-binding domains is consistent with the fact that E3 subunits 
from one source will often complement the overall enzyme complex activity of E l 
and E2 subunits from a heterologous source and can also form hybrid high-Mr 
complexes. The most sustained homologies are in the catalytic domain. The 
conserved His-602 in E. coli PDC E2 is an important active-site residue and is 
flanked by other conserved residues in a region that closely resembles the
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conserved active-site region of chloramphenicol acetyltransferases (Guest, 1987; 
Russell & Guest, 1990).
1 . 3 . 2 . 2  Peripheral Subunit-binding Domain
The binding of E l and E3 to the E2 cores are found to differ between 
prokaryotic and eukaryotic PDCs, resulting from the presence, in the latter 
complex, of the tightly bound protein X. As mentioned earlier, E. coli E2 (from 
PDC and OGDC) possesses an E3 binding domain between the outer lipoyl and the 
inner catalytic domains. A major part of the E l binding site resides in the E2 
catalytic domain. However, in some cases, Azotobacter vinelandii (Hanemaaijer et 
al„ 1988), B. stearothermophilus E2 (Packman et aL, 1988) and mammalian 
BCDC (Lau et aL, 1992), E l binding is also associated with the E3 binding 
domain. It was found that E l and E3 do not bind simultaneously but compete for 
space on the binding domain of E2 in these organisms (Lessard & Perham, 1995). 
In contrast, the similar subunit-binding domain of mammalian PDC and OGDC E2 
was thought to bind E l only (Rahmatullah et aL, 1989). The information 
presented above is summarised in Fig. 1.4 and the binding of E3 to mammalian 
PDC and OGDC will be discussed later.
Unexpectedly, the binding of E3 to the E2 binding domain of B. 
stearothermophilus was found to be at a molar ratio of 1:1 (i.e one E3 dimer binds 
to only one E2 binding domain) (Hipps et aL, 1994). The crystal structures of the 
E3 complexed with the E2 binding domain revealed that the site of attachment was 
in close proximity to the two fold axis of the E3 dimer and that both subunits of the 
dimer provided interacting residues (Mande et aL, 1996).
1 . 3 . 2 .3  Lipoyl Domains
The lipoyl domains each cairy a lipoic acid prosthetic group, covalently 
bound to a lysine side chain via an amide linkage. This post-translational 
modification is carried out by specific ligases, which recognise not only the 
domain, but also the specific lysine residue (Brookfield et aL, 1991). It is not
1 2
known whether these enzymes are protein specific or generally recognise the 
lipoylation sites of E2. Lipoylation causes no conformational changes, consistent 
with the lipoyl-lysine being a swinging arm, free in solution (Dardel et aL, 1990;
'Perham, 1996). The number of domains is variable and there appears to be no 
correlation with the source of the complex. Thus, prokaryotic PDCs fr om E. coli 
and A. vinelandii (octahedral) have three lipoyl domains whereas the prokaryotic S, 
faecalis (icosahedral) and mammalian (eukaryotic) PDC have two (Hodgson et aL,
1988) . In contrast, yeast PDC has a single lipoyl domain. BCDC and OGDC 
from all sources have been found to contain a single lipoyl domain per E2 
polypeptide (Fig. 1.4).
It is not clear why E. coli E2 contains three lipoyl domains because two can 
be removed without affecting catalytic activity (Guest et aL, 1985); the insertion of
extra domains to a genetically engineered complex containing a single domain is 
increasingly detrimental but not inactivating (Machado et aL, 1992). Each domain 
is known to be able to function independently of the other lipoyl domains (Allen et 
aL, 1989). Although the number of lipoyl domains does not appear to affect 
catalytic activity, it has been shown that wild-type PDC (containing three lipoyl
domains) confers a gi'owth advantage on E. coli compared to strains expressing 
PDC with fewer lipoyl domains (Guest et aL, 1996).
The attachment of the lipoyl cofactor to protein domains is an important 
structural feature for catalysis in all complexes. Its ability to act as a substrate for 
E l is enhanced for attached lipoic acid, as judged by the Kcat/Km factor, which is 
10 000 fold higher than for the free substrate (Graham et aL, 1989). Lipoyl 
domains proteolytically cleaved from the PDC of bovine heart were efficiently 
reductively acetylated by the E l component whereas free lipoic acid or lipoamide 
was not (Bleile et aL, 1981). Furthermore, a lipoylated decapeptide with an amino 
acid sequence identical with that surrounding each of the three lipoyl-lysine residues 
in the E. coli E2 chain of PDC was ineffective as a substrate indicating that a folded 
lipoyl domain is essential to the reaction (Graham et aL, 1989). Additionally, the
13
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E l from OGDC only recognises the lipoyl domains from the same complex and 
vice versa. The DKA motif, found on either side of the lipoylated lysine is not 
required for recognition by the ligase enzymes, but is important for E l recognition 
since replacement of the aspartic and alanine residues caused a decrease in the rate 
of reductive acétylation (Wallis & Perham, 1994)
The lipoamide cofactor, covalently bound to a lysine residue, is very 
flexible, forming 14Â long ‘swinging arms’ which facilitate interaction between the 
three active sites (Reed, 1974). iH  NMR spectroscopy of E2s from E. coli PDC 
and OGDC has shown that extra flexibility is provided by the mobile linker regions, 
which give the lipoyl domains theh extended conformation and provides the means 
for active-site coupling (Perham et al., 1981), In the intact complex, the lipoyl 
domains and the subunit-binding domain extend outwards from the inner E2 core, 
interdigitating between the E l and the E3 components. The E l and E3 catalysed 
reactions take place outside the E2 core, whereas the acylti*ansferase reaction takes 
place in the inner E2 core (Perham, 1996). The lipoyl-lysine residues can interact 
with each other by means of an extensive network of intramolecular coupling 
reactions that allow the channelling of the acyl groups between different E2 
subunits in the enzyme core (Bates et aL, 1977). It has been shown for the PDC 
complex that any one E l component can be visited by more than one lipoyl group. 
Thus there is no need to have the three active sites in close proximity to each other 
and distant sites can be coupled (Perham, 1996).
1 . 3 . 2 . 4  3-Dimensional Structure Determination
The mobility of the lipoyl domains has hindered the growth of well ordered 
crystals (Fuller et aL, 1979); thus, three dimensional structural determination has 
concentrated on separate domains. NMR spectroscopy has been used to solve the 
structures of the small E3 binding domain (35 amino acids) on the E2 component of 
E. coli OGDC (Robien et aL, 1992) and jS. stearothermophilus PDC (Kalia et aL, 
1993). The same technique was used in the determination of the 3-D structures of 
the lipoyl domain from B. stearothermophilus (Dardel et aL, 1993) and E. coli
14
Fig. 1.5: Three-dimensional structure of the B. stearothermophilus lipoyl 
domain
The exposed p-tum containing the lipoyl-lysine residue is shown, 
indicating the positions of the conserved DKA motif.
Reproduced from Dardel et al. (1993).
PDC (Green et al., 1995). This domain is composed of two (3-sheets making a 
flattened barrel forming a core of hydrophobic residues with the lipoyl-lysine 
perched at the tip of an exposed (3-turn (Fig. 1.5), a feature shared with the 
biotinyl-lysine swinging arm in the biotinyl domain of pyruvate carboxylase 
(Perham, 1996). The structure of the catalytic domain of E2 from Azotobacter 
vinelandii PDC was determined by X-ray crystallography and structure analysis has 
demonstrated a similarity to chloramphenicol acetyltransferase (CAT) (Mattevi et
'ah, 1992b; Schulze cr a/., 1991).
1 .3 .3  P ro tein  X
Protein X, unique to PDC from mammals and yeast, was originally thought 
to be a proteolytic fragment of E2. However, De Marcucci and Lindsay (1985) first 
showed that it was a distinct protein, tightly bound to E2, by the use of specific
. ■:
antisera and peptide mapping. Since X is so tightly bound, it was originally
suggested that it integrates into the core system during the assembly of the E2 core 
(Rahmatullah et ah, 1989), but Sanderson et ah (1996a) have postulated a post­
assembly interaction in mammals which is consistent with genetic evidence from 
yeast which reveals that the oligomeric E2 can form in the absence of protein X
. a
(Lawson et al., 1991a). Protein X has a similar domain structure to E2 (Fig. 1.4), 
deduced by limited proteolysis of the bovine heart PDC (Neagle & Lindsay, 1991; 
Rahmatullah et at., 1989). Sequence analysis of the distinct gene encoding the/ 
yeast protein X (Behai et al., 1989) indicated that the single lipoyl domain and the 
adjacent subunit binding domain was homologous with that of yeast E2 but the rest 
of the structure had no sequence similarity with any other protein. Significantly, 
the C-terminal domain had no acetyltransferase active site motif. Very recently 
PDC, purified from Crithidia fasciculata, a primitive eukaryote, has been found to 
contain protein X but unusually it contained multiple lipoyl domains (Diaz & 
Komuniecki, 1995).
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The essential role of protein X was found to be in binding and positioning 
E3 to the E2 core (Rahmatullah et a l, 1989) in a specific manner that is essential for Ifunctional PDC. E3 was found to protect the protein X component from 
degradation by proteases, trypsin and ai’g C (Gopalkrishnan et a l, 1989; Neagle &
Lindsay, 1991). Deletion of the subunit binding domain o f protein X led to 
lowered affinity for E3 and subsequent loss in PDC activity (Lawson et a l, 1991a).
Moreover, studies with a protein X deficient S. cerevisiae mutant indicate that, in 
the absence of protein X, the E2 core assembles properly but does not bind E3 
(Lawson e ta l ,  1991a).
The lipoyl gi’oups of protein X and mammalian E2 have the unique property 
of undergoing diacetylation, whereby both S°,S8-thiols incorporate acetyl groups in 
the presence of pyruvate or acetyl-CoA (Hodgson et a l,  1986). It is not known if 
this is a catalytic function of X, but it has been proposed that diacetylation could
:■
permit PDC to act as a reservoir for acetyl groups under conditions of excess acetyl 
CoA and NADH. Moreover, protein X has been shown to be able to substitute for 
the lipoyl domains of E2, allowing 10-15% of residual activity of E2 lacking lipoyl 
domains (Lawson et a l, 1991b). It is thought that the lipoyl domains of protein X 
can seiwice the E2 active site (Sanderson et a l, 1996a).
A puzzling aspect is the absence of an equivalent E3 binding protein in the 
mammalian OGDC and BCDC. Interestingly, the sequence of the human and rat 
E2 gene of OGDC showed that it lacked the highly conserved E3 and/or E l binding 
domain found in all other E2 (OGDC) sequences to date (Nakano et a l ,  1991;
Nakano et a l, 1994). Proteolytic analysis and sequence comparisons by Rice et a l  
(1992) revealed that the N-terminus of OGDC E l from bovine heart was involved 
in promoting the stable interaction of E3 with the assembled complex. ‘Domain 
shuffling’ was apparent in this case as sequences related to the lipoyl domain of 
protein X and its putative E3 binding domain are situated in the N-terminal region 
of the E l enzyme. The E l component probably binds to an as yet unidentified 
sequence in the inner catalytic domain in the eukaryotic OGDCs.
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1 . 3 . 4  Dihydrolipoamide Dehydrogenase (E3)
E3 is the FAD-containing enzyme of the three 2-oxoacid dehydrogenase 
complexes, the distantly related glycine decarboxylase (GDC) where it is named L- 
protein and the bacterial acetoin dehydrogenase system involved in acetoin 
utilisation. It reoxidises the dihydrolipoamide moieties, covalently linked to a 
specific lysine residue in the E2 components of the 2-oxoacid dehydrogenases and 
the dihydrolipoamide of the hydrogen-carrier protein of the glycine cleavage 
system, utilising NAD+ as the final electi'on acceptor. Sequence comparison has 
shown that aU E3s from prokaryotic and eukaryotic sources exhibit a high degree of
homology. Porcine heart and human E3 have 96% identity with each other and 
44% identity with E. coli E3 whereas A. vinelandii has 40% identity with E. coli 
E3. Since E3 caiTies out the same reaction in all the complexes it would be 
reasonable to expect it to complement the activities of all the 2-oxoacid
dehydrogenases and GDC within the same species. However, with the explosion
in purification and cloning studies of E3 in recent years, from a variety of
organisms, the situation has become less clear cut.
Only one E3 gene {Ipd) has been characterised in E. coli, placed adjacent to
.the ace'EE operon genes encoding the E l and E2 genes of PDC (Stephens et al.,
1983). The sue KB genes encoding E l and E2 of OGDC are found on a separate 
codon and are complemented by the Ipd gene product to form an intact complex.
This is facilitated by differential transcription of the aceEFdpd genes and the Ipd 
gene from two separate promoters, as determined by quantification of mRNA
"I
(Quail et al., 1994; Spencer & Guest, 1985). Most of the E3 for PDC is 
synthesised as read through transcripts from the 6415-base pair aceEF-lpd genes, 
but a 1670-base Ipd transcript supplies most of the E3 for OGDC. A second 
distinct E3 enzyme, present in low amounts, was purified by Richarme (1989) fi'om 
an lpd~ mutant of E. co li, deficient in the PDC and OGDC E3. It was smaller than 
the already characterised E3, being 46 000 Da in comparison to 50 554 Da. The 
role of this new E3 is still unknown, but the author suggested an involvement in
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binding protein-dependent transport of maltose and galactose. E3 is present in 
single copy in A. vinelandii (Westphal & Kok, 1988) m à  P . fluoréscens\ however, 
unlike E. coli the genes were found on the OGDC operon (Westphal & Kok, 
1990). The E3 gene can also be transcribed independently of the OGDC E l and E2 
genes in these organisms.
A second important function of E3 is as a component of BCDC. This 
complex is not only found in eukaryotes, but also in bacteria which can utilise 
branched-chain amino acids for growth e.g. Pseudomonas putida  and P. 
aeruginosa. They are known to contain a specific E3 for BCDC (LPD-val), found 
in the BCDC operon, which is different from the PDC, OGDC and GDC E3 (LPD-
glc). LPD-val was induced in media containing branched-chain amino acids as a 
carbon source (McCully et al., 1986; Sokatch et al., 1981) and LPD-glc was 
induced in glucose synthetic medium (Sokatch & Burns, 1984; Sokatch et at.,
1983). A third E3 (LPD-3) discovered in P. putida by Bums et al. (1989a) was not 
part of a 2-oxoacid dehydrogenase operon and appeared to be able to replace LPD- 
glc as the component for PDC and OGDC but its precise role is unknown. It has
.been suggested that it may be part of the newly discovered acetoin dehydrogenase
complex (Oppermann & Steinbuchel, 1994). Primary sequence comparisons of :
LPD-3 found it to be more closely related to the eukaryotic E3. Freudenberg et al.
(1989) have recently identified an atypically small E3 subunit, associated with GDC 
from the anaerobic bacterium Eubacterium acidaminophilum. This appears to be the 
only GDC specific E3 characterised to date.
Recently, cloning of the PDC and the OGDC opérons in the strictly 
respiratory bacterium, Alcaligenes eutrophus, revealed a new example of multiple 
isoforms of E3. In contrast to E. coli and A. vinelandii, where the E3 gene is 
found on the PDC operon, or on the OGDC operon, respectively, A. eutrophus 
uniquely possesses genetically distinct E3s for both PDC and OGDC (Hein &
Steinbuchel, 1996). Both E3s appear not to be closely related, but it remains to be 
elucidated whether they are interchangeable. The PDC E3 was found to be a new
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type of enzyme, containing a lipoyl domain at its N-terminus which was separated 
from the rest of the enzyme by a flexible hinge region, as in E2 (Hein & 
Steinbuchel, 1994). This unique property was shared only with the E3 component 
{acoL gene product) of the acetion dehydrogenase enzyme system of the strictly 
fermentative, gram-positive bacterium Clostridium magnum.
Unusually, uncomplexed E3 has been discovered in the absence of the 2- 
oxoacid dehydrogenase complexes, both in prokaryotic species (halophilic and 
thermophilic archaebacteria, Danson et a l,  1984) and in the bloodsti'eam form of 
the eukaryotic African parasite. Trypanosoma brucei (Danson et al., 1987). In T. 
hrucei it is closely associated with the plasma membrane but it remains to be 
established whether it performs a similar role in tr ansport, suggested for the second 
E3 enzyme of E. coli.
The situation in eukaryotes is similar to that found in E. coli. A  mutant in 
the yeast Ipdl gene abolishes all PDC and OGDC activity (Dickinson et al., 1986) 
and in mammals, immunological data (Matuda & Saheki, 1985) and reconstitutional 
studies (Sakurai et al., 1970) all indicate that PDC, OGDC and BCDC use the same 
E3 subunit. The best evidence for a single copy of E3 comes from studies of lactic 
acidosis in man wlicre the genetic lesion affects the production of lipoamide 
dehydrogenase. PDC, OGDC and BCDC are all affected since pyruvate, 2- 
oxoglutarate and branched-chain amino acids accumulate in the serum of these 
patients (Robinson et al., 1977). It has been assumed that the E3 subunit also 
promotes GDC activity in mammals, although an intact complex has never been 
isolated intact from this source. Cloning of the E3 gene for glycine decarboxylase 
(termed L-protein) from pea leaf mitochondria (Bourguignon et al., 1992; Turner et 
al., 1992), and subsequent analysis of PDC E3 from the same organelle has 
confirmed the presence of a single B3 complementing all the mitochondrial 2- 
oxoacid dehydrogenase complexes (Bourguignon et a l, 1996), Efforts to detect 
multiple isoforms in mammals have yielded what appear to be conformational 
isomers of the same protein (Williams, 1976). There is also some isolated evidence
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that rat liver mitochondria contain two immunologically distinct E3, one being 
specific to GDC (Carothers et al., 1987).
1 . 3 . 4 . 1  Domain Structure
E3 is related, structurally and mechanistically, to the pyridine nucleotide- 
disulphide oxidoreductases - a family of fiavoenzymes, which are distinguished by 
containing an redox active disulphide. Other members include glutathione reductase 
(Krauth-Siegel et al., 1982; Schulz et al., 1978), mercuric reductase (Schiering et 
aL, 1991), thioredoxin reductase (Kuriyan et al., 1991a) and trypanothione 
reductase (Kuriyan et a l,  1991b), They are all active as homodimers (approx. 2 x 
50 kDa), a FAD cofactor is non-covalently bound to each of their subunits, they 
always catalyse an electron transfer between NAD(P)H and a disulphide/dithiol and 
they have significant sequence identity (>20%).
A complete amino acid sequence was first obtained for glutathione reductase 
(GR) and the complete tertiary structure by X-ray diffraction analysis (Thieme et 
al., 1981). The structural and mechanistic similarities between glutathione 
reductase and E3 have been recognised for many years (Williams, 1976) and since 
there is considerable homology at the primary amino acid sequence between GR 
and human E3 (33%), GR has been used as a model to predict the secondary 
structure of all E3s cloned to date. The first example of this was when the sequence 
of E. coli E3 was fitted into the 3 dimensional structure of GR (Rice et al., 1984). 
The well defined domain structure of GR, namely the FAD-binding domain 
(residues 1-157), NADPH binding domain (residues 158-293), a central domain 
(residues 294-364) and a dimer interface domain (residues 365-478), is found in all 
E3s. There is striking homology of the sequences around the nucleotide binding 
sites, the active site cysteines found in the FAD domain and in the contact region 
between the dimers. Distinctive chain folds around the nucleotide binding sites are 
evident. Fig. 1.6 shows a comparison of the overall secondary structure of GR and 
human E3.
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Fig. 1.6: Comparison of the chain fold of hum an glutathione reductase and 
hum an E3
Strands of beta-sheets are shown as arrows and alpha-heiices as rectangles.
The open rectangles indicate helices with little sequence conservation between 
E3 and GR. The four domains are separately identified by enclosure in boxes. 
Numbers indicate amino acid residues of human E3 and roman numerals identify 
alpha helices. The residues in ovals denote domain boundaries.
PP, pyrophosphate moieties of FAD and NAD; S-S, the redox-active dithiol 
(Cys-Cys of E3); N and C, amino and carboxy terminus, respectively. 
Reproduced from Thekkumkara et al. (1989).
The crystal structures of E3 from A. vinelandii, P, putida P. fluoresens 
(Mattevi et aL, 1992a; Mattevi et aL, 1993; Mattevi et a l ,  1991) have been 
elucidated in recent years and have confirmed many postulates of the catalytic 
mechanisms and active site residues. The reason for the arrangement of E3 as 
dimers became obvious when the crystal structures were analysed. In each enzyme 
the active sites are located at the dimer interface and essential amino acids are 
provided by each subunit. The active site is composed of three elements; the flavin, 
disulphide and a histidine which acts as the base. Thus, the monomer can not be 
catalytically active.
1 .4  Regulation
PDC is the link in the metabolism of glucose between glycolysis and the 
TCA cycle and since pyruvate can also be used for gluconeogenesis, it is subject to 
short-term (end product inhibition, covalent modification, response to hormonal 
changes) and long-term regulation by nutritional changes. In addition, the tight 
control of glucose metabolism and catabolism of branched-chain amino acids 
assures continuous availability for energy production, biosynthetic intermediates 
and protein synthesis and disposal of excess substrates for prevention of the toxic 
effects of high levels of these substrates (Patel & Harris, 1995).
Eukaryotic PDC and BCDC are the only mitochondrial complexes found to 
be regulated by reversible phosphorylation (James et al., 1995; Linn et al., 1969). 
The E l a  from PDC and BCDC becomes phosphorylated at three and two specific 
serine residues, respectively, leading to a dramatic decrease in the Vmax and 
therefore, inactivation of the complex. Inactivation correlates with phosphorylation 
at only the first site (Cook et al., 1983; Davis et al., 1977; Yeaman et al., 1978; 
Zhao et al., 1994) and it is thought that phosphorylation at the additional sites may 
play a regulatory role in inhibiting dephosphorylation of the inactivating site 
(Sugden etal., 1978). Zhao et al. (1994) confirmed, by site directed mutagenesis 
of BCDC, that site 1 was indeed responsible for kinase-mediated inactivation of E l
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but phosphorylation at site 2 played no role in lowering the binding affinity of the 
E l for E2, previously suggested by Cook et a i  (1985). Analysis of the amino acid 
sequence of mammalian PDC and BCDC, surrounding the principal 
phosphorylation site (site 1) reveals considerable homology. There is no evidence 
for the phosphorylation of OGDC, although ATP alters kinetic parameters of the
■complex by causing an increase in the for 2-oxoglutarate (Hunter & Lindsay,
1986). The major regulator of OGDC activity is Ca^^.
Control of PDC activity is m anifested in the control of the 
phosphorylation/dephosphorylation cycle itself. The Mg^+ requiring PDC kinase is 
inhibited by the 2-oxoacid substrates and stimulated by the reaction products (i.e.
NADH, ATP and the acyl CoA), whereas BCDC kinase is insensitive to control by 
the reaction products (Paxton & Harris, 1984). PDC kinase is also inhibited by 
ThDP as a result of binding at the catalytic site of E l and thereby altering the 
conformation about phosphorylation site 1 so that the serine is less accessible to the 
kinase.
Specific kinases of PDC and BCDC are tightly bound to their E2 
components and co-purify with them. The K1 and K2 isoforms of E l kinase of 
PDC as well as the kinase component of the BCDC bind to the inner lipoyl domain 
region of E2. Interestingly, in preparations of bovine PDC, as few as 1 molecule
of kinase are bound to the E2 core but a large number of E l (20-30 E l tetramers)
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can be rapidly phosphorylated. This has been explained by evidence suggesting^ 
efficient transfer of the kinase between the lipoyl domains of different E2 
components in the core (Ono et a i, 1993). While Stepp et a i  (1983) suggested that 
the PDC kinase was a heterodimer, there is very little evidence for this conclusion.
The K1 subunit can bind to E2 and function as a kinase alone. However, patterns 
in native gel electrophoresis are consistent with the following dimer forms for two 
kinase subunits - [K l]2, [K1K2] and [K2]2 (see Roche et a l  (1996) for review).
Such a dimer state would help explain movement at the surface of the E2 core by a
Î
“hand over hand” mechanism involving continuous partial dissociation by one 
subunit followed by interchange to another lipoyl domain (Liu et a l,  1995).
The BCDC and PDC kinase genes have been cloned from rat liver and heart 
cDNA libraries (Popov et al., 1992; Popov et al., 1993; Popov et al., 1994) and 
surprisingly they did not reveal significant sequence similarity with any known 
eukaryotic serine or threonine protein kinase. However, considerable sequence 
similarity exists between the kinase for BCDC and PDC and the prokaryotic family 
of histidine protein kinases. This work established a new family of mitochondrial 
protein kinases in eukaryotes.
Much less is known about the complex-specific phosphatases. They are 
known to be less tightly bound to the complexes and can be purified as separate 
enzymes. PDC phosphatase consists of two subunits of Mr 97 000 and 50 000, 
with catalytic activity residing in the smaller subunit. The significance of the FAD 
molecule in the larger subunit is unclear (Teague et al., 1982). The enzyme 
requires Mg^ "*" for activity and is stimulated by Ca^+ ions which reduce the Km for 
Mg2+ and its E l substrate (Pettit et al., 1972; Reed & Yeaman, 1987). It has been 
proposed that the phosphatase has one intrinsic Ca^+ binding site and a second one 
is generated when the phosphatase is complexed with E2. It is not known whether 
the second site is present on the phosphatase or on E2 but it may facilitate Mg2+ 
dependent dephosphorylation by positioning the phosphatase and phosphorylated 
E l favourably on E2. The other effectors of phosphatase activity are NADH, 
which inhibits phosphatase activity and the polyamine, spenuine, which stimulates 
by lowering the Km for Mg^+ (Roche et al., 1989). Effectors of PDC kinase and 
phosphatase are shown in Fig. 1.7.
Acute control of mammalian complexes by hormones has been studied 
extensively. The effects of adrenaline in the heart and vasopressin in the liver are 
mediated by increased Ca^"  ^ levels in the cytosol and hence in the mitochondrial 
matrix. Direct binding of Ca^+ to the OGDC causes allosteric activation by 
reducing the Km for its substrate, 2-oxoglutarate (McCormack & Denton, 1979).
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Fig. 1.7: Schematic representation of the covalent modification of 
pyruvate dehydrogenase and its control by effectors
Reproduced from Sugden and Hoiness (1994).
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This is antagonised by ATP which increases the Km for the substrate. PDC is also 
activated by Ca '^'* in vitro, but by a different mechanism. In this case it appears that 
Ca^"  ^stimulates the phosphatase by the mechanisms described above (Denton & 
McCormack, 1985). Insulin is known to promote the dephosphorylation of PDC, 
enhancing its activity in adipose tissue. The second messenger activating the 
phosphatase has not been verified since Marshall et al. (1984) showed that the 
effects of insulin were insensitive to Ca^+ concentrations. BCDC is insensitive to 
Ca^+ levels and there is a lack of evidence for hormonal control of this complex. A 
major mechanism for acute control of BCDC is via inhibition of BCDC kinase by 
the 2-oxoacid substrates (Jones & Yeaman, 1986) and high circulating levels of the 
2-oxoacids in animals fed a high protein diet are likely to inhibit the kinase, 
maintaining the complex in its active form.
I
"•I'1.5 Disease States Associated with the 2-Oxoacid
Dehydrogenase Complexes
As the 2-oxoacid dehydrogenase complexes play a central role in 
metabolism, genetic defects in the PDC and BCDC result in metabolic aberrations 
causing a build up of toxic levels of their substrates. The availability of the gene 
sequences for most of the subunits and knowledge about their gene structure,
■I
organisation and regulation have facilitated the identification of inherited disorders 
of PDC and BCDC metabolism at the genetic level in recent years.
Human PDC deficiency is a potentially severe inborn error of oxidative 
metabolism. Owing to the multisubunit structure of PDC, a variety of genetic 
defects are possible. Heterogeneity in PDC deficiency has been shown to occur at 
both protein and mRNA levels. In almost all cases, the basic defect appears to be in 
the E l component, and in particular E l a  (Ho et al., 1989). However, there are 
cases resulting from defects of E2, E3 or protein X (Marsac et al., 1993; Robinson 
et al., 1990). Characteristic features are metabolic acidosis and neurological 
disorders, distinguished by significant structural abnormalities of the central
nervous system. There is a wide range of severity of symptoms, beginning with 
severe lethal lactic acidosis developing a few hours after birth to a mild form with 
no significant acidosis. All forms of PDC deficiency present with neurological 
disorders (Brown et al., 1989) ), largely resulting from the dependence of the brain 
on glucose oxidation for energy production..
Inherited disorders of BCDC, described over 30 years ago, lead to maple 
syrup mine disease (MSUD). This disease is chai'acterised by large increases in the 
concentration of branched-chain amino acids and their respective 2-oxoacids in the 
blood, tissues and urine (Patel & Harris, 1995). Again, there are varying degrees 
of severity of this disease, from physical and mental impairment and early death to a 
milder form later in life. The genetic lesions are more heterogeneous than with 
PDC errors as defects involve any of the subunits of BCDC.
Primary biliary cirrhosis (PBC) is a chronic autoimmune disease of the liver 
in which the epithelial cells of the small bile duct are destroyed by inflammation, 
leading to liver cell damage and cirrhosis (Kaplan, 1987; Yeaman et al., 1989). In 
Europe it is the commonest indication for liver transplantation. PBC is 
characterised by the presence of circulating autoantibodies targeted against 
mitochondrial antigens, mainly located on the inner mitochondrial membrane. 
PBC-specific mitochondrial autoantigens have been characterised (Berg & Klein, 
1988), with antibodies to one (M2a antigen) predominating in 85-95% of patients 
with PBC. The predicted protein sequence from the M2a cDNA (Coppel et al., 
1988) and imraunoblotting the sera from PBC patients with purified E2 protein 
identified the autoantigen as E2 of mammalian PDC. The majority of the serum 
samples (95%) were found to cross-react positively with PDC E2 (Yeaman et al.,
1988). Subsequently it was found that component X from PDC, E2 from OGDC 
and BCDC (Fussey et al., 1988) and E la  and El(3 from PDC (Fregeau et al.,
1989) all cross reacted with antisera from PBC patients. However, the E2 
component is the main autoantigen and the epitope has been mapped to the inner 
lipoyl domain of the molecule (Surh et al., 1990). The mechanism of how
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■autoantibodies in PBC sera are generated against intracellular mitochondrial 
antigens and why target tissues ai-e limited to the bile ducts of the liver are largely 
unknown. Furthermore, the role of these autoantibodies in the pathogenesis of 
PBC and the fine specificity of the antibodies specific to PDC E2 is still unclear 
(Gershwin & Mackay, 1991).
1.6 Plant 2-Oxoacid Dehydrogenase Complexes
fresh weight of tissue. A frequently cited example is the purification of a mere Img 
of mitochondrial PDC from 500 kg of broccoli florets (Rubin & Randall, 1977). 
Investigations of the plant complexes not only enhances the overall knowledge of 
the 2-oxoacid dehydrogenases, but also provides a comparison of the metabolic 
processes between animals and plants. Considerable metabolic similarities exist 
between plants and animals; however, the different anatomy, physiology and 
organismal requirements have led to an interesting diversity between these two
It is apparent from the evidence presented above, that a vast amount of
knowledge has been gained on the 2-oxoacid dehydrogenases from a variety of 
prokaryotic and eukaryotic sources. In stark contrast, little information is available 
on the equivalent plant complexes, owing to the low abundance of mitochondria per
classes of eukaryotes. PDC in plant cells illustrates both the similarities in 
metabolic processes and the differences dictated by the need to respond to diverse
iexternal stimuli (Randall et al., 1989). Uniquely plants contain two distinct and spacially separate PDCs, one located in the mitochondrial matrix and the other in the 
plastid stroma. Each PDC isoform has its own structural, catalyic and regulatory 
properties (Miernyk et a l, 1985).
A main characteristic of plant cells is the greater complexity of subcellular 
organisation in comparison to animal cells. Fig. 1.9 illustrates the interaction of 
metabolic pathways found in chloroplasts, peroxisomes and mitochondria of plant 
cells. All de novo fatty acid and the latter steps in isoprenoid biosynthesis by plant 
cells occurs within the plastids (Ohlrogge et a l ,  1979), and as such a separate
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glycolytic pathway exists in plastids for the production of acetyl CoA for this 
process (Dennis & Miemyk, 1982). Examples of plastids are chloroplasts in light- 
grown leaves, chromoplasts in fruits and floral tissues and the leucoplasts and 
amyloplasts in seeds and other non-gi*een tissues. A second, classical glycolytic 
pathway is found in the cytoplasm of plant cells. Another feature, unique to plant 
cells, is the existence of two separate systems for electron transport-coupled to 
synthesis of ATP. One is oxidative phosphorylation in mitochondria, operative in 
the dark and photophosphorylation in chloroplasts, operative in the light. 
Mitochondrial PDC occupies an ideal position for regulation of carbon flow into the 
TCA cycle during photosynthesis (Randall et ah, 1989).
The following discussion will centre around PDC, since it is the only 
complex from plants to have been purified and characterised. Of the components, 
E3 has received a great deal of attention in our laboratory, with its purification to 
homogeneity from a variety of plants and the cloning and sequencing of the 
mitochondrial gene from potato leaves presented in this thesis.
1 .7  Plant Mitochondrial PDC
Mitochondrial PDC serves as an entry point for caibon into the TCA cycle. 
Based upon sedimentation analysis, mitochondrial PDCs are large aggregates, 
similar to their mammalian counterparts (Rubin & Randall, 1977). Kinetic 
characterisation of the purified PDC from broccoli florets found that cofactor 
requirements (NAD+, ThDP, CoA, Mg^+ and Ca^+) were similar to that of E. coli 
and yeast. Initial analysis of pea mitochondrial PDC by western blotting with 
antibodies raised against PDC from broccoli florets (Rubin & Randall, 1977) 
revealed subunits of Mr 97 700, 67 400, 58 100, 43 300 and 37 000 (Camp & 
Randall, 1985). The 58 100 Da subunit seemed to be E3 since it also cross reacted 
with anti-porcine E3 and the 43 300 and 37 000 Da species conesponded to E la  
and p, respectively. Further analysis of pea mitochondrial PDC was carried out by 
Taylor et al. (1992) using antibodies to specific components of bovine heart PDC.
30
There was no appreciable cross reaction with mammalian anti-El; however, it did 
cross-react with yeast anti-El, highlighting a band of 41 000 Da, which is thought 
to be E la . This corresponds to the 43 300 Da polypeptide identified by Camp et 
al. (1988) and Luethy et aL (1995) who used a monoclonal antibody to maize E la . 
The anti-bovine E2 cross reacted with a 50 000 Da polypeptide which is lower than 
mammalian E2 (70 000 Da) but similar in size to the yeast protein and is consistent 
with the presence of a single lipoyl domain (Taylor et a i,  1992). However, recent 
immunological blotting of E2 expressed from a clone isolated from Arabidopsis 
thaliania found that its Mr was close to 80 kDa and suggested that the 50 kDa band 
may represent protein X (Guan et aL, 1995). E3 was thought to be a 67 000 Da 
species but since this work was carried out, purified pea mitochondrial E3 has been 
shown to be 58 000 Da (Conner et a i ,  1996). This is in close agreement with 
previously reported values (Bourguignon et al., 1992; Turner et al., 1992).
In recent years, the PDC E l a  gene (Luethy et al., 1995), the E ip  gene 
(Luethy et al., 1994) and the E2 gene (Guan et al., 1995) have been cloned from 
Arabidopsis thaliana and have revealed the high sequence homologies between 
plants and other eukaryotes and prokaryotes. A common feature of all these genes 
is the presence of a mitochondrial targeting pre-sequence. E l a  gene has an open 
reading frame of 1176 bp, encoding a protein of 389 amino acids. Overall 
homology with other eukaryotic E l a  sequences falls within the range of 47-51% 
identity and 63-69% sequence similarity. The sequence surrounding the ThDP 
binding site and phosphorylation sites 1 and 2 are highly conserved; however, a 
serine is replaced by a threonine at site 2. The E lp  gene has an open reading frame 
of 1230 bp and the deduced amino acid sequence (363) has 65% sequence identity 
with S. cerevisiae E ip . Arabidopsis E2 contains regions which are highly 
homologous to the human and yeast E2 and it appears that the E2 contains two 
lipoyl domains, similar to human E2 (Perham, 1991). The E3 and/or E l binding 
site shows lower sequence identity with human E2.
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1 .7 .1  Regulation of M itochondrial PDC
Since PDC occupies an important branch point of various metabolic routes, 
it is a logical site for regulation. The many layers of regulation of plant 
mitochondrial PDC are very similar to mammalian mechanisms. If the energy
photorespiration when, for example, glycine is converted to serine with 
concomitant production of NADH in C3 plants (Randall et aL, 1990b).
Fine control is mediated through competitive inhibition by the reaction 
products, NADH and acetyl CoA, with inhibition constants in the micromolar range 
(Rubin et aL, 1978). The complex from plants was observed to be more sensitive 
to the in vitro NADH:NAD+ ratio than to the acetyl CoA:CoA ratio (Rubin et aL, 
1978). The possible regulation by ThDP has been suggested because of its very 
rapid dissociation from the broccoli complex.
The suggestion that plant PDCs could be regulated by covalent 
modification, in the same manner as the mammalian PDCs, was put forwai'd with 
the demonstration that PDC could be inactivated in an ATP-dependent manner, and 
subsequently reactivated through a Mg^+-stimulated process (Randall & Rubin,
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The only E3 to be cloned to date is that of pea leaf L-protein from glycine 
decarboxylase (GDC) by Turner et aL (1992) and Bourguignon et al. (1992). The 
gene has a 1503 bp open reading frame, encoding 501 amino acids, with a Mr of 49 
721. The amino acid sequence was found to be highly conserved between human, 
porcine and yeast E3, particularly within the functional domains (FAD- and NAD- 
binding) and the authors predict the pea E3 shares a similar secondary and tertiary 
structure with other E3s. This protein was subsequently found to be the same as 
the E3 for PDC in pea leaf mitochondria using a number of biochemical criteria, 
including precise subunit Mr comparisons using electrospray mass spectrometry 
(Bourguignon et aL, 1996),
demands of the cell could be met by some means other than the TCA cycle, the 
PDC is the site for regulatory mechanisms reducing input into the cycle and 
conserving reduced carbon. Such a condition may exist during photosynthesis and
1977; Rao & Randall, 1980). Phosphorylation was verified by 32p incorporation 
from [32p]ATP of a single subunit of Mr 43 100 (Randall et aL, 1981). This 
subunit was shown to be E l a  by precipitation of the bound radioactivity using 
PDC-specific antibodies (Miernyk et aL, 1985).
The site for phosphorylation appears to be significantly different from that 
of bovine, porcine or yeast PDC since antibodies to a synthetic peptide containing 
phosphorylation sites 1 and 2 of bovine E l a  did not cross react with plant 
mitochondiial or plastid PDC. In addition, the synthetic peptide does not serve as a 
substrate for the plant phosphorylation system unless the serine is substituted for a 
threonine. These data conflict with in situ evidence, which suggests that serine is 
the phosphorylation site (Randall et aL, 1989). Covalent modification has been 
found to be a mechanism used by a host of mitochondrial PDCs, for example 
spinach leaves (Rao & Randall, 1980), pea (Randall et aL, 1981) and the nongreen 
endosperm of developing castor oil seeds (Rapp & Randall, 1980).
The activity of mitochondrial PDC is under steady state control (Budde & 
Randall, 1988b) in which the activity of PDC is dependent upon the ratio of the 
kinase to phosphatase activity. The steady state favours inactivation of the complex 
since in vitro rates of the phosphatase are usually six times lower than the kinase. 
Therefore, it seems that in the absence of effectors the in vivo complex would be 
phosphorylated and inactive all the time (Miernyk & Randall, 1987). Adjustments 
to the steady state are made by inhibiting inactivation and stimulating reactivation 
(Budde et aL, 1988a). Fig. 1.8 provides a model summarising the information 
about the control of reversible phosphorylation of pea leaf mitochondrial PDC.
Plant PDC kinase has been difficult to study due to its low abundance and 
the fact that it dissociates from the complex during purification from pea seedlings 
(Randall et aL, 1989). Thus, all in vitro studies in regulation have used partially 
purified PDC or mitochondrial extracts. In situ experiments, measuring the various 
respiratory states of intact mitochondria from green pea seedlings with the oxygen 
electrode have verified most of the in vitro results and helped to establish that
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Fig. 1.8: Model illustrating effectors of the reversible phosphorylation 
of pea leaf mitochondrial PDC
Reproduced from Leuthy et al. (1996).
reversible phosphorylation of PDC does take place under physiological conditions.
There were some differences in the degree of regulation and order of importance of 
various effectors in situ, compared with the in vitro situation as described in the 
following paragraphs.
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In vitro activity is maximal at pH 7.5, with Mg-ATP the preferred 
phosphoryl donor. The Km for ATP is low (2.5 p.M) in comparison with the Km 
for Mg^+ (3.8 mM), so PDC will always be in the inactive (phosphorylated) state if 
the kinase is not regulated. In contrast to the mammalian PDC and in vitro 
observations of the plant complex, changes in the ATPrADP ratio had no effect on 
the activation state of the complex (Budde & Randall, 1987) in situ, whereas ATP 
added exogenously caused inactivation of PDC. Inactivation lasted until ATP was 
removed by ATP-scavenging with excess glucose and required 20-40 fold less 
Mg2+ (0.5 mM) than was needed for in vitro inactivation. (Budde et aL, 1988a).
This concentration of Mg^+ is found to be physiologically relevant in inhibiting the 
kinase.
The phosphorylation state of PDC is mainly under the control of pyruvate 
concentration. Inhibition of the kinase by pyruvate is uncompetitive with respect to 
ATP (Schuller & Randall, 1989). However, the stimulatory effect of K+ and 
NH4*** ions, reflecting oxidation of glycine, (Schuller & Randall, 1989) seems to 
override the inhibitory effect of pyruvate and ThDP in vitro. The mechanism of 
stimulation by these monovalent ions is to increase the affinity of the kinase for 
ATP (Schuller et al., 1993). Stimulation by NH4+, a product of photorespiratory 
carbon metabolism, provides a mechanism for regulating the citiic acid cycle during 
photosynthesis and will be discussed later under control of PDC by 
photorespiration in the light.
Confusing in vitro observations were made about the effect of acetyl-CoA 
and NADH on kinase activity. As these products inhibit PDC activity, they would 
be expected to stimulate kinase activity; however an inhibition of kinase activity was 
observed. Similarly, citrate inhibition of the kinase (causing PDC to remain active)
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is unexpected since increased citrate levels would indicate a decreased demand for 
acetyl CoA. It is possible that there are alternative uses for citrate and acetyl CoA 
outside the mitochondrion, for example, in fatty acid and isoprenoid synthesis 
which takes place in the chloroplast (Randall et aL, 1989).
The phosphatase requires a divalent cation (Mg^+) for activity, with 
activation by Mg^+>Mn^+>Co^+ having Km values of 3.8, 1.7, and 1.4 mM, 
respectively (Miernyk & Randall, 1987). Interestingly, while the mammalian PDC 
phosphatase is stimulated by Ca^+, the pea enzyme was found to be inhibited in 
vitro by micromolar levels of this ion. This result contradicted the in situ result that 
Ca^+ had no effect on PDC activity (Budde & Randall, 1988b).
1 . 7 , 2  Effect of Light and Photosynthesis on PDC Activity
Protein phosphorylation tends to occur in response to extracellular signals, 
therefore regulation was investigated in planta by Budde and Randall (1990) to 
determine the effect of light on PDC activity. Upon illumination of pea leaves, 
there was a decrease in steady-state mitochondrial PDC activity to 10-20% of the 
levels exhibited by dark adapted leaves, which could be reversed within minutes of 
returning plants to the dark. In experiments where photosynthesis and/or 
photorespiration was chemically inhibited, the light-dependent inactivation of PDC 
was also prevented, indicating that both these processes are essential for regulation 
(Budde & Randall, 1990; Gemel & Randall, 1992). It can be concluded from these
Iexperiments that when mitochondria are able to oxidise substrates other than pyruvate, PDC is quickly inactivated by phosphorylation, conserving carbohydrate 
when the cell is photosynthetically active, (Gemel & Randall, 1992; Randall et aL, 
1990b). An example is the photorespiratory metabolite, glycine, which is the 
preferred substrate for ATP production in mitochondria during illumination and is 
the only photorespiratory intermediate that is metabolised in the mitochondria 
during photosynthesis (Fig. 1.9). PDC inactivation when mitochondria are 
oxidizing glycine reflects the decreased pyruvate levels characteristic of
photosynthetically active tissues, the increased NADH levels due to glycine
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oxidation and increased ATP levels due to oxidative phosphorylation. This 
inactivation would be enhanced by NH4+ ions (by-product of glycine oxidation) on
the kinase. Mitochondrial ATP production is then supported by glycine oxidation 
and conserves carbohydrates that provide pyruvate.
1.8  Plant Plastid PDC
Plastid PDC provides acetyl CoA for lipid, isoprenoid and amino acid 
synthesis and is the only known source of NADH in chloroplasts. This role for 
plastid PDC has been well established in developing castor oil seeds, where large 
quantities of fatty acids are synthesised for storage (Dennis & Mierynk, 1982) and 
in chloroplasts of green tissues for de novo synthesis of fatty acids (Williams & 
Randall, 1979). To date, PDC has been found in plastids isolated from every plant 
source investigated with the exception of the leucoplasts from germinating castor oil 
seeds (Rapp & Randall, 1980). Plastid PDC catalyses the same overall reaction and 
has the same kinetic mechanism as the mitochondrial PDC; however, it is 
structurally different and has higher pH and Mg^+ requirements (Camp & Randall, 
1985). The higher Mg^+ (10 mM) and alkaline pH (pH 8) is in accordance with 
indirect regulation by light/dark transitions.
The complex appears to be less tightly associated than the mitochondrial 
form and the only subunit to be identified was the 58 000 Da E3 component (Camp 
& Randall, 1985). Taylor et aL (1992) carried out an immunological investigation 
into the plastid PDC from pea leaves, using antibodies to specific components of 
bovine heart and yeast PDC. The E l component seemed to be an immunologically 
distinct protein since no cross reaction was observed with the E l antisera. In 
contrast, the pea mitochondrial protein exhibited a band of 41 000 Da. The E2 
polypeptide appeared to be a 50 000 Da protein; however, following the work of 
Guan et a l  (1995) with the pea mitochondrial complexes it may possibly represent 
protein X. The molecular weight is consistent with one lipoyl domain. Mammalian 
E3 antisera cross reacted with a protein of 52 000 Da, smaller than the 58 000 Da
37
identified by Camp and Randall (1985). Organelle specific isoforms of E3 were 
suggested by Taylor et aL (1992) and closer inspection confirmed that this was 
indeed the case. Resolution of total pea leaf extracts on Mono Q ion exchange 
chromatography revealed two peaks of B3 activity. The first was found to 
correspond to mitochondrial E3 with a Mr of 58 000 and the second smaller peak 
was a related plastidic E3 with a Mr of 52 000 (Conner et aL, 1996). Both proteins 
were found to be structurally distinct.
1 . 8 . 1  Regulation Of Plastid PDC
Plastid PDC resembles mitochondrial PDC in that it is subject to 
competitive, end product inhibition by NADH and acetyl CoA. However, a major 
difference between their regulatory mechanism is the lack of reversible 
phosphorylation. In this sense they resemble bacterial complexes (Randall et aL,
1989). Phosphorylation would be counter-productive since fatty acid biosynthesis, 
which is light driven, demands acetyl CoA and NADH. Moreover, ATP is being
Isynthesised at its highest rate by photophosphorylation. The only metabolites |
specifically affecting PDC activity were 50 jiM oleic acid (57% inhibition) and :
palmitic acid (36% stimulation) (Camp et aL, 1988). :i
Evidence suggests that the main form of regulation of plastid PDCs is light- '
dark transition and the changes it brings about in the physical environment. The 
stroma of non-illuminated plastids is at neutral pH and there is a low concentration 
of divalent ions. Upon illumination the pH rises to 8 and the concentrations of free 
Mg^+and Ca^ "** ions increase substantially (Hind er <3/., 1974). Plastidic PDCs are 
well suited to the conditions found within the stroma during illumination. Their Km 
for pyruvate is lowest at pH 8 and greater concentrations of divalent ions (1 mM) 
are required than mitochondrial PDCs (0.4 mM) for maximal activity (Camp &
Randall, 1985). The complex is also relatively insensitive to inhibition by ATP and 
NADPH, which would increase in concentration during illumination (Camp et aL,
1988).
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The source of acetyl CoA for fatty acid biosynthesis has been under debate 
for a number of years. Two pathways exist for the generation of acetyl CoA: 1) 
action of plastid PDC via the decarboxylation of pyruvate; 2) action of acetyl CoA 
synthetase which converts acetate to acetyl CoA. The acetate is proposed to 
originate in the mitochondria, having been converted from acetyl CoA by acetyl 
CoA hydrolase (Zeiher & Randall, 1990). Kang and Rawsthorne (1994) found that 
pyruvate was five times better than acetate as a substrate for fatty acid synthesis in 
plastids from developing embryos of oil seed rape. However, acetate has been 
shown to be a better substrate in other cases (Springer & Heise, 1989). On the 
other hand, malate has been reported to be better than both pyruvate and acetate, but 
malate conversion to fatty acids involves PDC (Smith et aL, 1992). The conclusion 
drawn from these observations was that the species to species variations in 
substrate incorporation into fatty acids may be dependent on the relative levels of 
the various enzymes present in the plastid. For example, castor oil endosperm have 
a higher level of NADP-malic enzyme relative to other plastids allowing for higher 
rates of malate incorporation into fatty acids (Smith et aL, 1992). The levels of 
plastid PDC relative to mitochondrial PDC are also species dependent. In pea 
leaves, 75-90% of the total cellular PDC is mitochondrial (Camp & Randall, 1985), 
whereas in barley leaves 60% of the PDC is plastidic (Kromer et aL, 1994). In 
general plastid PDC is the major source for acetyl CoA, but additional acetyl CoA 
could be supplied by mitochondrial PDC.
1.9  Plant OGDC
OGDC from plants has not been studied as extensively as PDC since its 
activity is masked by high levels of NADH oxidase activity and has proven to be 
impossible to isolate as an intact complex. The E3 component readily dissociates 
from the complex; hence Poulsen and Wedding (1970) reported the isolation of the 
E1/E2 subcomplex from cauliflower. They subsequently obtained intact OGDC 
activity by reconstitution with cauliflower or porcine heart E3. A higher level of
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activity was obtained with the cauliflower E3 in comparison with the porcine E3, 
suggesting that the mode of binding of the two E3s was different. The 
determination of kinetic parameters was carried out using porcine heart E3 because 
of the difficulties encountered in the purification of cauliflower E3 and the inhibition 
of the overall reaction produced by impurities in the purified samples. Direct 
molecular mass measurements were not carried out but a complex with a high Mr 
was suggested by sedimentation analysis and elution of the complex in the void 
volume from a Sephadex G-lOO column. OGDC has only been reported in plant 
mitochondria and this location was confirmed by A. Carmichael in pea (PhD thesis, 
Glasgow University, 1994). However, due to the poor activity of OGDC in plant 
extracts, its presence in other organelles cannot be ruled out.
The reconstituted complex was very similar to bacterial and mammalian 
complexes for the following reasons. It was found to be totally dependent on 2- 
oxoglutarate, CoA, ThDP and NAD+ for activity, with a pH optimum of 6.9, and 
underwent product inhibition with succinyl-CoA. As with mammalian and plant 
PDC, the addition of Mg^+ or Ca^+ ions restored activity of the complex, 
diminished by the addition of 1 p,M EDTA. However, in contrast to mammalian 
PDC but similar to bacterial OGDC, 5 "-AMP is found to be the preferred adenine 
nucleotide for activation by reducing the Km of the enzyme for 2-oxoglutarate, 
causing a 10-fold activation (Wedding & Black, 1971). Craig and Wedding (1980) 
discovered later that this effect was pH dependent and at pH values above 8, 5'- 
AMP inhibited by increasing the Km- The effect of AMP is thought to be in the 
tighter binding of Mg-ThDP to the E l component. In addition, there seems to be an 
interaction in the regulation of OGDC and PDC within plant mitochondria as OGDC 
was shown to be extremely sensitive to pyruvate inhibition (Dry & Wiskich, 1985).
1 .10  Plant BCDC
Gerbling and Gerhardt (1988) demonstrated the presence of BCDC in 
peroxisomes from mung bean hypocotyls. It catalysed, in a CoASH- and NAD-
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dependent reaction, the release of CO2 from branched-chain 2-oxoacids and the 
concomitant formation of NADH and the acyl-CoA, which contains one carbon 
atom less than the substrate. Fatty acid degradation occurs in the peroxisomes of 
plant cells and the substrate in these non-fatty tissues results from the degradation 
of branched chain amino acids (leucine, isoleucine and valine). Intermediates of 
their catabolism are branched-chain 2-oxoacids which are activated by BCDC 
(Gerbling & Gerhardt, 1987). The branched-chain 2-oxoacids are then converted 
to propionyl-CoA by a series of steps, which are then metabolised by modified 13- 
oxidation to acetyl-CoA. The physiological role of peroxisomes has yet to be 
determined, although the analogous organelles, glyoxysomes, in fatty tissue are 
involved in the conversion of lipid to sucrose during germination (Gerbling & 
Gerhardt, 1989).
BCDC has not been purified and so regulatory mechanisms have not been 
determined. A. Carmichael (Ph.D. thesis, Glasgow University, 1994) reported a 
possible BCDC location in pea and potato mitochondria. Therefore, the absence of 
BCDC activity in the past may be due to inactivation of the complex by 
phosphorylation or the developmental synthesis of BCDC.
1 .11  Glycine Decarboxylase (GDC)
GDC is a loosely associated multienzyme complex located in the 
mitochondria which catalyses the oxidative decarboxylation of glycine (Walker & 
Oliver, 1986a). It is pai'ticularly worth mentioning as it has many similarities with 
the 2-oxoacid dehydrogenase complexes. Additionally, the activities of GDC 
determine the regulation of plant PDC in the light, as discussed above.
GDC has been found in plants (Sarojini & Oliver, 1983), animals (Hiraga & 
Kikuchi, 1980) and bacteria (Klein & Sagers, 1966). In mammalian tissues, GDC 
converts glycine derived from protein catabolism into one-carbon fragments that can 
be used in the anabolic functions of the mitochondria and serine that can enter three- 
carbon metabolism and glycolysis (Oliver, 1994). The complex is found at its
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In C3 plants, the flux of carbon through the photorespiratory pathway is 
about equal on a molar basis to the flux through the photosynthetic C3 cycle, thus 
making it a major metabolic pathway in leaves. The conversion of glycine to serine 
in green leaf mitochondria is currently considered to be the major source of CO2 
released during photorespiration (Douce et aL, 1994). The CO2 released is about 
25% o f the amount fixed by Rubisco, and so this pathway decreases the carbon that 
is available to support plant growth. The rate of release is nearly 10 times
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highest levels in the mitochondria of photosynthetic tissue and its physiological 
relevance is that it carries out a key step in photorespiration. The photorespiratory 
cycle diverges from the photosynthetic carbon fixation reactions with the 
oxygenation of ribulose 1,5-bisphosphate by the oxygenase reaction of ribulose- 
1,5-bisphosphate carboxylase/ oxygenase (Rubisco) in the chloroplast (Husic et aL,
1987). The recycling of the phosphoglycolate into 3-phosphoglycerate for the 
Calvin cycle proceeds in leaf cells via a long chain of reactions in which O2 and 
ATP are consumed while CO2 is released and spans three different organelles (Fig,
1.9). The product of the reaction, phosphoglycolate, is hydrolysed to glycolate and 
converted to glycine by transamination in the peroxisome. Glycine enters the 
mitochondria where it is cleaved by GDC to CO2, NH3 and ,Nl^-methylene- 
THF with the reduction of NAD+ to NADH. The latter compound reacts with a 
second molecule of glycine to form serine in a reaction catalysed by serine 
hydroxymethyltransferase (SHMT). Serine then returns to the peroxisomes where
it is converted to glycerate for re-entry to the chloroplast. Ribulose 1,5-
'bisphosphate is regenerated from the glycerate via glycerate 3-phosphate.
1) GDC: glycine 4- NAD+ + T H F > methylene-THF + CO2 + NH4+ + NADH
2) SHMT: glycine + methylene-THF+ H2O ---- > serine + THF
overall reaction: 2 glycine + NAD'*' > serine + CO2 + NH4+
: :
Fatty
AddsCalvin cycle
DCMU3-PGA
?V ^A cÆ 0A 
I PDC
NADPH 
ATPRuBP P-Glycolate
Pyruvate
AGlycolate
GlycerateGlycolate
^ hpms 
Glyoxylate OH-Pyruvate
Pyruvate
Glydne Senne
Glycine GDC Serine Pyruvate Malate
AO-
Ac-CoA OAA
MalateCitric acid cycle
Citrate
Fig. 1.9: Interactions of the photosynthetic, photorespiratory and citric acid 
cycles
Not all the intermediates are shown and stoichiometry has not been maintained. 
GDC: Glycine decarboxylase complex, PDC: Pyruvate dehydrogenase 
complex. The photorespiratory cycle takes place in all three organelles. 
Reproduced from Leuthy et aL ( 1996).
higher than the rate of primary NH4+ fixation, and the released must be re­
cycled with good efficiency to prevent the loss of nitrogen (Oliver, 1994). 
Although the NADH produced is available to the mitochondrial electron transport 
chain, the photorespiiatory cycle results in net energy consumption
The reaction carried out by GDC requires the sequential action of four 
enzymes: 1) P-protein (97 kDa homodimer): a pyridoxal 5-phosphate (PLP)~ 
dependent amino acid decarboxylase; 2) H-protein (13.9 kDa monomer): a carrier 
protein with a bound lipoamide cofactor; 3) T-protein (45 kDa monomer): a 
tetrahydrofolate (THF) transferase; 4) L-protein (50 kDa homodimer): a 
flavoprotein dihydrolipoamide dehydrogenase. The reaction, shown in Fig. 1.10, 
begins with the a-amino group of glycine forming a Schiff base with pyridoxal 5- 
phosphate at the active site of the P-protein. The lipoamide containing H-protein 
reacts with glycine bound to the P-protein to form a methylamine-H-protein 
intermediate. During the reaction the a-carboxyl of glycine is lost as CO2. The T- 
protein catalyses the transfer of the carbon of the methylamine group to 
teü'ahydrofolate (THF), with the formation of N^,N 10-methylene-THF and the 
release of the amino group of glycine as NH3. The reduced lipoamide from the H- 
protein, resulting from this transfer migrates to the active site of L-protein and 
where it is reoxidised back to lipoamide with the sequential reduction of FAD and 
NAD+.
The dihydrolipoamide acyltransferase function of E2 has been divided 
between the H-protein and the T-protein of GDC. The long flexible arm of the 
lipoamide attached to a lysine residue of H-protein moves reaction intermediates and 
reducing equivalents between the reactive sites located on the other three subunits of 
the complex in a similar manner to E2 (Walker & Oliver, 1986a). The transferase 
domain is located in T-protein and is a tetrahydrofolate-based methyltransferase 
instead of the CoASH-dependent acyl transferase used by PDC, OGDC and 
BCDC. L-protein is the only component to be involved with other complexes
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THF
T"protein
COg FADPLP
NADHP-protein L-protein
lADCOON FADH
H -  C  -  NH
H
Fig. 1.10: The reaction mechanism of glycine decarboxylase multienzyme 
complex
The GDC reaction requires all four component proteins of the multienzyme complex. 
The lipoamide cofactor on the H-protein cai'ries reaction intermediates between the 
reactive sites of the P-protein, T-protein and L-protein.
Reproduced from Oliver (1994).
(PDC and OGDC) in pea leaves and is encoded by a single gene (Bourguignon et 
al., 1992; Bourguignon et al., 1996).
Mitochondria isolated from etiolated pea shoots and potato tubers oxidise 
glycine poorly, whereas mitochondria from green leaves show rapid rates of 
glycine oxidation (Oliver, 1994). GDC is present at a very high concentration in 
plant mitochondria, where it comprises 30-50% of the soluble proteins present in 
the matrix (Oliver et al., 1990). This is necessary to cope with the rapid glycine 
release during the course of photorespiration which can be as much as 50% of the 
photosynthetic rate and ten times the rate of the TCA cycle (Douce et al., 1994). 
This is in contrast with mammalian mitochondria where GDC represents a minor 
fraction of the total matrix protein. The high protein concentration influences the 
formation of a loose multienzyme complex in pea leaf mitochondria with an 
approximate subunit ratio of 2 P-dimers:27 H-protein monomers: 9 T-protein 
monomers: 1 L-protein dimer (Oliver et al., 1990). Upon dilution the complex 
tends to dissociate into its component enzymes. This has precluded purification of 
the intact complex by gel filtration or ultracentrifugation. The only method that 
yields intact complex is the isolation of the separate enzymes followed by 
reconstitution in vitro (Bourguignon et a l, 1988; Walker & Oliver, 1986a)
As with other photosynthetic and photorespiratory enzymes, the synthesis 
of GDC is light dependent. The component enzymes are present in low amounts in 
etiolated leaves and increases dramatically (about 10-fold) upon exposure to ligh^ 
(Walker & Oliver, 1986b). The increase in activity results from de novo protein 
synthesis, largely regulated at the transcriptional level (Kim & Oliver, 1990; 
Bourguignon et al., 1988). Day et al. (1985) and Bourguignon et al. (1988) have 
shown that this accumulation led to an increase in the density of mitochondria on 
PercoU gradients. There is also evidence for spatial regulation in the expression of 
GDC activity. In spinach, GDC is abundant in mitochondria from photosynthetic 
tissues whereas it is expressed at much lower levels in the mitochondria of roots, 
stalks and leaf veins (Gardestrom et al., 1980)
46
GDC is subject to feedback inhibition by the products of the reaction, 
NADH and serine (Bourguignon et aL, 1988) . However this is prevented by 
unique substrate transporters in plant mitochondria. NADH is shuttled out of the 
mitochondria by an oxaloacetic acid/malate transporter in conjunction with malate 
dehydrogenase activity in the matrix and cytosol (Oliver & Walker, 1984). 
Glycine/ serine exchange proteins in the inner mitochondrial membrane prevent 
inhibition by serine.
1 .12  Aims of this Thesis
As discussed earlier, E3 is a single gene product in the mammalian and pea 
2-oxoacid dehydrogenase complexes. Evidence in prokaryotes for complex 
specific isoforms and for isoforms unrelated to any complexes has been increasing 
in recent years, dispelling the idea that E3 is a single gene product in all organisms. 
The primary aim was to investigate the possible complex specific roles of three E3 
isoforms, termed Œ2, a p  and p2, discovered in potato tuber mitochondria by 
Fullerton et al, (1996). The idea was based on previous work which suggested 
tissue specific expression of the isoforms. The 0 ,2  form was found to predominate 
in leaf mitochondria where GDC is the major complex and the p2 form was found 
in greater amounts in tuber mitochondria and was postulated to be specific for PDC 
and OGDC. A complex specific role of the three isoforms from potato 
mitochondria seemed more plausible with the discovery of an organelle specific E3 
isoform in chloroplasts.
Initially, complex specificity was to be addressed by determining if any of 
the potato E3 isoforms preferentially restored intact complex activity to plant and 
mammalian OGDC E1/E2 subcomplexes which had been stripped of their native E3 
components. The results of these experiments were to be compared with similar 
experiments carried out on PDC and GDC by others. Prior to the reconstitution 
experiments being carried out, the yield of the three potato isoforms obtained by the 
existing purification procedure required improvement.
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The latter approach employed was the cloning and expression of the potato 
E3 gene(s) in order to determine the relationship between the a  and p polypeptides. 
The added significance of this work was that the E3 gene(s) from potato would 
represent only the second to be cloned from a plant source to date.
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Chapter 2
iMaterials and Methods
la
a
I
2 .1  Materials
2 . 1 . 1  Plants
Potato tubers {Solatium tuberosum, cv. Maris Piper) were puichased from 
Glasgow Fruit Market.
Eschenchia coli DHSa; a recombination deficient, suppressing strain 
for the propagation of plasmid DNA.
Genotype: supEAA- A/acf/169 ({()80 lacZtsMlS) hsdR ll recAl endAl gyrA96 thi- 
1 relAl (Hanahan, 1983).
2 . 1 . 2  Anim als
Bovine hearts were obtained from Paisley Abbatoir, Sandy ford Road, 
Paisley. New Zealand White Rabbits for antisera production were bought at 3 
months old from MRC accredited resources.
2 .1 .3  cDNA L ib rary
The potato leaf cDNA library was a kind gift of Dr. H. Hesse, Max 
Planck Institute for Plant Molecular Physiology, Golm, Germany. It was made 
using the Uni-ZAP XR vector kit containing Lambda ZAP H, a lambda insertion 
type cDNA cloning vector (Stratagene, USA).
2 . 1 . 4  Bacterial and Bacteriophage Strains
Escherichia coli X Ll-B lue M RF (Stratagene Ltd., Cambridge): a 
restriction and recombination deficient host strain for propagating plasmid DNA,
'■I
plating Lambda ZAP II cDNA libraries and double-stranded sequencing.
Genotype: A(mcM)183, A{mcrCB-hsdSMR-mrr) 173, endA l, supE44, thi- 1 
recA l, gyrA96, relA l, Lac [F'proAB, lacN ZAM lS, TnIO(tetO] (Bullock et aL,
1987)
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Escherichia coli B L21(D E 3) (Novagen, USA): employed for the 
high level expression of genes cloned into expression vectors containing the 
bacteriophage T7 promoter.
Genotype: hsdS gal (Kclts%51 indl Sam i ninS lacUV5~Tl gene 1) (Studier & 
Moffatt, 1986)
Escherichia coli S O L R  (Stratgene Ltd, Cambridge): a non­
suppressing strain used with VCSM13 helper phage (Stratagene Ltd, Cambridge) 
for the in vivo excision of Bluescript SK- from Lambda ZAP II vectors. 
G enotype: SOLR: el4-(m cM ) AimcrCB-hsdSM R-mr^) 171 sbcC recJ uvrC 
umuC :: Tn5(kanO lac gyrA96 relAl thi~l endAl [F'proAB la c î^A M lS ]  Su" 
(Hay & Short, 1992)
2 .1 .5  P lasm id Vectors
The vectors used for cloning in this thesis are tabulated below and 
presented Figs. 2.1 and 2.2. The maps of pBluescript SK +/- (Fig. 2.3) and 
Lambda ZAP II (Fig. 2.4) are presented for reference.
Name Characteristics Purpose
pBluescript II Ampicillin resistance. General cloning vector
KS + Lac Z gene for blue/white colour
(Stratagene) selection.
F" origin of replication for single- 
strand rescue by helper phage. 
M l3 forward and reverse primer 
sites for sequencing.
pET28c Kanamycin resistance. Heterologous expression
(Novagen) Ribosome-binding site and initiating 
codon for translation.
Histidine tag.
of foreign genes in E. coli
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pEr-28a-c(-f ) Vectors
T he pET-28a-c(+) vecto rs carry  an  N-tenrunal His*Tag*/throtnbuvT7»Tag* configuration plus 
an  o p tiona l C-term inal His«Tag sequence. Unique s ites  a re  showm on  tlie c ircle m ap. Note tha t the 
seq u en ce  is n um bered  by  th e  pBR322 convention, so  the T7 ex p ress io n  region is reversed  on  the 
c irc u la r  m ap. T he  c lom ng/expression  region o f the  coding s tra n d  tran sc rib ed  by  T7 RNA po ly ­
m erase  is show n below . T he f l  origin is orien ted  so  th a t in fec tion  w ith h e lper ph ag e  will p ro d u ce  
v in o n s  co n ta in ing  single-stranded DNA that co rresponds to  the  cod ing  strand . T herefore , single- 
s tra n d e d  sequencing  shou ld  b e  perfo rm ed  using the T7 te rm in a to r  prim er.
pCT-2ta(+)
T7 p ro m o te r  370-386
T7 tra n sc rip tio n  s ta r t  369
H is 'T a g  c o d in g  seq u en ce  270-287
T7«Tag c o d in g  seq u en ce  207-239
M ultiple c lo n in g  s ites  
(B a m H l-X h o ï)  158-203
H is 'T a g  co d in g  seq u en ce  140-157
T7 te rm in a to r  26-72
la d  cod ing  seq u en ce  773-1852
p8R 322 orig in  3286
Kan cod ing  seq u en ce  3995-4807
fl orig in  4903-5358
The m ap s fo r  pET-28b(+) an d  pET-28c(+) 
are  th e  s a m e  a s  pET-28a(-t-) (show n) w ith  
th e  follow ing excep tions; pET-28b(+) is a  
5368bp p lasm id ; su b tra c t Ib p  from  e ach  s ite  
beyond Bam H  I a t  198. pE T -28c(+ ) is a  
5367bp p lasm id ; su b tra c t 2bp  from  e ach  s ite  
beyond B am H  1 a t  198.
Xho I(15S)E»gl<i6SiNot 1(166)
H ind  111(173)Sal 1(179)
Sac 1(190)ECOR 1(192)Bam H  1(190)Nhe 1(231)
N d e  1(23®)Nco 1(296)Dra 111(5127)
3gl 11(401)*903-5358) SgrA 1(442)
Sph 1(590)
PVU 1(4426)
Sgl 1(4426)
pET-28a(+)
(5369bp)
Sm a 1(4300)
Cla 1(4117) J j 1? 
Nai 1(4083)
Eco57 1(3772)
AlwN 1(3640)
Bsi 1(3397)
BspLUII 1(3224)
Sap 1(3108)
Bst1107 1(2995)T th i11 K23S9)
BspG 1(2750)
ApaB 1(8071
.  , 1 ^ 8 0  1(11371
BsiE '1.1704' 
CO i I iB m g  1(1332) - h  I  ‘' A p S  1( 1334)
/p /B ssH  1(1534) 
/  /E C 0 P V (1 5 7 3 )  
/  /  7 H p a  (16291
P sh A  1(1968: 
P ill  1 0 8  1(2010' 
1(2187)
F sp  1(2205)
Psp5 11(2230)
p E T  u p n r a 4 ir> p tm s r  #69214-1——►_gaUL
T7 protno(« pnmw #69348-1 -►
AGATCTCGHTCCCGCŒAAATTAATACGACTCACTATAOGOCAATTCTOACtGSATAACdATTCCCCICTAGAAATAATTrrOTTTAACTr-AAGAASO*!:*
Atari HiyTmg AW.I_ WHai T 7 .T w
TATACCATGGGtAGCAGCtATCATCATCATCATCACAGCAGCGGCCTGGIGCCGCGCGCCAGCCATATGOCTAGCATGACTCGTGGACAGtAA 
MetG lySerS«rH l sMI #H ) ïHi *H) tH nSgrSerG I yLptfKo t ProAr-qG ly S c r ll i »M#1A t aOcrilct TAcGl yG ) yG I - I . n 
Eag I th rom bin
— -  ■'B*nH I Cconi S a r i 53/1 Htarill Won Xhot_______
ArGGGTCGCGGATCCGAATTCGAGCTGCCICCACAAGGTTGCGGCCGtACTCGAGCACCACCACCACCACCACtGACArCCCGCTGCriArAAAGCC: D E r- 2 8 a ( - l
M etG tv A r 9 G iv S cr 1 3 lu P ft« G li4 L eu A r g A rg C ln A la C y iC ly A rg T h rA r g A lQ f'ro P r o P r o fro P r o L cu A rg S er G ly C y sE '’C
.GCTCGGGATCCGAATTCCACCTCZGTCCACAAGCTTGCGCCCGCACTCGAGCACCACCACCACCACCACTGACATCCGGCTGCTAACiAiCCC: peT-2ab{-). C I yArgAfpProA*nS«rS«rS»r*Vot A«pLy*LtMA (oAl oA lot.*uGI uHi sH t sH i sHi sHl xKi «End
CGrcSGATCCCAATTCGACCTCCGTCGACAAGCTTCCGCCCGCACTCGACCACCACCACCACCAC:ACTGAGATCCGGCTGCTAA:AiA3CC: bET-28cl'fCI yArgTTYArgf t eArqA I oProSerrhrSgrLeuArgProH i $SerS*rThr ThrThrThrThrThrGI ul I eArqLeuLeuThr.vsPro__________ _ _
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2 .1 .6  C hem icals
The following reagents were obtained from Sigma Chemical Co., Poole, 
D orset, UK: substrates and coenzym es for enzym atic  assays,
phenylmethylsulphonyl fluoride (PMSF), benzamidine-HCl, Coomassie Brilliant 
Blue type R250, antifoam A concentrate, Percoll, thio-octic acid amide, 3-(N~ 
Morpholino) propane-sulphonic acid (MOPS), polyvinylpyiTolidone (PVP), N- 
tris[hydi*oxymethyl]-methyl"2-aminoethane-sulphonic acid (TES), L-ascorbic acid 
and diethyl pyrocarbonate (DEPC).
Polyethylene glycol 6000 grade, Triton X -100 and Tris-buffered phenol 
were obtained from Fisons, Loughborough, England. Pyronin Y dye was obtained 
from George T. Gurr Ltd., London. Folin and Ciocalteu’s phenol reagent was 
from FS A Laboratory supplies, Loughborough, England. 2-Mercaptoethanol was 
purchased from Prolabo, Paris, France, Leupeptin was from the Marketing 
Association, Herts, England. DTT was obtained from Boehringer Mannheim 
GmbH, Germany. CTAB, sarcosyl and guanidine thiocyanate were from Fluka, 
Germany. Growth media for bacterial cultures were purchased from 
Mikrobiologie. All other chemicals including reagents for SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) were of Analar grade from BDH Chemicals Ltd., 
Poole, UK. or were of the highest grade commercially available.
2 .1 .7  E nzym es
Bovine serum albumin (BSA), protein A (Staphylococcus aureus, Cowan 
1 strain), dihydrolipoamide dehydrogenase from porcine heart, bovine mucosa and 
yeast were obtained from Sigma Chemical Co., Poole, Dorset.
DNA restriction enzymes, DNA ligase, calf intestinal alkaline 
phosphatase, proteinase K, Pfu and Tag polymerases were supplied by Promega 
Ltd., Southampton or Boehringer Mannheim Ltd., Lewes, UK.
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2 . 1 . 8  Molecular Size and Weight Markers
Low molecular weight marker proteins for determinations by SDS-
2 . 1 . 9  Synthetic Oligonucleotides
PAGE were purchased from Pharmacia Ltd., Milton Keynes. The standards 
comprised phosphorylase b (Mr 94 000), albumin (M^ 67 000), ovalbumin (Mr 43
000), carbonic anhydrase (Mr 31 000), soya bean trypsin inhibitor (Mr 20 100) and 
lysozyme (Mr 14 000). The following standards were used as size markers for the 
analysis of nucleic acids by gel electrophoresis:
1
100 bp ladder (GIBCO/BRL)
RNA ladder (GIBCO/BRL)
DRIgest lll,X  DNA-H indliy^X~l74  RF DNA-HaeTll digest (Pharmacia)
Synthetic oligonuleotides for PCR were made in the Division of
Biochemistry and Molecular Biology by Dr. V. Math, using an Applied Bio systems 
381A DNA synthesiser for the phosphite-tiiester method.
M l3 Universal and M l3 Reverse primers were purchased from Pharmacia 
Ltd., Milton Keynes, England.
2.1.10 Photographic Materials
The X-Omat“ 100 processor and X-Omat S film was obtained from Kodak 
Ltd., Dallimore Road, Manchester, England. High performance Hyperfilm-ECL 
was supplied by Amers ham International, Bucks, UK.
2.1.11  M iscellaneous 
FPLC columns, gel chromatography materials and CNBr-activated
Sepharose 4B were purchased from Pharmacia Ltd., M ilton Keynes. 
Nitrocellulose filters (0.22|rm) and sterile Millex-gv syringe filters were from 
Millipore S.A., Molsheim, France. Rat serum, Freund’s complete and incomplete 
adjuvant were obtained from Sigma Chemical Co., Poole, Dorset. Hybond-C 
extra, Hybond N+, the ECL iramuno blotting kit and [a-^^Pj-dCTP (3000
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Ci/mmol) were bought from Amersham International, Bucks., U.K. Non-immune 
donkey serum was supplied by the Scottish Antibody Production Unit (SAPU), 
Lanarkshire, Scotland. The Micro BCA assay kit was obtained from Pierce, 
Illinois, USA. Plast-X autoradiography cassettes were from Anthony Monk 
(England) Ltd., Sutton-in-Ashfield, U.K. Centricon-10, 30 and Centriprep-10 and 
30 concentrators were bought from Amicon Ltd., Stonehouse, Gloucestershire. 
Chromaspin-30 and 100, equilibrated in TE were purchased from Clonetech, USA.
2 .2  Methods
2 . 2 . 1  Growth of Plants
Potato tubers were allowed to sprout by storing in the dark, at room 
temperature, for approx. two weeks. Sprouts were removed with approx. 3-4 cm 
of tuber tissue, planted in pots of compost and grown at 200 mE.m-2.s-l, in a 
growth chamber with a 12 h photoperiod (22°C light/18°C dark). After the primary 
leaves had emerged the plants were re-potted and leaf tissue was collected for 
harvesting approx. 3 weeks later.
2 . 2 . 2  Determination of Protein Concentration
Protein concentrations were determined by the method of Lowry et al. 
(1951), modified by Markwell et at. (1976). For very low protein concentrations 
(0.5 p.g.ml-1 - 20 jig.mpl) the Micro BCA Assay was used. Protein standards 
were constructed with bovine serum albumin and absorbances were read at 660 nm 
and 562 nm respectively.
2 . 2 . 3  Dialysis of Samples
Dialysis was carried out in Visking Tubing at 4°C, with enough buffer 
changes to dilute out salts or exchange buffers. The tubing was pre-treated by 
boiling for 5 min in 1 mM EDTA (pH 8.0) and 10 mM sodium bicarbonate. It was
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Screw cap. Oak Ridge centrifuge tubes (PPCO) were from Nalgene, USA.
■
then rinsed and boiled in distilled water for a further 5 min and stored in 100% 
ethanol.
2 . 2 . 4  Concentration of samples
Protein samples were concentrated in dialysis tubing by covering with dry 
poly(ethylene glycol) (PEG 6000) at 4°C until the desired volume had been reached. 
The other method employed was ultrafiltration using Amicon Centricon or 
Centriprep concentrators with a molecular weight cut-off of 10 000 or 30 000 Da. 
The samples were spun for 20-40 min at 5000 g. They were useful for 
concentrating and desalting in a single step.
2 . 2 . 5  SDS"Polyacryiamide Gel Electrophoresis (SDS-PAGE)
Proteins were resolved using the discontinuous buffer system according 
to the method of Laemmli (1970) under denaturing conditions. Stock solutions 
were used to polymerise resolving gels of 7-15% (w/v) acrylamide containing 
0.368 M Tris-HCl, pH 8.8, 0.1% (w/v) SDS (sodium dodecyl sulphate), 0.1% 
(w/v) ammonium persulphate and 0.001% (v/v) TEMED (N,N,N%N’-tetramethy 1- 
ethylenediamine) with stacking gels of 4.4% (w/v) acrylamide containing 0.12 M 
Tris-HCl, pH 6.8, 0.1% SDS (w/v), 0.1% (w/v) ammonium persulphate and 
0.001% (v/v) TEMED. Solutions were filtered through 0.2 pm filters, degassed 
prior to use and gels stored at 4°C.
Stock solutions:
Acrylamide solution: 29.2% (w/v) acrylamide
0.8% (w/v) bis acrylamide 
Resolving gel buffer: 0.735 M Tris-HCl, pH 8.8
0.2% (w/v) SDS 
Stacking gel buffer: 0.17 M Tris-HCl, pH 6.8
0.14% (w/v) SDS 
Ammonium persulphate: 10% (w/v)
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Protein samples were boiled in an equal vol of Laemmli sample buffer 
(containing 0.062 M Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (w/v) sucrose, 10 
mM DTT and a trace of pyroninY) for 2-3 min before loading on to the gel.
Gels were run using vertical electrophoresis kits from Bethesda Research 
Laboratories (BRL) at a constant current of 60 mA. Electrode buffer contained 
0.025 M Tris-HCl pH 8.3, 0.2 M glycine and 1% (w/v) SDS.
2.2.6 Staining and Destaining Gels
Staining was carried out using 0.1% (w/v) Coomassie Brilliant Blue R- 
200 dissolved in 10% (v/v) acetic acid, 50% (v/v) methanol. Gels were destained 
in 20% (v/v) methanol, 10% (w/v) acetic acid. Gels to be dried for storage were 
first allowed to soak overnight in 35% (v/v) ethanol and 2% (v/v) glycerol before 
being dried in an Easy Breeze apparatus (Hoefer Scientific Instruments, USA).
Silver staining was used as an alternative to Coomassie Blue 
staining when nanogram quantities of protein/band were to be analysed. The 
procedure was carried out using the method of Wray et al. (1981). Protein was 
fixed by immersing the gel in 50% (v/v) methanol for 8 h at room temperature. The 
gel was then placed for 20 min in the staining solution consisting of 0.8% (w/v) 
silver nitrate, 0.12 M ammonia solution and 0.08% (w/v) NaOH with constant, 
gentle shaking. The gel was washed with several changes of distilled water over 
the course of an hour and a developer (0.24 mM citric acid and 0.02% (v/v) 
formaldehyde), prepared not more than 5 min before use, was then added until all 
protein bands could be visualised. The gel was washed again with distilled water to 
remove all traces of developer.
2 .2 .7  Western Blotting and Immunological Detection of Proteins 
by Enhanced Chemiluminescence (ECL)
Following separation by gel electrophoresis, proteins were 
electrophoretically transferred onto Hybond-C nitrocellulose paper in the presence 
of buffer containing 192 mM glycine, 0.02% (w/v) SDS, 20% (v/v) methanol and
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■25 mM Tris-HCl (pH 8.3) as described by Towbin et al. (1979) and Batteiger et ah 
(1982). This was carried out in a BioRad Trans-Blot cell either at 40 mA overnight 
or at 400 mA for 2.5 h. The nitrocellulose was briefly stained with Ponceau S 
solution which allowed visualisation of transfemed protein bands. The membrane 
was washed free of this stain with distilled water and excess binding sites were 
blocked by immersing it for 1-2 h with agitation, at 37°C in a solution containing 20 
mM Tris-HCl, pH 7.2, 15 mM NaCl, 5% (w/v) non-fat dried milk, 5% (v/v) 
normal donkey serum and 0.2% (v/v) Tween-20.
Excess blocking reagent was then washed from the membrane at room 
temperature, with a solution containing 20 mM Tris-HCl, pH 7.2, 15 mM NaCl,
1% (w/v) non-fat dried milk and 1% (v/v) normal donkey serum. Washing was 
carried out twice briefly, once for 15 min and then twice for 5 min using 200 ml of 
wash buffer each time. The membrane was then incubated overnight, at 4°C in 100
ml of solution containing 20 mM Tris-HCl, pH 7.2, 1% (w/v) non-fat dried milk, 
1% (v/v) normal donkey serum, 0.1% (v/v) Tween-20 and the appropriate dilution 
of the primary antibody.
The membrane was washed again as detailed above and incubated for 2 h 
at room temperature with a 1:1000 dilution of horseradish peroxidase labelled 
secondary antibody. This was carried out in approx. 10 ml of buffer containing 20 
mM Tris-HCl, pH 7.2, 150 mM NaCl, 1% (w/v) non-fat dried milk, 1% (v/v) 
normal donkey serum. In order to keep the volumes of the antibody solutions as 
small as possible, incubation was sometimes carried out in a sealed bag. Following 
incubation in secondary antibody the membrane was given three 30 min washes in 
wash buffer and one 30 min wash with a buffer containing 20 mM Tris-HCl, pH
7.2 and 150 mM NaCl. The detection steps were carried out in a dark room 
following the protocol outlined in the ECL kit manual. Exposure times were 
typically 15 s to 1 min.
2.2.8 Preparation of Antiserum
Antisera to the native 2-oxoacid dehydrogenase complexes isolated
from bovine heart were prepared as in the method reported by De Marcucci et al.
(1985). Subunit specific antisera were prepared as follows: 0.25-1.0 mg of desired 
antigen, dissolved in 0.75 ml of 0.9% (w/v) NaCl and mixed with 0.75 ml of 
complete Freund’s adjuvant was injected subcutaneously into rabbits at various 
sites in the neck, back and thighs. A booster dose was then administered four 
weeks later consisting of 0.1-0.5 mg antigen in 0.75 ml of 0.9% (w/v) NaCl and 
0.75 ml of Freund’s incomplete adjuvant. The rabbits received a further boost 2 
weeks prior to bleeding. Antiserum was collected by bleeding the rabbit from an 
ear vein. The blood was allowed to clot overnight at 4°C and the antiserum was 
removed using a Pasteur pipette. Antiserum was centrifuged at 700 g for 5 min to 
remove any remaining red blood cells and stored in 1 ml aliquots at -80°C. Further 
collections of antisera were made at monthly intervals, 2 weeks after additional 
booster injections, using the regime described above.
2 . 2 . 9  Purification of Enzymes
2 . 2 . 9 . 1  Purification of Pyruvate Dehydrogenase Complex (PDC)
'and 2-Oxoglutarate Dehydrogenase Complex (OGDC) from Bovine 
Heart.
PDC and OGDC were purified according to the method of Stanley and 
Perham (1980) with the following modifications (De Marcucci & Lindsay, 1985).
All procedures were performed at 4°C.
Bovine heart was cleared of fat and connective tissue and stored at -80°C 
until required. Routinely, 600 g of tissue was homogenised for 5 min in 1 litre of 
50 mM MOPS buffer, pH 7.0 containing 2.7 mM EDTA, 0.1 mM DTT, 3% (v/v)
Triton X-100, 1 mM PMSF, 1 mM benzamidine-HCl, silicone antifoam (0.5 ml.l'
1). The homogenate was then diluted with an equal vol of the same buffer and 
centrifuged at 10 000 g for 20 min. The pellets were discarded and the pH of the
I;
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supernatant adjusted to 6.45 with 10% (v/v) acetic acid. Protein was precipitated 
with the addition of 0.12 vol of 35% (w/v) polyethylene glycol 6000 (PEG 6000) 
and the solution was left stirring on ice for 30 min followed by centrifugation at 18 
000 g for 15 min. The resulting pellets were resuspended by homogenisation with 
a loose-fitting Teflon glass homogeniser in 400 ml of 50 mM MOPS buffer, pH 6.8 
containing 2.7 mM EDTA, 0.1 mM DTT, 1% (v/v) Triton X-100, 0.15 \xM 
leupeptin, 1 mM PMSF, 1 mM benzamidine-FICl before being centrifuged at 25 
000 g for 40 min. The supernatant was filtered through muslin to remove fat 
particles and 0.013 vol of 1 M MgCl2 and 0.05 vol of 1 M sodium phosphate 
buffer (pH 6.3) was added with the drop wise addition of 0.5 M NaOH to keep the 
pH above 6.8. The pH was then adjusted to 6.45 with 10% (v/v) acetic acid for a 
second addition of 0.12 vol PEG 6000 (35% w/v). The supernatant was left to stir 
on ice for 30 min after which it was centrifuged at 25 000 g for 10 min. The pellets 
were resuspended in 160 ml of 2.7 mM EDTA, 0.1 mM DTT, 1% (v/v) Triton X- 
100, 1 mM PMSF, 1 mM benzamidine-HCl, 50 mM MOPS buffer, pH 6.8 and 
0.5% (v/v) rat serum. Rat serum was added to the buffer as a source of protease 
inhibitors to prevent losses of up to 50% OGDC activity from occurring overnight 
(Wieland, 1975).
The following day, the suspension of partially purified enzyme was 
homogenised and centrifuged at 25 000 g for 1 h to remove any denatured protein. 
A third, differential PEG 6000 precipitation was then carried out by which PDC and 
OGDC were separated from each other. The pH was adjusted again to 6.45 with 
10% (v/v) acetic acid and 0.06 vol of 35% (w/v) PEG 6000 was added to the 
stirring solution for 30 min. The amount of PEG added is variable at this point 
depending on the purity of PDC or OGDC required. It was found that 0.05 vol of 
PEG would give purer PDC and 0.04 vol for purer OGDC. This solution was 
centrifuged at 25 000 g for 10 min to pellet the OGDC. PDC was to be found in the 
supernatant and was pelleted by centrifuging at 100 000 g for 150 min. Both the 
PDC and OGDC pellets were resuspended in 4-6 ml of 50 mM MOPS buffer, pH
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6.8 containing 2.7 mM EDTA, 0.1 mM DTT, 1% (v/v) Triton X-100, 0.15 |iM 
leupeptin, 1 mM PMSF, 1 mM benzamidine-HCl and stored at 4°C.
2 .2 .9 .2  Separation of E3 from E1/E2 Core of OGDC
Approx. 20-30 mg of OGDC were dissociated by a 20 min incubation on 
ice in the following buffer: 50 mM potassium phosphate buffer, pH 7.6, 1 M NaCl, 
1 mM DTT and 0.01% (v/v) Triton X-100, 1 mM M gCh  and 0.2 mM ThDP. The 
E1/E2 and E3 components were separated by gel filtration using a Superose 12 
column (HR 16/50, approx. 100 ml bed vol) which was attached to a Pharmacia 
FPLC system. The column was pre-injected with 2 M NaCl to maintain a 
dissociating front and was run in the same buffer as above. Peak fractions were 
dialysed in 50 mM potassium phosphate buffer (pH 7.6) containing 1 mM MgCH, 
0.2 mM ThDP. The E3 fraction was heat-treated at 65°C for 10 min and the heat 
labile proteins removed by pelleting at high speed in a microfuge.
2 .2 .9 .3  Preparation of a Crude Mitochondrial Dihydrolipoamide 
Dehydrogenase E xtract from Potato Tubers
Potato tuber tissue was ground using a Waring commercial blender at high 
speed for five second bursts approx. five times. In each case 3-4 vol of grinding 
buffer were used containing 0.3 M sucrose, 50 mM MOPS buffer (3-[N- 
Morpholinojpropane-sulphonic acid), pH 7.6, 2 mM EDTA, 2 mM MgCl%, 1% 
(w/v) polyvinylpyrrolidone and 2 mM glycine. Fresh Iso-ascorbic acid (30 mM) 
was added on the day of preparation and the pH adjusted to 7.6.
The homogenate was filtered through four layers of pre-wetted muslin 
into cold centrifuge buckets containing protease inhibitors (1 mM 
phenylmethylsulphonyl fluoride (PMSF), 1 mM benzamidine-HCl and 0.15 jiM 
leupeptin) and centrifuged at 1000 g for 5 min. The supernatant fluid was retained 
and centrifuged at 12000 g for 20 min. The resulting crude mitochondrial pellet 
was solubilised, with the aid of a hand homogeniser, in 200 ml of extraction buffer 
(50 mM potassium phosphate buffer, pH 6.8, 1 mM EDTA, 1 mM DTT, 0.1%
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(v/v) Triton X-100, 1 mM phenylmethylsulphonyl fluoride (PMSF), 1 mM 
benzamidine-FICl and 10 \xM leupeptin). The extract was heat-treated at 65°C for 
30 min followed by pelleting of denatured protein at 12000 g for 20 min. The heat- 
treated extract was dialysed into 20 mM potassium phosphate buffer, pH 6.8 
containing 1 mM DTT and the protease inhibitors in preparation for application to a 
DEAE-52 ion exchange column.
2 .2 .9 .4  Preparation of Dlethylaminoethyl Cellulose (DEAE-52) Ion 
Exchange Chromatography Columns
The dry cellulose was stirred in an excess of 20 mM Tris, pH 8 for 30 
min after which it was left to settle. The buffer was replaced before pouring 
columns (55 ml bed vol) which were packed by gravity flow of the buffer through 
the material. The column was equilibrated with 20 mM potassium phosphate 
buffer, pH 6.8. Small columns (1 ml) were poured in Pasteur pipettes, plugged 
loosely at the bottom end with some glass wool.
2 .2 .9 .5  Mitochondrial Isolation from Potato Tubers
Mitochondria from potato tubers were isolated by a process described by 
Day et al. (1988) with all procedures carried out at 4®C. Tubers were homogenised 
and filtered as described in section 2.2.9.3. The homogenate was centrifuged at 
1000 g for 5 min, the supernatant retained and re-centrifuged at 12 000 g for 20 
min. The resulting crude mitochondrial pellet was resuspended using a hand 
homogeniser in 30 ml of wash buffer containing 0.3 M sucrose, 0.1% (w/v) BSA, 
1 mM glycine and 10 mM (N-tris[hydroxymethyl]-methyl-2-aminoethane-sulphonic 
acid (TES), pH 7.2. Both spins were repeated and the resultant mitochondrial 
pellet resuspended in approx. 2 ml of wash buffer. The mitochondrial extract was 
then layered onto a self generating gradient comprising 10 mM potassium 
phosphate, pH 7.2, 30% (v/v) Percoll, 1 mM EDTA, 0.1% (w/v) BSA and 
centrifuged at 40 000 g for 35 min. The mitochondria formed a distinct broad band 
near the bottom of the gradient. This could be removed using a Pasteur pipette
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carefully so as not to disturb the upper regions of the gradient which contain the 
membrane fractions.
The Percoll was then removed from the mitochondiial fraction by diluting 
it in 5 vol of wash buffer minus glycine prior to centrifugation at 12 000 g for 15 
min. The upper section of the supernatant fraction was removed and the pellet 
further diluted with wash buffer minus glycine and BSA and again centrifuged at 12 
000 g for 15 min. This last step was repeated until a firm mitochondrial pellet was 
formed which was then resuspended in a minimal vol of wash buffer minus glycine 
and BSA. j
I
2 .2 .9 .6  Mitochondrial Isolation from Cauliflower Florets j
Approximately 1.5 kg of cauliflower florets were homogenised using a |
Waring commercial blender at high speed for five second bursts approx. five times j
in 1.5 1 of grinding buffer (50 mM MOPS, pH 7.4, 0.6 M sucrose, 1 mM KCl, 5 I
mM EDTA, 10 mM MgCH, 0.05% (w/v) BSA, 0.1% (w/v) PVP-40, 30 mM Iso- 
ascorbic acid). The homogenate was filtered through six layers of pre-wetted j
muslin into cold centrifuge buckets containing protease inhibitors (1 mM 
phenylmethylsulphonyl fluoride (PMSF), 1 mM benzamidine-HCl and 0.15 jiM 
leupeptin). The homogenate was centrifuged at 6000 g for 15 min and the resulting !
pellet was gently teased into suspension with a paintbrush into 60 ml wash buffer 
containing 50 mM MOPS, pH 7.0, 0.4 M sucrose, 1 mM EDTA, and 10 mM 
MgCl2. The supernatant was retained from the next centrifugation at 600 g for 10 
min. It was further centrifuged at 12 000 g for 10 min and the pellets resuspended f
into 60 ml wash buffer (minus sucrose), containing 0.1% (v/v) Triton X-100.
Solubilisation of the crude mitochondrial pellet was allowed to continue at 4°C for 
30 min after which time it was centrifuged at 12 000 g for 10 min.
2 .2 .9 .7  Purification of E3 from a Variety of Sources
Native E3 from bovine heart OGDC and PDC was isolated by a 20 min 
incubation at 4°C in the presence of 20 mM potassium phosphate buffer, pH 7.6
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and 1 M NaCl followed by heat treatment at 65°C for 10 min to remove heat labile 
proteins (pelleted at 10 000 g, 15 min). The bovine heart E3s and commercial 
preparations of porcine heart (Type III) and Candida utilis yeast E3 (Type IV) were 
dialysed against 50 mM potassium phosphate buffer, pH 7.6, 1 mM MgCl2 and 0.2 
mM ThDP and concentrated on Centricon-30 centrifugal concentrators before use. 
The potato E3 isoforms were purified as described in section 2.2.9.3 and Chapter 3 
(for Mono Q separation of the individual isoforms) and dialysed against the same 
buffer.
2 .2 .1 0  Enzym e Assays
2 .2 .1 0 .1  2“Oxoacid Dehydrogenase Complexes
The overall activities of the 2-oxoglutarate dehydrogenase and pyruvate 
dehydrogenase complexes were assayed according to the method of Brown and 
Perham (1976). The reaction mixture used was 50 mM potassium phosphate buffer 
(pH 7.6) containing 3 mM NADL 1 mM MgCh, 0.2 mM ThDP, 2.6 mM cysteine- 
HCl, 0.13 mM coenzyme A, 2 mM 2-oxoglutarate (or 2 mM pyruvate when 
assaying for PDC activity). Assays were performed at 30®C in a final vol of 0.7 
ml. The assay was initiated by the addition of enzyme and the reaction followed by 
monitoring the fonnation of NADH spectrophotometrically at 340 nm (Danson et 
a l ,  1978).
2 .2 .1 0 .2  Dihydrolipoamide Dehydrogenase
Assays were performed according to the method of Jackman et a l  (1990) 
at 30°C in a final vol of 0.7 ml. The assay mixture contained 50 mM potassium 
phosphate buffer, pH 7.6, 3 mM NAD'*", 1 mM MgCH, 0.2 mM ThDP and 20 |ig 
of dihydrolipoamide (for preparation see 2.2.10.3). The reaction was initiated by 
addition of enzyme and activity followed by monitoring NADH formation at 340 
nm. All enzymatic data presented in this thesis represent an average of duplicate 
determinations differing by less than 5%.
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2 .2 .1 0 .3  P repara tion  of Dihydrolipoamide
Dihydrolipoamide was prepared according to the method described by 
Reed et al. (1958). 400 mg of lipoamide (thio-octic acid amide) was dissolved in 
80% (v/v) methanol at 4°C. 400 mg of sodium borohydride was dissolved in 2 ml 
of distilled water, also at 4°C, and then added to the lipoamide/methanol. The
solution was stirred at room temperature until it became clear (approx. 45 min). 
The pH of the solution was then lowered to 2.0 with 0.25 M HCl and extracted 
with 40 ml of chloroform. The lower layer containing the dihydrolipoamide was 
removed and dried down under N2. This material was re-dissolved by stirring on a 
hot plate in toluene/lieptane (2.5:1.0). After drying down once more under N2 until 
a minimal vol of liquid remained, the dihydrolipoamide was allowed to crystallise 
naturally and stored at -20°C. For use, approx. 20.7 mg of dihydrolipoamide was 
dissolved in 1 ml of ethanol. I
2 .2 .1 0 .4  Reconstitution Studies on Bovine Heart OGDC
Reconstitution of bovine heart E1/E2 core with the E3 component was 
carried out in Eppendorf tubes by incubating increasing amounts of E3 (0-50 pg) 
with a fixed amount of E1/E2 core (7 pg) at 30°C. The final vol of each 
reconstitution was kept constant with the addition of 50 mM potassium phosphate 
buffer, pH 7.6, 1 mM MgCl2 and 0.2 mM ThDP. After 12 min a sample 
(equivalent to 5 |ig of E1/E2) was added to an assay cuvette containing solutions A,
,:4B and C required for the assay of OGDC activity, performed as in section 2.2.10.1.
The determination of the time course of reconstitution was carried out in 
one Eppendorf tube by adding 12 x the assay amount of E1/E2 (60 |ig) and a 
saturating amount of E3. Aliquots equivalent to 5 pg of E1/E2 were removed at 
specified intervals after incubation and assayed for activity.
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2 .2 .1 1  M edia for the Growth of B acteria and B acteriophage
Standard growth media, as described by Sarabrook et al. (1989), were 
used throughout this work. They were sterilised by autoclaving for 20 min at 15 
psi, or if heat labile, were filter sterilised.
LB medium ; 1% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 0.5%
(w/v) NaCl, pH 7.5 (adjusted with NaOH).
As LB medium plus the addition of 15 g of agar per litre. 
1% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 0.5% 
(w/v) NaCl, 10 mM MgS0 4 -7H2 0 , 10 mM MgCli, pH 
7.0. Filter sterilised glucose solution (1 M) to a final 
concentration of 20 mM added after autoclaving.
NZY Bottom A gar; 1% (w/v) casein hydrolysate, 0.5% (w/v) NaCl, 0.5%
(w/v) yeast exti*act, 0.2% (w/v) MgS0 4 .7FÎ2 0 , pH 7.5, 
15 g of agar per litre.
NZY Top A garose; 1% (w/v) casein hydrolysate, 0.5% (w/v) NaCl, 0.5%
(w/v) yeast extract, 0.2% (w/v) MgS0 4 .7H2Û, pH 7.5, 7 
g agarose per litre.
Ampicillin and kanamycin (Sigma) were made up at 50 mg.ml"! in water 
and filter sterilised. They were used at a concentration of 0.075 m g.m l'l. 
Carbenicillin (Sigma) was used in place of ampicillin in most cases as it is a more 
stable analogue. It was used at a concentration of 0.1 mg.ml'F Tetracycline was^ 
made up at a concentration of 10 mg.ml'l in ethanol and used at a concentration of 
0.012 mg.ml'L The long term storage of the antibiotics was at -20°C.
Escherichia coli {E. coli) bacterial cultures were grown at 37°C in Luria- 
Bertani media (LB) supplemented with the appropriate antibiotics in an orbital 
shaker at 225 rpm. Strains for short terra storage were maintained on LB plates at 
4°C and those for long term storage were mixed with glycerol to a final 
concentration of 15% (v/v) and stored at -70°C. Cultures used for the preparation 
of competent cells by the Hanahan method (2.2.27.1) were grown in SOC medium.
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Bacteria required to produce a lawn for subsequent bacteriophage 
infection were grown in LB supplemented with 0.2% (w/v) maltose and 10 mM 
MgS0 4 . Bacteriophage were stored as phage suspensions in SM buffer (100 mM 
NaCl, 10 mM MgS04 ,.H2 0 , 50 mM Tris-HCl at pH 7.5 and 0.01% (w/v) gelatine)
supplemented with 0.01% (v/v) chloroform at 4°C.
2 .2 .1 2  Storage of DNA
DNA vectors, recombinants and oligonucleotides were routinely stored in 
TE buffer (10 mM Tris-HCl, pH 8.0 and 1 mM EDTA) at -20°C. DNA stored in 
this way remains stable for several years. Long-term storage of DNA was under 
100% ethanol at-70°C.
2 .2 .1 3  Phenol/Chloroform Extraction
Phenol, equilibrated with TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM 
EDTA) and containing 8-hydroxyquinoline at 0.1% (w/v) as an antioxidant, was 
mixed with chloroform/isoamylalcohol (24:1) at a ratio of 1:1. Extraction of an 
aqueous DNA solution was carried out by adding an equal vol of 
phenol/chloroform and vortexing the mixture. The aqueous layer was collected 
after a 5 min spin in a microfuge and the organic layer was re-extracted with an 
equal vol of TE buffer. The aqueous layers were pooled and the extraction was 
repeated once with water saturated chloroform.
2 .2 .1 4  Ethanol or Isopropanol Precipitation of DNA
A salt solution was added to an aqueous solution of DNA (either Na- 
acetate, pH 5.2 to 0.3 M or NaCl to 0.2 M) and the DNA precipitated with 2.5 vol 
of 98% ethanol (v/v) or 0.7 vol of isopropanol at -70°C for 15 min. The precipitate 
was recovered by centrifuging at 10 000 g for 15 min at 4°C and then washed with 
70% (v/v) ethanol to remove any salt that may have co-precipitated. I
I
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2 .2 .1 5  R estriction M apping
Restriction digests were routinely carried out for 1-5 h at 37°C (or the 
temperature recommended by the enzyme supplier) in 20-100 |il aliquots which 
contained a suitable amount of DNA, 1-10 units per ]ig DNA of the appropriate 
restriction enzyme and Ix restriction buffer supplied with the enzyme. One unit of 
restriction enzyme is defined as the amount of enzyme required to digest 1 |ag of 
DNA to completion in one hour. In practice a several-fold excess was usually
added to digest the DNA. Genomic DNA was incubated overnight using 8 units of 
restriction enzyme per pg of DNA. The completion of the digest was monitored by 
electrophoresis of an aliquot through an agarose gel.
2 .2 .1 6  DNA E lectrophoresis in Agarose Gels
É.Agarose gels were routinely used to separate DNA fragments in the size 
range 0.1-20 kb. Slab gels were prepared by dissolving agarose (BRL ultraPURE) 
in TBE buffer, pH 8.3 (89 mM Tris, 89 mM boric acid and 2 mM EDTA) at the 
desired concentration (0.7-1.2% [w/v]). TAB pH 8.0 (40 mM Tris, 20 mM acetic 
acid and 1 mM EDTA) was the buffer of choice when gel purification of the DNA 
was required. Ethidium bromide was added at a concentration of 0.1 qg.mP 1 to 
allow visualisation of the DNA in the gel. Samples were prepared for loading by 
the addition of 0.2 vol of 6x loading buffer (0.25% (w/v) bromophenol blue, 40%
(w/v) sucrose and 50 mM EDTA). The gel was placed in a tank containing TBE or 
TAE buffer and the samples were loaded into the submerged wells. Electrophoresis 
was carried out at 2-5 volts/cm. DNA was visualised under 320 nm UV light and 
photographed with a UVP imager.
For DNA in the range of 50-400 bp, 12 % (w/v) non-denaturing TBE- 
polyacrylamide mini-gels were made using the protocol in section 2.2.5. The SDS 
was eliminated from the mixture and lOx TBE was used as the buffer component.
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2 .2 .1 7  Electrophoresis of RNA using Formaldehyde Gels
A 1% (w/v) formaldehyde agarose gel was made by adding 1 g of agarose 
and 10 ml lOx MOPS buffer (0.2 M MOPS, pH 7.0, 0.5 M sodium acetate, pH 7.0 
and 0.5 M EDTA) to 73 ml of water. After the agarose had dissolved by heating in 
a microwave it was cooled to 55°C and 17 ml of formaldehyde was added. The gel 
was cast in a fume hood, allowed to set for 30 min and submerged in Ix MOPS 
electrophoresis buffer. RNA samples were prepared (10-30 jrg RNA, 12.5 ill of 
deionised formamide, 2.5 pJ lOx MOPS, 4 pi formaldehyde and water to 25 pi), 
denatured at 65°C for 5 min and kept on ice. They were mixed with loading dye 
(2.2.16) and loaded into the wells. Electrophoresis was carried out at 80 - 100 
volts until the bromophenol blue dye was 1 cm from the bottom of the gel. The gel 
was directly processed for Northern blotting or was stained with ethidium bromide 
(0.5 pg.ml"^ in 10 mM ammonium acetate) for 30 min followed by destaining in 
sterile water.
2 .2 .1 8  Recovery of DNA from Low Melting Point Agarose
Low melting point agarose gels were prepared in the same way as 
standard agarose gels (using TAE buffer [section 2.2.16] ) except that they were 
run in the cold room. The desired band was excised from the gel with a scalpel and 
transferred to an Eppendorf tube. Three vol of TE buffer were added to the agarose 
gel slice and the sample was placed at 65°C for 5 min to melt the agarose. The 
sample was extracted once with phenol equilibrated with TE as described in section 
2.2.13. The aqueous phase was re-extracted with phenol/chloroform and twice 
with water saturated chloroform before it was ethanol precipitated.
The Geneclean II Kit (BIO 101 Inc. USA) was used as a more efficient 
alternative to phenol/chloroform extraction. The protocol in the manufacturer’s 
instruction manual was followed. This method gives clean DNA for ligations and 
has a working range of between 1-5 pg.
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2 .2 .1 9  Recovery of DNA from Non-Denaturing Polyacrylamide  
Gels
The ‘crush and soak’ method was used for the purification of low 
molecular weight PCR products from polyacrylamide gels. The PCR reaction was 
cleaned by phenol/chloroform extraction and ethanol precipitated. The entire 
sample was separated on a 12% TBE-polyacrylamide gel (section 2.2.16) and the 
bands visualised with ethidium bromide. The band of interest was cut out of the 
gel, transfen'ed to a microfuge tube and crushed using a yellow tip. The crushed 
gel was rotated at 37°C for 4 h (room temperature for 10-16 h) in 1-2 vol of elution 
buffer (0.5 M ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA, pH 8.0 
and 0.1% (w/v) SDS). The gel pieces were pelleted by centrifugation at 12 000 
rpm for 5 min in a microfuge. Remaining gel pieces were removed by spinning the 
sample through glass wool and the DNA was then precipitated overnight at -20°C 
with 10 mM MgCH and 3 vol of 100% ethanol. The sample was re-precipitated 
with 0.3 M sodium acetate and 2.5 vol of 100% ethanol. The final pellet was 
dissolved in 10 ql of water or TE buffer.
2 .2 .2 0  Small Scale Preparation of Plasmid DNA
A 3 ml overnight culture was prepared from a single colony of 
transformed bacteria in LB medium supplemented with the appropriate antibiotics. 
The bacterial suspension (1.5 ml) was transferred to a microfuge tube and the cells 
pelleted at 5000 rpm for 5 min at 4°C. The pellet was washed in 150 jul of cold 
STE (0.1 M NaCl, 10 mM Tris-HCl, 1 mM EDTA pH 8.0) followed by 
resuspension in 38 pi cold solution 1 (50 mM glucose, 25 mM Tris-HCl, pH 8.0 
and 1 mM EDTA) and 75 pi solution 2 (0.2 M NaOH, 1% (w/v) SDS). After a 10 
min incubation on ice 110 pi of cold solution 3 (4 vol of 5 M potassium acetate, 0.6 
vol acetic acid and 0.4 vol distilled H2O) was added and incubated on ice for a 
further 10 min. The bacterial debris was pelleted in a microfuge at high speed for 
10 min at 4°C. An equal vol of isopropanol was added to the supernatant and 
plasmid DNA allowed to precipitate at room temperature for 10 min. The
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precipitate was pelleted in a microfuge at high speed for 5 min, dried and 
resuspended in 50 |il TE-RNase A (1 iig.ql'l). Following a 15 min incubation at 
37°C, the RNA free plasmid DNA was recovered by ethanol precipitation.
2 .2 .2 1  Large Scale Preparation of Plasmid DNA
The Qiagen Midi Prep Kit (Qiagen GmbH, Germany) was used to obtain 
up to 150 fig of plasmid DNA from a 30 ml bacterial culture. Manufacturer’s 
instructions were followed carefully to purify plasmid DNA suitable for ligations 
and sequencing.
Alternatively, the same method described in section 2.2.20 could be used; 
however, the volumes of all the solutions were scaled up to allow for an overnight 
transformed bacterial culture of 130 ml in LB supplemented with antibiotics. The 
cells were harvested by centrifugation for 15 min at 6000 rpm in a Beckman J2-21 
centrifuge using a JA14 rotor and washed in 13 ml cold STE (0.1 M NaCl, 1 mM 
EDTA, 10 mM Tris-HCl, pH 8.0). Solution 1 (section 2.2.20) contained 5 mg 
lysozyme to aid the breakdown of cell walls. Prior to ethanol precipitation the 
plasmid DNA was cleaned by phenol/chloroform extraction (section 2.2.13). 
Routinely 130-150 fig of DNA were recovered.
2 .2 .2 2  The Polymerase Chain Reaction (PCR)
The polymerase chain reaction is a technique for the in vitro amplification 
of specific DNA sequences by the simultaneous primer extension of complementary 
strands of DNA. Standard PCR amplification reactions were set up in a total vol of 
50 fil. The reaction mix contained: 5 fil of Promega lOx Taq DNA polymerase 
buffer (500 mM KCl, 100 mM Tris-HCl, pH 9.0, 100 mM NaCl, 0.1 mM EDTA, 
5 mM DTT, 1.0% (v/v) Triton X-100), 0.2 mM each dATP/dGTP/dCTP/dTTP, 2 
mM MgCH, 1 unit Taq DNA polymerase, 10 praol each of the two oligonucleotide 
primers used (or 1000 pmol of degenerate primers) and a suitable amount of target 
DNA. Optimum MgCH concentrations can vary for different primer pairs between
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2 .2 .2 3  First-Strand cDNA Synthesis and PCR Amplification using 
Degenerate and Nested Primers
2 .2 .2 3 .1  First-Strand cDNA Synthesis from Plant RNA
The First-Strand cDNA Synthesis Kit was obtained from Pharmacia 
Biotech to generate full-length first-strand cDNA from an RNA template, catalysed
0.5 mM and 2.5 mM; however the lowest possible optimum concentration was 
used as this led to increased fidelity of the Taq enzyme (Brown, 1992)].
Pfu DNA polymerase (Stratagene) was used where proof-reading and 
high fidelity were required. The basic components of the reaction mix were: 0.6 
mM nucleotide mix, 10 pmol primers, Ix Pfu buffer and 2.5 units of either native 
or cloned Pfu DNA polymerase. The ‘hot stai't’ technique was used with Pfu PCR
reactions. Typically all reactants, except the polymerase, were mixed and overlaid 
with mineral oil. After the tubes had stabilised at 95°C for 1 min, the polymerase 
was added below the mineral oil and normal cycling continued.
The reaction was overlaid with 100 jil of mineral oil to prevent 
evaporation during heating and the reaction carried out in a Techne PHC-3 thermal 
cycler. The exact conditions used for amplification varied with the nature and 
length of the target sequence and the primers. The stages involved in the PCR were 
an initial denat-uration at 95°C, followed by repeated cycles of dénaturation (94°C), 
annealing of primers (50-60°C), extension from primer (65°C). The cycles were 
followed by a final extension time at 72°C. Finally the reactions were cooled to 4°C 
and the PCR amplified products analysed on agarose or polyacrylamide gels (for 
products in the range of 50-200 bp).
PCR products to be purified and cloned were extracted with phenol 
/chloroform (section 2.2.13) before being ethanol precipitated (section 2.2.14). 
The products were gel purified using the Gene Clean kit, described in section 
2.2.18, following restriction digestion with the appropriate enzymes.
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by CLONED FFhCpure Moloney Murine Leukemia Virus (M-MuLV) reverse 
transcriptase. The source of RNA used for this work was potato leaf RNA.
The RNA sample (5 fig) was made up to a total vol of 20 pi with RNAse- 
free water, heat denatured at 65°C for 10 min and then chilled on ice. The Notl- 
d(T)i8 primer was diluted 25x in RNAse-free water. The following components 
were combined in a sterile tube: 11 pi of bulk first-strand reaction mix (containing 
the reverse transcriptase and dNTP mix), 1 pi of DTT, 1 pi of the diluted Notl- 
d(T)i8 primer (0.2 pg) and the heat denatured RNA. The reaction was allowed to 
proceed at 37 °C for 1 h.
2 .2 ,2 3 .2  Second-Strand Synthesis and Amplification of DNA by 
PCR
The resulting RNA:cDNA hetreoduplex from the first-strand reaction 
(section) was used directly for second-strand synthesis by PCR. Degenerate 
primers or gene specific upstream primers, used in conjunction with the 
downstream A od-d(T)i8 primer, were designed to amplify the cDNA encoding 
potato mitochondrial E3. A portion of the first-strand reaction (5 pi) was heated at 
90°C for 5 min to denature the RNA:cDNA duplex and inactivate the reverse 
transcriptase and then chilled on ice. A PCR amplification reaction was set up as 
described in section 2.2.22 using 5 pi first-strand reaction. Cycling parameters 
used for the PCR amplification of the first-strand cDNA are detailed in chapter 5.
2 .2 .2 4  Quantification of Nucleic Acids
2 .2 .2 4 .1  Absorbance at 260 nm
The absorbance of various dilutions of DNA samples was measured using 1 
ml quartz cuvettes in a spectrophotometer at 260 nm. An absorbance unit of 1 
corresponds to approx. 50 pg.m pl for double-stranded DNA, 40 pg.mL^ for 
single-stranded DNA and RNA and 30 pg.ml'^ for oligonucleotides (Sambrook et 
al., 1989). For a quantitative assay of more dilute solutions, the GIB CO DNA 
Mass Ladder was used. It consisted of 6 blunt ended fragments ranging in size
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from 100-2000 bp. Electrophoresis of 2 pi of DNA Mass Ladder resulted in bands 
containing 100, 60, 40, 20 and 5 ng of DNA.
2 ,2 .2 4 .2  Fluorometry
Accurate measurements of DNA concentrations, down to 10 ng.ml’% were 
determined using a TKO 100 DNA minifluorometer (Hoefer Scientific Instruments, 
USA). DNA solutions were added to 2.0 ml of a working dye solution (see below). 
Aliquots of the working dye solution, of final vol 100 ml, were replaced daily and 
stored in the dark at room temperature. Each aliquot consisted of: 90 ml double­
distilled, filter sterilised water (to remove particulate contaminants), 10 ml TNE, lOx 
(100 mM Tris-HCl pH 8.0, 10 mM EDTA, 1.0 M NaCl; adjusted to pH 7.4 with 
conc. HCl) and Hoechst H33258 dye solution to a final concentration of 100 ng.mk^. 
Readings were performed as described in the manufacturer’s instructions. Serial 
dilutions of calf thymus DNA, from 10-500 ng.ml'l final concentration, were used to 
construct standard curves from which the DNA concentration of a fixed vol of sample 
DNA was determined.
2 .2 .2 5  Déphosphorylation of Plasmid DNA
In cases where only one enzyme was used to cut the vector, the 5"- 
phosphate groups of the linear plasmid were removed by calf intestinal alkaline 
phosphatase (CIP) to avoid self-ligation of the vector. The reaction mix containing 
1 pg of linearised vector DNA, CIP buffer (1 mM MgCl2, 1 mM ZnCl2, 1 mM^ 
spermidine and 50 mM Tris-HCl, pH 8.4) and 1 unit of calf intestinal alkaline 
phosphatase, in a total vol of 50 pi, was incubated at 37°C for 30 min. SDS and 
EDTA were added to final concentrations of 0.5% (w/v) and 5 mM respectively. 
Proteinase K was added to a final concentration of 100 pg.mpl and incubation 
continued for 30 min at 37°C. The reaction was subjected to a phenol and 
phenol/chloroform extraction and the DNA recovered by ethanol precipitation.
t
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2 .2 .2 6  Ligations
Routinely, 200 ng of linearised vector DNA were used in a ligation in a 
total vol of 10 pL The vector:insert ratio was 1:3, 1 pi of lOx ligation buffer (50 
mM MgCl2, 50 mM DTT, 500 pg.ml-1 BS A and 200 mM Tris-HCl, pH 7.4) and 1 
pi of 10 mM ATP were added to the DNA and the ligation initiated by the addition 
of 1 Weiss unit of bacteriophage T4 DNA ligase. The sample was incubated for 8- 
16 h at 16°C
2 .2 .2 7  Preparation and Transformation of Competent Cells
2 .2 .2 7 .1  Hanahan Method
E. coli XL 1 Blue and DH5a cells were made competent by the method 
developed by Hanahan (1983) as described by Sambrook et al. (1989). This 
procedure allowed the preparation of highly competent cells (1x107-10% 
transformants pg'^ of plasmid DNA) which were stored frozen in lOOpl aliquots 
for future use.
To transform the cells, 100 pi were allowed to thaw on ice and plasmid 
DNA (no more than 50 ng) was added. After a 30 min incubation on ice, the tubes 
were ti’ansferred to a 42°C water bath, incubated for 90 s and rapidly transferred to 
an ice bath. After 5 min, 800 pi of SOC media (section 2.2.11) was added and 
incubated for 45 min at 37°C in an orbital shaker to allow the bacteria to express the 
antibiotic resistance. LB agar plates, containing the appropriate antibiotic, were 
prepared for colour selection by spreading 4 pi of filter sterilised, 20% (w/v in 
water) IPTG on each one. The plates were allowed to dry and then spread with 40 
pi of a 2% solution (w/v in dimethyl formamide) of the chromogenic substrate, X- 
gal. Dilutions of the bacterial suspension were made and spread evenly on the LB 
plates.
2 .2 .2 7 .2  Calcium Chloride
The E. coli strains BL21(DE3) and BL21(DE3)pLysS, used for the 
expression of heterologous protein, were made competent by the CaCl2 method.
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These competent cells were usually made freshly on the day. An overnight culture 
was used to inoculate 30 ml of LB medium and cells were allowed to grow to a 
density of 0.3 (Agoo). The pelleted cells were resuspended in half the volume with 
ice cold CaCl2 (100 mM), incubated on ice for 20 min and centrifuged again at 
3000 g for 3 min. The final pellet was resuspended in one tenth of the original 
volume with ice cold CaCl2. The cells were now ready to be transformed.
Plasmid DNA was diluted to a concentration of 2 ng.ppl in TEN buffer
(50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM NaCl), For transformation, 100 
ng of DNA was added to 100 pi of cells and incubated on ice for 30 min. The cells 
were heat shocked at 37°C for 90 s and then returned back to incubate on ice for 30 
min. LB medium (1 ml) was added followed by incubation at 37°C in an orbital 
shaker for 45 min. The transformed cells were resuspended in a final vol of 200 pi 
of LB and 10-30 pi aliquots were plated on LB kanamycin plates, prepared with 
IPTG and X-gal as in section 2.2.27.1.
2 .2 .2 8  Extraction and Purification of Total RNA from Plant Tissue
Potato leaves were grown as described in section 2.2.1. They were 
harvested, snap frozen in liquid nitrogen in batches of 5 g and stored at -80°C until 
required.
This procedure required elimination of ribonucleases from all glassware, 
pipette, tips and solutions. All chemicals were used exclusively for “RNA work”, 
glassware and spatulas were rinsed with chloroform and baked overnight at 180°C, 
tips were soaked in 0.1% (v/v) diethyl pyrocarbonate (DEPC) and solutions were 
made with sterile Milli Q water previously treated with 0.1% (v/v) DEPC. DEPC is 
a non-specific inhibitor of ribonucleases; however it is a potent alkylating agent of 
RNA and must be destroyed completely before use by autoclaving.
Potato leaves (10 g) were ground to a fine powder in the presence of 
liquid nitrogen and transferred to a 50 ml Nunc disposable tube. This was followed 
by the addition of 1 ml of solution D for every gram of starting material (4 M 
guanidinium-isothiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% (w/v) sarcosyl,
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0.1 M 2-mercaptoethanol). The following solutions were added per gram of tissue 
in a sequential manner, shaking the tube after each addition: 0.2 ml.g~l of 2 M 
sodium acetate (pH 4), 1.0 ml gH of water saturated phenol and 0.4 ral.g-1 of 
chloroform:iso-amyl alcohol (24:1). After vigorous shaking the material was kept 
in ice for 15 min. The mixture was centrifuged at 10 OOOg for 20 min at 4°C in 
screw cap Oak Ridge tubes and then 1 vol of isopropanol was added to the resulting 
supernatant. The precipitated RNA was spun down at 10 000 g for 25 min and the 
pellet was given at least three washes with 2.5 M sodium acetate (pH 5.2). The 
final pellet was washed with 70% ethanol and air dried. The RNA pellet was 
dissolved in sterile, DEPC treated water and stored at -80°C.
2 .2 .2 9  Transfer and Detection of Nucleic Acids
The following solutions were required for Northern and Southern blots:
20x SSC (pH 7.0) 3 M NaCl
0.3 M Na] citrate
20x SSPE (pH 7.4) 3.6 M NaCl I
0.2 M sodium phosphate I
0.02 M EDTA I
lOOx Denhardt’s 2% (w/v) BSA 
2% (w/v) Ficoll 
2% (w/v) PVP
10 pg.m pl sonicated salmon sperm DNA: dissolve in water overnight 
with stirring and then sonicate the DNA to an average length of 400-800 bp as 
judged by agarose gel electrophoresis.
8 0
%2 .2 .2 9 .1  Radiolabelling of DNA Fragments
The Megaprime DNA labelling system from Amersham was used for the
radioactive labelling of probes for hybridization. DNA required for labelling was 
diluted in water to a final concentration of 5 ng.pl" h A total of 5 pi (25ng) of DNA 
were denatured for 5 min in a boiling water bath in the presence of random 
sequence nonameric primers (5 pi). The DNA was cooled to room temperature and 
10 pi of the labelling buffer (containing dGTP, dATP, dTTP, MgCl2, 2- 
mercaptoethanol and Tris-HCl buffer, pH 7.5), 23 pi of water, 2 pi Klenow 
enzyme and 5 pi [a-^^P]dCTP (3 000 Ci/mmol) were added. The reaction was 
incubated at 37°C for 30 min. 4Chromaspin-10 columns were used to separate the unincorporated free 
nucleotides from labelled DNA. Chromaspin columns were shaken to mix the resin 
and spun at 1700 g for 3 min to pack the resin. The 50 pi sample was applied to
Ithe centre of the bed and was spun at 1700 g for 4 min to collect the product.
2 .2 .2 9 .2  Southern Blotting and Hybridisation
Alkali blotting was the method employed to transfer resolved DNA
fragments from agarose gels to positively charged nylon membranes (Hybond-N+). 
After electrophoresis, the DNA was depurinated by placing the agarose gel in 0.25 
M HCl for 10 min after the bromophenol blue dye had changed colour (blue to 
bright yellow). This treatment was essential for the transfer of DNA fragments 
larger than 5 kb. The gel was rinsed in distilled water and the DNA denatured by 
soaking the gel in 0.4 M NaOH for 30 min. A capillary blot was set up as 
described by Sambrook et al. (1989) using 0.4 M NaOH as the transfer buffer and 
the Hybond-N+ membrane. Transfer was allowed to proceed overnight after which 
time the blot was disassembled. The wells were marked on the membrane with a 
pencil and it was washed with 2x SSC. The membrane could then be stored dry, 
between clean Whatman 3 MM paper, or it could be processed for hybridisation.
A pre-hybridisation mix was made up in a final vol of 25 ml as follows: 
5x SSPE, 5x Denhardt’s solution, 0.5% (w/v) SDS and 100 pg.m l'l heat
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denatured, sonicated salmon sperm DNA. The membrane was pre-hybridised in a 
Mini 10 hybridisation oven (Hybaid LTD, UK) at 65°C for a minimum of 2 h. The 
heat denatured probe (1-5 pg.ml"! hybridisation buffer, 10%-10^ cpm.pg"^) was 
snap-cooled on ice and then added to the pre-hybridisation mix and further 
incubated for 12-16 h at 65°C. The membrane was washed once in 2x SSC, 0.1% 
(w/v) SDS for 15 min at 65°C and subsequently once in Ix SSPE, 0.1% (w/v) SDS 
for 20 min and finally in O.lx SSPE, 0.1% (w/v) SDS for 15 min. The membrane 
was then dried and autoradiographed for the desired time. If the membrane was to 
be re-washed or stripped and re-hybridized then it was kept damp at all times.
2 .2 .2 9 .3  Northern Blotting and Hybridisation
RNA from a formaldehyde gel was transferred by the capillary blotting 
method using 20x SSPE as the transfer buffer and Hybond-N membranes. The gel 
was not pre-stained with ethidium bromide as this would reduce the efficiency of 
RNA transfer. Following an overnight transfer, blots were washed gently with 2x 
SSPE and air-dried. RNA was fixed to the membrane by baking at 80°C for 2 h. 
The hybridisation and washing protocols were identical to the southern blot.
2 .2 .3 0  Screening a Lam bda ZAP II cDNA L ibrary
2 .2 .3 0 .1  Plating and Titering the Library j
LB medium (25 ml), supplemented with 0.2% (w/v) maltose (to induce |
the lamB gene coding for the bacteriophage X receptor) and 10 mM MgS04 was 
innoculated with a single colony of freshly plated E. coli XL IB lue MRF". The 
culture was grown at 37°C at 225 rpm in an orbital shaker until it had an Agoo of !
0.5. The bacterial culture was pelleted at 2000 rpm for 10 min and the cells were 
resuspended and diluted to a density of 1.0 at Agoo iii 10 mM MgSOa. These cells i
were stored at 4°C overnight. i
A serial dilution of the library was made with SM buffer (100 mM NaCl,
10 mM MgSOa 7H2 0 , 50 mM Tris-HCl, pH 7.5 and 0.01% (w/v) gelatine) and 10
pi was mixed with 990 pi of the bacterial host cells. The cells were incubated at t
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37°C for 20 min for the phage to infect the host. The entire content of the tube was 
mixed with 8 ml of top agar at 42°C and plated on two day old bottom agar plates 
(140 mm diameter), previously equilibrated to 37°C. The inverted plate was 
incubated at 37°C for 8 h or until the plaques were clearly visible, but not confluent 
and the titre of the library was calculated as follows:
total no of plaques x Dilution factor x 1000 , . , _ . .---------------    number of plaque forming units per ml (pfu. ml )volume of phage plated (lOpl)
2 .2 .3 0 .2  Plaque Lifts
Plaques were prepared as outlined in 2.2.30.1. For the primary screen 
500 000 phage, at a density of 60 000 plaques per plate, leading to confluent 
growth. For the secondary and tertiary screens each positively hybridising phage 
sample was plated at a density of 50-500 plaques so that individual plaques could 
be distinguished. Plates were chilled at 4°C for 60 min to allow the top agar to 
harden before plaque lifts were attempted. Meanwhile, the appropriate number of 
charged nylon membranes (Hybond-N+) were labelled. A membrane was laid 
carefully onto each plate from the centre outward, so that it made direct contact with 
the plate without smearing the plaques. Several asymmetric points were marked 
with a needle to record the orientation of the membrane on the plate and after 60 s it 
was peeled off using blunt forceps. When duplicate lifts were made, the second 
membrane was left on the plate for a 2 min duration.
Each membrane was placed, DNA side up, for 4 min on two sheets of 
Whatmann 3 MM paper soaked in dénaturation solution (0.5 M NaOH, 1.5 M 
NaCl). The membranes were drained of excess dénaturant and transferred to two 
sheets of 3 MM paper soaked in neutralisation solution (0.5 M Tris-HCl, pH 7.5 
and 1.5 M NaCl) for a further 4 min. Finally, the membranes were rinsed in 2x 
SSC for 5 min and left to dry on 3 MM paper. The membranes were then alkali 
fixed with 0.05 M NaOH for 20 min, rinsed with 5x SSPE and then air-dried.
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The membranes were hybridised with a [%^P]-labelled homologous probe 
as described in section 2.2.29.1 and 2. For homologous screening the protocol 
from Sambrook et al. (1989) was followed. Just before autoradiography the 
reference marks on the membrane were spotted with radioactive ink (500 pi ink and 
1 pi [32p]-dCTP).
2 .2 .3 0 .3  Selection of B acteriophage L am bda Plaques 
The pattern of spots produced on the film, by hybridisation of plaque
DNA with a probe, were aligned with their corresponding position on the plate with 
the help of the reference marks on the membrane and plate. Plaques of interest 
were removed from the plate as plugs using a cut 1 ml disposable tip. The agar 
plug was transfeixed to a 1.5 ml microfuge tube which contained 1 ml of SM buffer 
and 50 pi of chloroform, vortexed briefly and left at room temperature for 1 h to 
allow the phage to diffuse out into the solution. The phage suspension was titred as 
described in section 2.2.30.1 and the process of screening was repeated with a 
lower plaque density per plate until plaque purity was attained. This typically took 
three rounds of screening.
2 .2 .3 0 .4  P repara tion  of P late Lysate Stocks 
Once a single hybridising plaque had been isolated and titred, 6x10^  ^pfu
were used to produce confluent lysis of a bacterial lawn grown on a 140 mm 
diameter plate. Phage were eluted from the agar by the addition of 8 ml of SM 
buffer to the plate, which was left shaking gently at 4°C overnight.
The next day the bacterial suspension was recovered into a sterile 
polypropylene tube and the plate rinsed with 2 ml of SM buffer. A volume of 0.3% 
(v/v) chloroform was added to the suspension, vortexed and incubated at room 
temperature for 15 min. Bacterial cell debris was removed from the suspension by 
centrifugation at 3000 rpm in a JA20 rotor (Beckman) for 10 min. The supernatant 
was transferred to a fresh tube and chloroform was added to 0.3% (v/v) to prevent 
any bacterial growth. Phage lysates were stored at 4°C.
2 .2 .3 0 .5  Purification of Recombinant Bacteriophage DNA
Wizard Lambda DNA Purification System from Promega was used to 
prepare recombinant phage DNA. The protocol was followed as described by the 
manufacturer.
2 .2 .3 1  In  Vivo Excision of the pBluescript Phagemid from the 
Lambda ZAP II Vector
The potato leaf cDNA library was made using a lambda insertion type 
cDNA cloning vector, Lambda ZAP II. This vector contains the phagemid, 
pBluescript SK- (Short et al. 1988) which can be excised by the M13 based helper 
phage, VCSM13 (Stratagene).
The following components were combined in an Eppendrof tube: 200 pi 
of X Ll Blue MRF" cells (cultured in LB supplemented with 0.2% (w/v) maltose 
and 10 mM MgSOq and stored in 10 mM MgSOq) at an Agoo of LO, 250 pi phage 
stock (>1x1Q 5 phage particles in SM buffer) and 1 pi of the VCSM13 helper phage 
(>1x10^ pfu.pl'i). The tube was incubated at 37°C for 15 min, 3 ml of LB was 
added and incubated for a further 3 h with shaking and during this time the 
phagemid containing the insert was excised in the presence of the gene II protein 
provided by the helper phage. The single-stranded pBluescript phagemids were 
circularised and then packaged into filamentous phage particles with the proteins 
provided by the helper phage. Heat treatment at 65°C was carried out for 20 min to 
inactivate the parent lambda phage vector, kill the bacterial cells and release the 
phage particles into the supernatant after which the debris was pelleted at 1000 g for 
15 min. The supernatant, containing the excised pBluescript phagemid packaged as 
filamentous phage particles, was decanted into a fresh Eppendorf tube and was 
stable at 4°C for 1-2 months.
E. coli SOLR cells (Stratagene) were cultured in LB and stored for a 
maximum of 24 h in 10 mM MgSOq at an Agoo of 1-0. To rescue the excised 
phagemids, 200 pi of the bacterial cells were added to 100 pi and 10 pi respectively 
of the phage supernatant. The samples were incubated at 37°C for 15 min before
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being plated on LB-ampicillin plates (200 pi per 140 mm plate). The plates were 
incubated at 37°C, overnight and colonies appearing the next day contained the 
pBluescript double-stranded plasmid. Single colonies were suspended in 100 pi of 
sterile water and 5 pi was used for screening by PCR amplification. The rest of the 
sample was used to inoculate a 3 ml overnight culture for the preparation of glycerol 
stocks and for mini preparations of the cloned DNA.
2 .2 .3 2  Generation of Clones for Sequencing by Directed Deletions
The Erase-A-Base system from Promega was routinely used for 
generating nested deletions from one end of the cloned DNA. The system is based
on the procedure developed by Henikoff et ah (1984) in which Exonuclease III 
(Exo III) is used to specifically digest insert DNA from a 5" protruding or blunt 
restriction site. The adjacent sequencing primer binding site is protected by a 4- 
base 3 " overhang restriction site as it is resistant to digestion by Exo III.
8 6
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2 .2 .3 2 .1  Restriction Digestion of Plasmid DNA
Typically 5-7 pg of the plasmid was restricted with two restriction 
enzymes from one end of the insert which were known not to cut within the cloned 
insert. One enzyme produces a 5" overhang and the other a 3" overhang. The 3" |
overhang must be toward the vector, thus protecting the primer binding site and the 
other enzyme must be close to the insert. Examples of appropriate enzymes are 
listed in the manual accompanying the kit. A reaction volume of 50 pi was always 
preferred with two enzymes having compatible reaction buffers and incubation 
temperatures. If the enzymes have different salt concentration requirements then the 
lower salt buffer was used first with its enzyme and then the salt concentration was 
adjusted for the second enzyme. After an incubation of 2-3 h the digestion of the 
plasmid was checked on a gel. The rest of the digest was isolated with 
phenol/chloroform and ethanol precipitated (section 2.2.13).
I
2 .2 .3 2 .2  Exo III Digestion, Ligation and Transformation
The plasmid pellet was thoroughly resuspended in Exo III Ix buffer (66 
mM Tris-HCl, pH 8.0 and 0.66 mM MgCl2). In the mean time 7.5 pi of SI 
nuclease mix was added to the appropriate numbers of tubes which were kept on 
ice. The DNA was warmed up to 37°C in a water bath and 500-600 units of Exo III 
was mixed rapidly. After a 20 s lag period, 2.5 pi of the sample was transferred 
into a SI nuclease mix tube at 30 s intervals and mixed. When all the samples had 
been transferred, the S1 nuclease tubes were incubated at room temperature for 30 
min. The nuclease reaction was stopped by the addition of 1 pi of S 1 stop buffer to 
each tube. The S i was heat inactivated at 70°C for 10 min. At this point the Exo 
in digestion was checked by electrophoresis of 2 pi of the above samples on a 1% 
agarose TBE gel. To each sample 1 pi of Klenow mix was added and the samples 
incubated for 5 min at 37°C. Then 1 pi of dNTP mix was added to each tube and 
incubation was continued for another 10 rain. The DNA was then ligated by the 
addition of 40 pi of ligase mix to each tube and incubation at 16°C overnight. The 
following day, E. coli cells were transformed by the Hanahan method, as 
described in section 2.2.27.1.
2 .2 .3 3  Automated Dyedeoxy Terminator Cycle Sequencing
Automated sequencing was carried out on double-stranded plasmid 
template (Qiagen purified) using the Taq Dyedeoxy Terminator Cycle Sequencing 
kit (Applied Biosystems Inc, USA). A 20x reaction pre-mix contained 80 pi of 5x 
TACS buffer (400 mM Tris-HCl, 10 mM MgCli, 100 mM (NH4)2S0 4 , pH 9.0), 
20 pi dNTP mix, 20 pi of each of the Dyedeoxy A, T, G and C terminators and 10 
pi AmpliTaq DNA polymerase. A typical sequencing reaction consisted of 1 pg of 
the plasmid DNA, 5 pmol of primer (M l3 universal or reverse or gene specific 
primers), 9.5 pi of dyedeoxy reaction pre-mix and sterile water to a final vol of 20 
pi. Each reaction mix was overlayed with mineral oil and the cycle sequencing 
reaction carried out in a Perkin-Elmer Cetus thermal cycler, model 480 with the
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1following cycling parameters; rapid thermal ramp to 96°C for 2 min, 25x [96°C for 
30 sec, 50°C for 15 sec, 60°C for 4 min], soak at 4°C.
The products were purified by a modified phenol/chloroform extraction 
and ethanol precipitation, as detailed in the manual. The dried pellet was stored at 
-70°C until used.
Later sequencing reactions were carried out using the new ABI PRISM 
kit, which contained a modified AmpliTaq DNA polymerase. The reactions 
contained 0.5 pg plasmid DNA, 4-6 pmol of sequencing primer, 8 pi of the 
reaction mix (containing AmpliTaq, the four dye labelled dNTPs) and water to a 
final vol of 20 pi. The cycling parameters were exactly the same as above. As 
smaller concentrations of the dyes were used in comparison to the Taq Dyedeoxy 
Terminator Cycle Sequencing kit, only the ethanol precipitation step was required.
Sequagel-6 from National Diagnostics, USA was routinely used to cast 
the gel for DNA sequencing. The gel was pre-run with Ix TBE buffer (section 
2.2.16). The samples were mixed with 3 pi of formamide and denatured at 90°C 
for 2 min. They were chilled on ice before being loaded on the gel.
Sequence data were analysed using the Genetic Computer Group (GCG), 
Wisconsin sequence analysis package, version 8.1.
2 .2 .3 4  Expression of Heterologous Proteins
The pET system (Novagen) was chosen to subclone and express 
eukaryotic genes in E. coU under the control of strong bacteriophage T7 
transcription and translation signals.
2 .2 .3 4 .1  Subcloning the Target Gene into an Expression Vector
The recombinant plasmids (pBluescript) were purified using a Qiagen 
Midi Prep kit (section 2.2.21) and digested with suitable restriction enzymes to cut 
out the inserts. The restriction sites had to be chosen with care so that the inserts 
could be subcloned into the expression vector in the sense orientation. Digested 
inserts were gel purified using the Gene Clean kit (section 2.2.18) and ligated to
. ■i
either the pET28a, b or c translation vector, depending on the reading frame of 
expression relative to the Bam Rl site as described in section 2.2,26.
The ligated plasmids were initially cloned into a host not possessing the 
T7 RNA polymerase gene, thereby maintaining them in a transcriptionally silent 
form. The host strain chosen for transformation was E. coli DH5a, made competent 
by the Hanahan method (section 2.2.27.1). Cells were plated on LB supplemented 
with kanamycin (75 pg .m l'l) and putative clones were isolated after an overnight 
incubation at 37°C. Each colony was cultured in 3 ml LB media with kanamycin 
and 1.5 ml used for a small scale plasmid preparation (section 2.2.20). The 
recombinant plasmids were analysed for the correct insert by digesting the vector 
with the restriction enzymes used for cloning. Positive clones were stored as 
glycerol stocks until required for expression.
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2 .2 .3 4 .2  Transformation of the Expression Vector to an Expression 
Host Strain
In order to be expressed, the recombinant plasmid had to be transferred to 
suitable expression hosts, E. coli BL21(DE3) and BL21 (DE3)pLysS. They contain 
a chromosomal copy of the T7 RNA polymerase gene which is induced by the 
addition of isopropyl-p-D-thiogalactopyranoside (IPTG).
LB kanamycin plates were streaked with the transformed DH5a glycerol 
stock and a colony was used to inoculate 50 ml of LB media also supplemented 
with kanamycin. Plasmids, prepared using the Qiagen Midi Prep kit, were 
transformed into BL21(DE3) cells and BL21(DE)plysS made competent by the 
calcium chloride method (section 2.2.27.2). The transformed cells were finally 
resuspended in 200 pi of LB and 10, 20 and 30 pi of these cells were plated on LB 
kanamycin for BL21(DE3) cells or LB kanamycin/chloramphenicol for 
BL21(DE3)plysS. Separate colonies were transferred to LB plates, sectioned in a 
grid form, the following day and allowed to grow overnight at 37°C. The colonies 
were stored in this form at 4°C for up to a month.
!
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2 .2 .3 4 .3  Expression and Purification of Heterologous Protein
One colony on the gridded plate was touched briefly with a yellow tip and
this was used to inoculate a mini culture of LB supplemented with kanamycin or
!':v
kanamycin/chloamphenicol. Following overnight growth, 1 ml of this culture was 
inoculated into 100 ml LB with the appropriate antibiotic, and the cultures grown at 
225 rpm to an Agoo of about 0.5 at 30°C or 37°C. At this point the cells were in 
mid log phase and ready to be induced with 0.4 mM of freshly prepared IPTG.
Samples of 1 ml were removed at 0, 1 ,2  and 3 h after induction (for 
analysis on SDS-PAGE gels) and their A^qq was noted. The cells were pelleted in 
a microfuge, resuspended in 10 pi per 0.1 of an absorbance unit of Laemmli buffer 
containing 10 mM DTT and 5-20 pi were loaded on a 10% SDS-polyacrylamide gel 
as described in section 2.2.5.
After incubation for 3 h, the cultures were spun at 6000 rpm in a JA14 
rotor (Beckman) for 15 min and resulting pellets were washed with STE (0.1 M 
NaCl, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0). The final pellets were
•Ire suspended in 15 ml of 50 mM potassium phosphate buffer, pH 7.6 containing the 
protease inhibitors, benzamidine and leupeptin. The samples were subjected to 3-4 
passages through a French press, keeping them on ice at all times. Any precipitate 
was spun down and the samples assayed for E3 activity (section 2.2.10.2). 
Untransformed BL21(DE3) cells were used as a control for the background activity 
of bacterial E3.
2 .2 .3 5  Molecular Mass Determination by Electrospray Mass 
Spectrometry
Protein samples required for mass spectrometry were washed to remove 
all salts by diluting 50-fold with HPLC grade water and reconcentrated using 
Centricon-10 centrifugal concentrators. Mass spectrometry was performed on a 
VG Platform quadruple mass spectrometer fitted with a pneumatically assisted 
electrospray (ionspray) source and controlled via the VG MassLynx software (VG 
Biotech Ltd., Altrincham, Cheshire, UK). Carrier solvent (1:1 (v/v)
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acetonitrile/water, 0.2% formic acid) infusion was controlled at 10 pl.m l'l using a 
Harvard syringe pump (Harvard Apparatus, South Natic, MA, USA.). Protein 
samples were dissolved in carrier solvent at a concentration of 20 pmol.pl" 
centrifuged at 5000 g for 2 min and then 10-20 pi samples injected directly into the 
carrier stream. MaxEnt deconvolution (Ferrige et a l,  1992) was applied for 
quantitative analysis of the raw data using a 1.0 Da peak width and 1.0 Da per 
channel resolution.
I
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C h a p t e r  3
Purification and Mr Analysis of Dihydrolipoamide 
Dehydrogenase (E3) Isoforms from Potato Tubers
92
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3.1 Introduction
Dihydrolipoamide dehydrogenase (E3) has been purified from a variety of 
organisms and characterised at the biochemical and genetic level. Analysis of the 
plant 2-oxoacid dehydrogenase complexes and their component enzymes has lagged 
behind their bacterial and mammalian counterparts because of the low abundance of 
mitochondria per fresh weight of plant material (Randall & Miernyk, 1990a). 
Characterisation has concentrated on PDC and GDC, mainly from pea and broccoli. 
GDC is distantly related to the family of 2-oxoacid dehydrogenase complexes and 
has been especially well studied from pea leaf mitochondria (Bourguignon et a i, 
1988; Walker & Oliver, 1986a). While GDC has been purified from a number of 
plant and animal sources, it is found at its highest level in mitochondria of C3 plant 
leaves where it comprises about a third of the soluble matrix protein (Oliver et al., 
1990). The L-protein of GDC is a dihydrolipoamide dehydrogenase which has 
been shown to be a common constituent of GDC, PDC, and OGDC in pea by copy 
number analysis of the cloned gene from the mitochondria of pea leaves 
(Bourguignon et al., 1992; Turner et al., 1992). Further evidence to support this 
conclusion was provided by a comparison of the precise masses (obtained by 
electrospray mass spectrometry) of L-protein and PDC E3, also purified from the 
mitochondria of pea leaves, which were found to be identical (Bourguignon et al., 
1996).
In contrast to the detailed structural and mechanistic information available on 
GDC, the plant 2-oxoacid dehydrogenase complexes have yet to be fully 
characterised. Although the mammalian PDC complexes are confined to the 
mitochondrion, two distinct, spacially separate PDCs are found in plants, one 
located in mitochondria and the other in chloroplasts (Reid et al., 1977; Williams & 
Randall, 1979; Rubin & Randall, 1977). The mitochondrial PDC serves as a 
primary entry point for carbon into the citric acid cycle and related metabolism. 
Chloroplast PDC, on the other hand, provides the acetyl-CoA and NADH required
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for fatty acid and isoprenoid biosynthesis in photosynthetic tissues (Camp & 
Randall, 1985; Williams & Randall, 1979).
To date, it has not been possible to isolate intact OGDC from plants owing 
to its low abundance in comparison to PDC. Additionally, Poulsen and Wedding 
(1970) found that the E3 component readily dissociated from the complex during 
purification procedures. The only documented partial purification of OGDC was by 
Poulsen and Wedding (1970), who concentrated on the isolation of the E1/E2 
subcomplex of OGDC from cauliflower florets. Intact OGDC activity was obtained 
by these authors following reconstitution with saturating levels of porcine heart E3. 
The third 2-oxoacid dehydrogenase complex, BCDC, has been detected in the 
peroxisomes of mung bean hypocotyls but it has not, as yet, been purified 
(Gerbling & Gerhardt, 1988; Gerbling & Gerhardt, 1989).
Information on the subunit composition of the plant complexes is limited. 
Immunological studies, carried out by Camp and Randall (1985) and Taylor et al. 
(1992), revealed differences in the banding pattern between chloroplastic and 
mitochondrial PDC indicating the possible presence of organelle-specific subunits. 
Indeed, a distinct pea chloroplastic E3 has been isolated recently (Conner et al., 
1996) and is the first component of plastidic PDC to be identified to date. The N- 
terminal sequence of this E3 was compared with that of the pea mitochondrial E3, 
reported by Bourguignon et al. (1996) and was found to exhibit only 25-40% 
identity at the amino acid level, suggesting that it is encoded by a separate gene.
The novel isolation of three isoforms of E3 from the mitochondria of potato 
tubers {Solarium tuberosum, cv. Maris Piper) was first reported by this laboratory 
(Fullerton et al., 1996). The purification procedure included the use of an affinity 
column employing the E2/X core proteins from bovine heart PDC. Total E3 from a 
mitochondrial extract was found to bind to this column, eluting in a single peak of 
activity with high salt (1 M NaCl). This single peak of activity was then resolved 
into three peaks by Mono Q ion exchange chromatography in the ratio of 1:3:5, 
SDS-PAGE analysis of each peak revealed the presence of a 2, a p  and P2 dimers.
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arising from the three possible combinations of two polypeptide chains with subunit 
Mr values of approx. 58 000 (a ) and 56 000 (P). The presence of three E3 
enzymes was not caused by differential aggregation of a single form of E3 because 
re-application of the separate peaks to the Mono Q column resulted in their elution at 
the same point in the gradient. Moreover, proteolytic degradation was eliminated as 
a possibility since the same three E3 isoenzymes were observed from a preparation 
carried out in the absence of protease inhibitors (Fullerton et al., 1996). The 
tetraploid nature of Solanum tuberosum was found not to be a contributing factor to 
the presence of isoforms because three E3 isoenzymes were also obtained from a 
diploid strain of potatoes {Solanum phoreta). Additionally, the recent discovery of 
three E3 isoenzymes in barley leaves {Hordeum vulgare cv. Hart), another diploid 
strain, dispels the notion that this is a unique feature of potatoes (Fullerton et al., 
1996). However, further characterisation of mitochondrial E3s from other plants 
such as turnip {Brassica campestris), horseradish {Armoracia rusticana) and pea 
{Pisum sativum) indicate the presence of only one form of the enzyme in 
mitochondria (Fullerton et a l, 1996).
The heterodimeric nature of the peak 2 isoform is highly unusual as all E3s 
characterised to date are present as homodimers. The similarities between the a  and 
P polypeptides were highlighted by the fact that both cross-reacted strongly with 
antisera raised to yeast E3 and that they exhibited identical N-terminal sequences. 
Notably, the N-termini were identical with that of the pea leaf mitochondrial E3 
sequence (Bourguignon et al., 1992; Turner et al., 1992) with the exception of one 
amino acid at residue 11 where an isoleucine was replaced by a valine.
Although the three isoforms from potato tubers were purified to 
homogeneity, the yield in terms of protein was poor. Less than 0.2 mg of total E3 
protein from 5 kg of potatoes (R. Fullerton, Ph.D Thesis, Glasgow University, 
1995) was obtained after the affinity chromatography step, leading to only 0.03- 
0.06 mg of each isoform resolved by Mono Q resin. After resolution on the Mono 
Q column, approx. 0.5-2.5 units of each enzyme were obtained. Direct kinetic
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experiments were feasible on this small amount of enzyme as the assay for E3 was 
highly sensitive but experiments requiring more protein, such as investigation into 
the complex specific roles of the isoenzymes or the determination of the Mf values 
of the a  and p polypeptides by electrospray mass spectrometry, were impossible to 
carry out.
Clearly there was potential for improvement of the potato preparation in 
terms of final yield of E3. This chapter deals with attempts to increase the final 
yield of each of the E3 isoforms, for their further characterisation. Isolation of 
highly purified mitochondria generally led to 70-80% loss in E3 activity, prior to 
initiating the purification, owing to low yields of organelle recovery. Therefore, the 
rationale was to start with greater amounts of E3 by employing a crude 
mitochondrial fraction as the starting material. However, as the initial extract was 
to be obtained from a crude pellet and not highly pure mitochondria the purity of the 
E3 isoforms was expected to be compromised. Additionally, it was realised that 
scaling up the original procedure using crude mitochondrial pellets was likely to 
require amendments to the original purification scheme.
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3.2 Results
3 ,2 .1  P rep a ra tio n  of a C rude  O rg an ella r E x trac t from  Potato  
T ubers
The method for the preparation of the tuber mitochondiial extract, described 
by R. Fullerton (Ph.D Thesis, Glasgow University, 1995), was modified to reduce 
the number of steps which were routinely responsible for huge losses of the E3 
enzyme. These included purification of mitochondria from a crude pellet and the 
affinity purification step using the E2/X column mentioned in the introduction to 
this chapter. The modified method is described in detail in Materials and Methods 
(section 2.2.9.3).
Firstly, the homogenisation buffer was modified from 10 mM potassium 
phosphate (pH 7.6) to 50 mM MOPS (pH 7.6), to improve the buffering capacity 
of the medium and preserve the intactness of the organelles. Secondly, BSA 
(bovine serum albumin) was removed from all buffers as it tended to co-purify with 
the potato E3. The function of BSA was two fold: to bind free fatty acids which 
could have a detergent effect on mitochondria and to bind some alkaloids and 
polyphenols released from the vacuoles (e.g flavonoids and tannins). Two pilot 
purifications from potato tubers were carried out in the presence and absence of
BSA, and the difference in the total number of units extracted from the initial 
organellar pellets and the overall yields of mitochondrial E3 were very similar. This 
indicated that BSA was not necessary for maintaining organellar integrity or 
protecting the E3 enzyme from alkaloids and polyphenols in this method.
The isolation of mitochondria, by centrifugation through self-generating 
silica gradients (Percoll), was eliminated to avoid the 70-90% loss of this organelle 
during the long isolation procedure. The organelles were ruptured to release their 
contents by the use of 0.1% (v/v) Triton X-100 as described in Materials and 
Methods (section 2.2.9.3). A higher concentration of Triton X-100 was avoided
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since it is difficult to remove from the final, purified enzymes. Routinely, using
crude organellar pellets, it has been possible to obtain 20 to 30-fold more E3
enzyme at this stage than the original method. The initial specific activity of the 
extract obtained from the pure mitochondrial pellet was 2.8 units/mg (R. Fullerton, 
Ph.D Thesis, Glasgow University, 1995) compared with 1.3 units/mg from the 
crude organellar pellet (Table 3.1), suggesting that the crude pellet was approx. half 
as pure as the mitochondrial pellet. This surprisingly small difference in the purity 
of the crude pellet and the pure mitochondrial pellet obtained by R. Fullerton (Ph.D 
Thesis, Glasgow University, 1995) can be explained by the fact that although there 
are more contaminating organelles in the crude pellet, it is greatly enriched for 
mitochondria since large scale disruption of this organelle on PercoU gradients was 
avoided.
Heat-treatment at 65°C was retained in the protocol as a purification step, 
removing heat labile proteins and releasing any heat stable E3 still bound to the 
complexes. However, the time of heat-treatment was increased to 30 min from the 
original 10 min because it allowed a 3-fold purification (Table 3.1) compared with a 
1.5-fold purification at 10 min. Whereas R. Fullerton (Ph.D Thesis, Glasgow 
University, 1995) reported a loss of only 10% of the total E3, the modification 
resulted in an overall 20% loss. The crude, heat treated extract was bright yellow 
owing to the release of polyphenolic and other oxidising compounds from the 
potato tubers.
3 . 2 . 2  Elution of E3 from  a DEAE-52 Ion Exchange Column
Further purification of the extract on the bovine E2/X affinity column, as 
described by R. Fullerton (Ph.D Thesis, Glasgow University, 1995), was not 
performed since the binding capacity of this column was low (approx. 15 units of 
total E3); efforts to scale up the columns were difficult owing to the large amounts 
of E2/X required and the expense of the CNBr-activated Sepharose 4B. A further 
disadvantage was that preparation of the column was time consuming. However, it 
was desirable to add a chromatography step after heat treatment of the extract since
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direct application of the heat treated extract to the Mono Q column led to poor 
purification of the E3 isoforms. The method of choice was ion exchange 
chromatography using diethylaminoethyl cellulose (DEAE-52) since the scale-up of 
the columns was relatively cost effective. This chromatography step had to fulfil 
two more criteria: to remove the yellow polyphenolic compounds from the exti'act 
which tend to cause inactivation of enzymes and to concentrate the 200 ml extract to 
a manageable volume for Mono Q ion exchange chromatography. Use of 
Centriprep-30 concentrators was avoided because the concentration procedure led to 
significant loss in E3 activity.
Small scale experiments revealed that the best recoveries (up to 70-80%) 
were obtained from DEAE-52 columns (1 ml) eluting with 260 mM NaCl in 20 mM 
potassium phosphate buffer, pH 6.8. Larger DEAE-52 columns (55 ml bed vol) 
were prepared as described in Materials and Methods (section 2.2.9.4) and 
chromatography performed as described in Fig. 3.1. One peak of E3 activity was 
eluted (Fig. 3.1) which was now pale in colour and transparent. A bright yellow 
band was retained on the column which suggested that the chromatography step 
was successful in removing most of the polyphenols. Furthermore, concentration 
of the sample from approx. 200 ml after heat treatment and dialysis to 50 ml after 
chromatography was achieved without excessive loss in activity as recoveries were 
routinely in the 60-70% range (Table 3.1).
In comparison with the original preparation of total E3 isolated from 
mitochondria and purified by affinity chromatography (R. Fullerton, Ph.D. Thesis, 
Glasgow University, 1995), this modified protocol recovered 20 to 30-fold more 
units of E3 enzyme. In total, approx. 10 mg of E3 were obtained in comparison to 
0.2 mg by the original method. Both the affinity chromatography step of the 
original method and the DEAE-52 ion exchange chromatography performed in the 
modified method produced a 30 to 35-fold purification. Although the E3 from the 
affinity chromatography step was extremely pure (Fig. 3.2, lane 5), the DEAE-52 
column sample was not completely homogeneous. An indication of the difference
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Fig. 3.1: Elution of E3 activity from the DEAE-52 ion exchange column
Heat treated potato tuber extract was dialysed into 20mM potassium 
phosphate buffer, pH 6.8 (containing 1 mM DTT, 1 mM EDTA, 1 mM PMSF 
and 1 mM benzamidine-HCl). The sample was divided in half (2 x 100 ml) 
and applied to two separate columns packed with DEAE-52 (55 ml bed 
volume) which had been equilibrated with 20 mM potassium phosphate 
buffer, pH 6.8. Unbound protein was washed through with 1 vol of 120 mM 
NaCl and E3 was eluted with 260 mM NaCl (both prepared in 20 mM 
potassium phosphate buffer, pH 6.8). Fractions (9 ml) were collected and 
and assayed for E3 activity (2.2.10.2). Total units of activity were plotted 
against fraction number.
(Total units = pmol of NADH formation/min/9ml)
I
M 1 2 3 4 5
Fig. 3.2: Analysis of purification of potato tuber E3 by E2/X 
affinity chromatography
Protein from various steps in E3 purification on the E2/X affinity column 
from potato tuber mitochondria was electrophoresed on 10% (w/v) SDS- 
PAGE and silver stained. M: molecular weight markers, 1; purified porcine 
heart E3, 2: crude potato mitochondrial extract, 3: heat-treated mitochondrial 
extract (65°C/10 nun), 4: unbound protein, 5: peak E3 activity fraction from 
eluant
Reproduced from Fullerton et al. (1996)
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in purity of the two samples is provided by a comparison of the specific activities, 
which were approx. 100 units/mg (purification to homogeneity by affinity 
chromatography, R. Fullerton, Ph.D Thesis, Glasgow University, 1995) and 42 
units/mg (purification by DEAE-52 chromatography. Table 3.1). Additionally, the 
specific activity suggests that the E3 should be about 40% of the total sample after 
purification by DEAE-52 chromatography. Nevertheless, the enrichment achieved 
allowed the purification of the B3 isoforms to near homogeneity in the subsequent 
steps.
3 . 2 . 3  Resolution of the E3 Enzyme by Source 15Q Ion Exchange 
Chromatography
The final stage involved further purification and resolution of the three 
peaks of E3 activity on an ion exchange chromatography column attached to an 
FPLC apparatus. The 1 ml Mono Q anion exchange chromatogi’aphy column used 
in the original method was replaced with an 8 ml Source 15Q column to increase the 
binding capacity for the E3 enzyme. This strong anion exchanger is identical to 
Mono Q except that the bead size is larger. The sample, eluted from the DEAE-52 
column, was applied to the Source 15Q column as described in Fig. 3,3. E3 
activity assays (section 2.2.10.2) confinried the elution of three peaks of E3 activity 
(Fig. 3.3) in agreement with the results of Fullerton et aL (1996). However, it was 
noticed that the peak ratios were somewhat different. On average the peak ratios 
were 1:3:2 in comparison with 1:3:5 reported by R. Fullerton (Ph.D Thesis, 
Glasgow University, 1995). A single column run was sufficient to resolve the 
entire sample, allowing nearly 40-50% of the E3 enzyme to be recovered (Table
3.1). The units of activity were in the range of 60 units for peak 1, 185 units for 
peak 2 and 65 units for peak 3; nearly 20-fold more enzyme per peak compared 
with purification from isolated mitochondria. The protein concentrations were in 
the range of 1-3 mg per peak in comparison with 0.03-0.06 mg of E3 obtained per 
peak with the original method. The purification factor was difficult to determine 
since the single E3 sample was being separated into thi-ee distinct activities.
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Fig. 3.3: Resolution of the DEAE-52 purified potato extract by 
Source 15Q ion exchange chromatography
The peak fractions eluted from the DEAE-52 column were pooled and 
dialysed into 50 mM imidazole buffer containing 1 mM DTT before 
being applied to the Source 15Q column (8 ml) in buffer A (1 mM 
EGTA, 1 mM p-mercaptoethanol, 10 mM potassium phosphate buffer,
pH 6.8) at a flow rate of 1 ml.min-T Proteins were eluted with a linear
gradient (240 ml) of increasing potassium phosphate (10-400 mM in
buffer A) at a flow rate of 2 ml.min-1. Fractions (2 ml) were collected
for E3 activity assays (section 2.2.10.2).
O Units of E3 activity per fraction. (|imol NADH.min-l.2mFl)
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Fig. 3.4: Purification of the E3 isoforms from a crude organellar 
pellet from potato tubers, using the modified protocol
E3 was purified from potato tubers as described in the text. Samples 
(I mi) were collected at each stage and resolved on a 10% (w/v) 
SDS-PAGE gel (in duplicate) as described in Materials and Methods, 
section 2.2.5 and then subjected to silver staining (section 2.2.6). 
Peak 1: a2  isoform Peak 2: a|3 isoform Peak 3: P2 isoform
Analysis of the protein in each peak by SDS-PAGE and silver staining (Fig.
3.4) revealed that the purity of each E3 isoform was close to homogeneity apart 
from two or three low contaminating bands. In contrast, the isoforms reported 
by R. Fullerton (Ph.D Thesis, Glasgow University, 1995) had been purified to 
complete homogeneity. Therefore, the scale-up procedure increased the final yield 
of enzyme at the cost of slightly reduced purity. The gel showed that peaks 1 and 3 
represent the a 2 and p2 homodimers respectively and peak 2 the a p  heterodimer. 
The a  and P polypeptides are clearly distinguishable in the peak 2 sample.
3 . 2 . 4  Determination of the Subunit M olecular Mass of E3 by 
Electrospray Mass Spectrometry (Es-Ms)
An important consequence of the increased yield of the E3 isoenzymes was 
that it provided sufficient protein for the precise determination of subunit Mj- values 
by ES-MS. All traces of salt were removed from the E3 isoforms as described in 
Materials and Methods (section 2.2.35) to ensure low background signals from 
contaminating ions. ES-MS was performed by T. Krell at the facility based at
"sStrathclyde University.
Fig. 3.5A presents the electrospray mass spectra of the a p  heterodimer 
(peak 2 sample) and Fig. 3.5B is the MaxEnt deconvolution of the spectra showing 
the Mr of the a  and p polypeptides. The Mr for the a  polypeptide was calculated to 
be 49 446 ± 12.28 and the Mr for the p polypeptide 49 562 ± 6.83; a difference of 
approx. 116 Da. The small difference in mass between the two polypeptides 
present in this sample was clearly discernible by ES-MS, a measure of the accuracy 
of this technique. A confirmation of the two values was obtained from two separate 
samples by analysing the a 2 homodimer from peak 1 (Fig. 3.6A) and the p2 
homodimer from peak 3 (Fig. 3.6B). As can be seen from MaxEnt deconvolutions 
of the spectra, the Mr of the two major peaks in the sample agree very well with the 
Mr of the a  and P polypeptides cited above. Interestingly, these Mr values were 
lower than the ones obtained by SDS-PAGE (Fig. 3.4) which were approx. 58 000 
for the a  polypeptide and 56 000 for the p polypeptide.
1 0 6
Fig. 3.5A; Electrospray mass spectra of the a p  heterodim eric E3 
isoenzyme from potato tuber mitochondria
Fig. 3.5B: MaxEnt deconvolution of electrospray mass spectra of the 
aP heterodimeric E3 isoenzyme from potato tuber mitochondria
The Mr of the a  polypeptide is 49 446 ± 12.28 and the Mr for the p polypeptide is 
49 565 ± 6.83.
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Fig. 3.6A: MaxEnt deconvolution of electrospray mass spectra of the 
P2 E3 isoenzym e from potato tuber mitochondria; Mr for the p
polypeptide
Fig. 3.6B: MaxEnt deconvolution of electrospray mass spectra of the 
a 2 E3 isoenzym e from potato tuber mitochondria; M r for the a
polypeptide
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3 .3  Discussion
The aim of scaling up the original method for the purification of the E3 
isoenzymes was completed successfully since the yield of each isoform was 
increased 20-30 fold from the original method. The Source 15Q step was effective 
in resolving the three isoforms (Fig. 3.5). Approx. 1-3 mg of protein/peak were 
obtained in the final sample compai'ed with only 0.03-0.06 mg/peak obtained by 
purifying mitochondria prior to purification. However, in comparison with R. 
Fullerton (Ph.D Thesis, Glasgow University, 1995) who had reported completely 
pure E3s, the isoforms did contain some contaminating bands of low Mr value (Fig.
3.4). This is a reflection of the extraction of a crude (2-fold) organellar pellet as 
opposed to a pure mitochondrial pellet which was required for the scale-up 
procedure. Hence, the increased yield was at the cost of slightly reduced purity. 
The addition of the DEAE-52 column had the advantage that it removed most of the 
polyphenols from the sample at an early stage. This was important because these 
oxidising compounds are known to inhibit plant enzymes. Moreover, it provided a 
quick method of purification (36-fold) and concentration in one step, with minimal 
loss in E3 activity.
An important observation, with regard to the crude nature of the extract, 
was that no E3 species other than the three original mitochondrial isoforms were 
detected. This is strongly suggestive of E3s with a mitochondrial origin as they 
were directly comparable to the isoenzymes described by R. Fullerton (Ph.D 
Thesis, Glasgow University, 1995). However, very similar E3 isoforms existing 
in other organelles (i.e storage plastids of potato tubers) may not be distinguished 
by this method of purification. The ratio of the third pealc (compared to peaks 1 and 
2) eluting from the Mono Q column was found to be half the value reported in the 
original method. An explanation was provided subsequently by R. Cook 
(unpublished observations) who examined the heat stabilities of the three isoforms. 
Peak 3 (p2 isoform) was found to undergo 50% inactivation over a 30 min
111
incubation at 67°C. This result correlated well with the apparent reduction in 
activity of this isoform, presumably resulting from the heat treatment step.
The scaled-up purification procedure provided enough material for a precise 
Mr determination of the a  and p polypeptides by ES-MS. Previous attempts had 
failed because insufficient enzyme was available for the process. The Mr values 
were found to be 49 446 (a) and 49 562 (p). Thus, the Mr values from SDS- 
PAGE were over-estimated by approx. 12-15%. The discovery of the very small 
difference in mass between the two polypeptides was unexpected, especially as they 
could be clearly distinguished by SDS-PAGE. In addition, recent preliminary 
evidence from our laboratory (R. Cook, unpublished observations) has suggested 
that each isoform exhibits distinct biochemical properties. They were found to have 
differing Km values for NAD+ (120 p.M [ai], 200 |uM [ap] and 500 juM [P2]) and 
for dihydrolipoamide (80 [iM [a 2l, 220 qM [ap] and 240 pM  [p2]). Similarly, 
they had differing heat stabilities, with the a 2 exhibiting the greatest stability over a 
30 min incubation at 80°C. Their sensitivity to high ionic strength varied with the 
a 2 form, again being more resistant to inactivation with NaCl (R. Cook, 
unpublished observations).
It was unclear why the polypeptides ran anomalously through a denaturing 
polyacryamide gel as the larger p form travelled faster than the smaller a  form. The 
determined Mr values of the a  and p polypeptides are the same range found for E3 
subunits from a variety of sources. A comparison of Mr values, as predicted by 
sequence data, is presented in Table 3.2. In all cases, the Mr found by SDS-PAGE 
was approx. 6-8 000 more than the precise Mr determinations.
Of considerable interest is whether the two polypeptides are the products of 
two different genes or whether they are the products of differential splicing. Only 
sequence analysis will be able to disclose their relationship with each other. As 
there have been no reported post-translational modifications of E3s in any system, it 
is difficult to attribute post-translational modifications as a reason for the mass 
difference, or indeed the biochemical variations between the isoforms. Although
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the first 28 amino acids were shown to be identical by N-terminal sequencing 
(Fullerton et aL, 1996), it is possible that the small difference in size is due, co­
incidentally, to substitutions of amino acids very similar in mass in view of the 
differing enzymatic and protein-chemical characteristics of the three mitochondrial 
isoforms.
Table 3.2
A comparison of the Mr values from a variety of E3 subunits from
their deduced amino acid sequences
Source of E3 Mr /  subunit Reference
Human liver 50 216 Pons etal. (1988)
Saccharomyces cerevisiae 54 010 Ross et aL (1988)
Pseudomonas putida (LPD-Val) 48 949 Burns etal. (1989b)
Azobacter vinelandii 49 436 Westphal and De Kok (1988)
Pea leaf mitochondria 49 721 Bourguignon et al. (1992)
Potato tuber mitochondria (a  ) 49 446 This study
Potato tuber mitochondria (p ) 49 562 This study
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Chapter 4
Analysis of the Possible Complex Specific Roles of the 
Potato Tuber E3 Isoforms by Reconstitution of Intact
OGDC Activity
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4.1  Introduction
Considerable interest has focused on the question of whether all 
mitochondrial 2-oxoacid dehydrogenase complexes share a common E3 or whether 
each complex uses a different E3 subunit, each encoded by separate genes. E3s 
from a variety of organisms are found to have extensive identity at the amino acid 
level (human liver E3 shows 96% identity with that of pig heart E3) and remarkable 
similarity in theii' tertiary structures (Carothers et aL, 1989). They are all organised 
into four domains; the FAD-binding domain, the NAD-binding domain, the central 
domain and the interface domain, with a high degree of sequence conservation 
occurring within these domains.
Immunological data (Matuda & Saheki, 1985) and observations on human 
genetic disorders (Stansbie et aL, 1986) have suggested that a single E3 for PDC, 
OGDC, BCDC and probably GDC (Kochi et aL, 1986; O ’Brien, 1978) exists in 
mammals. However, there is some isolated evidence conflicting with this general 
view. Immunological evidence suggests the existence of two isoenzymes of E3 in 
rat liver; one possibly being specific for GDC (Carothers et aL, 1987). In support 
of this observation, patients with E3 deficiencies have excesses of the 2-oxoacids 
although they display normal glycine metabolism (Carothers etal., 1987).
In the bacterial organisms, Azotobacter vinelandii 2ind Pseudomonas 
fluorescens, one E3 gene product is present. Other species provide considerable 
evidence in support of distinct E3s complementing the 2-oxoacid dehydrogenases. 
Escherichia coli, was always thought to have a single E3 gene {Ipd), found on the 
PDC operon, which provided E3 for PDC and OGDC (Spencer & Guest, 1985). 
Incredibly, a previously unknown form of E3 was purified from a Ipd" E. coli 
mutant (Richarme, 1989). This distinct gene product was nearly 10 000 Da smaller 
than the normal E. coli enzyme, with a Mr of 46 000 Da and had been overlooked 
as it was expressed at low levels in wild-type E. coli. The function of this
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additional E3 is uncleai* but it was proposed to be involved in the binding protein- 
dependent galactose transport system.
Pseudomonas putida can use branched-chain amino acids for growth, and 
consequently possesses an E3 (LPD-Val) specific to BCDC (Sokatch et aL, 1981) 
in addition to the distinct E3 (LPD-Glc) component for OGDC, PDC (Burns et aL, 
1989b) and GDC (Sokatch & Burns, 1984). A third E3 (LPD-3) was discovered 
by Burns et aL (1989a) which was related to LPD-Glc. Alcaligenes eutrophus also 
has two distinctly different E3 components, one for PDC and the other for OGDC 
but it is not yet clear whether they are interchangeable. Freudenberg et aL (1989) 
reported the first purification of a specific GDC E3 from the anaerobic, glycine 
utilising, Eubacterium acidaminophilum which was unusually small (35 kDa).
E3s have been found in the bloodstream form of the eukaryotic African 
parasite, Trypanosoma brucei (Danson et aL, 1987) and halophilic archaebacteria 
(Danson et aL, 1984). This is an unusual situation as these organisms are known 
to lack the 2-oxoacid dehydrogenases, suggesting a cellular function for E3 which 
is yet to be elucidated.
In plants the situation also requires further clarification. However, initially 
Turner et aL (1992) and Bourguignon et al. (1992 & 1996), both publishing the 
sequence for GDC E3 from pea mitochondria, simultaneously concluded that the 
same E3 was shared between PDC, OGDC and GDC. Uniquely in plants, a 
distinct PDC is found in chloroplasts and as a reflection of this, a distinct E3 was 
recently purified from this organelle (Conner et aL, 1996).
Whilst it seems that the organisation of the E3 enzyme is unpredictable, it is 
surprising that three different enzymes have been discovered in potato tubers as 
Bourguignon et al. (1996) had confirmed the presence of one E3 in pea leaf 
mitochondria. Furthermore, analysis of other legumes (horseradish and turnip) in 
our laboratory revealed the presence of only one E3. More recently three 
isoenzymes were found in barley leaf mitochondria (Fullerton et aL, 1996), 
indicating that multi-isoforms of E3 are not unique to potatoes. As detailed in
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chapter 3, the isoenzymes in potato have arisen as a consequence of the existence of 
two polypeptide subunits; a  and p, which have the ability to combine into distinct 
Œ2, aP  and P2 dimeric species. Their physiological roles in potato and barley are 
not known but it is seems, at least in the potato, that they may have differing 
biochemical properties (R. Cook, unpublished observations).
Since the existence of complex specific isoforms has been reported in some 
prokaryotes, the presence of multiple isoforms may suggest that they are playing 
similar roles in potatoes. Reconstitution studies were designed to determine if one 
isoform would preferentially promote the activity of OGDC stripped of its E3 
component. OGDC was chosen because it is possible to dissociate only the E3 
component from the E1/E2 core, unlike PDC where both the E l and the E3 
components dissociate together. Initially, bovine heart OGDC E1/E2 core was used 
in consideration of its ready availability in the laboratory. It had been demonstrated 
that potato E3 has some affinity to the mammalian core since the enzyme could bind 
to an affinity column prepared with the E1/E2 core from bovine heart OGDC, 
similar to the E2/X column developed by Fullerton et ah (1996). Upon separation 
on a Mono Q column, the elution profile of the total E3 purified on this affinity 
column, showed three peaks of E3 activity which were identical to the potato 
isoforms described in Fig. 3.4 of chapter 3 (data not shown). Once the conditions 
for reconstitution were established, the experiments were to be extended to OGDC 
from potato tubers. The ability of E3 from heterologous sources (pig heart, bovine 
mucosa and Candida utilis [yeast]) to reconstitute the activity of bovine heart OGDC 
was to be compared to that of the potato isoforms. Analysis of PDC reconstitution 
by the potato isoforms was perfomied in conjunction with other researchers in the 
laboratory.
117
4 .2  Results
4 . 2 . 1  Dissociation of Bovine H eart OGDC
The first step was to dissociate and separate the E1/E2 subcomplex from the 
E3 component of bovine heart OGDC, prepared as described in Materials and 
Methods (section 2.2.9.1). Dissociation was first attempted using high salt (2 M 
NaCl) and alkaline conditions used previously in the laboratory for the dissociation 
of PDC into E2/X and E1/E3 subcomplexes. OGDC was incubated for 1 h as 
described in Fig. 4,2 (legend), after which the E1/E2 subcomplex was separated 
from the dissociated E3 component by gel filtration on a Superose 12 column (bed 
volume-100 ml) attached to a FPLC apparatus. Protein eluted in two peaks (Fig.
4.1), at 32 ml (void volume) and approx. 66 ml. SDS-PAGE analysis showed that 
the high Mr E1/E2 subcomplex eluted in the void volume (Fig. 4.2, peak 1); 
however alkaline pH treatment was found to be too harsh for the OGDC since the 
E l component was also being partially stripped from the core and co-eluting with 
the E3 fraction (Fig. 4.2, peak 2).
Dissociation was modified to a 20 min incubation on ice in the presence of 
lower salt (1 M NaCl) at neutral pH. Additionally, 1 mM MgCU and 0.2 mM 
ThDP were included to maintain the stability of the E l component. Again, the 
protein eluted in a similar profile from the gel filtration column as was illustrated in 
Fig. 4.1. SDS-PAGE analysis of the peak fractions (Fig. 4.3, peak 1) confirmed 
that the E1/E2 core was intact with no E3 contamination. Surprisingly, residual 
background OGDC activities were measurable in the E3 fraction which would 
interfere with reconstitution activities. The problem was solved by heat treatment of 
the E3 fraction at 65°C for 10 min followed by pelleting the denatured protein, 
which eliminated background activity without loss in E3 activity (Fig. 4.3). There 
is a heat stable contaminant (Mr 45 000) in the E3 sample which appears to co- 
purify with the OGDC sample on occasions. Attempts to identify it by N-terminal 
protein sequencing were unsuccessful.
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Fig. 4.1: Dissociation of bovine heart OGDC
OGDC (15 mg) was treated with 1 M NaCl as described in section 2.2.9.2 
prior to loading onto a Superose 12 FPLC column (100 ml bed volume). 
Running buffer (1 mM DTT,1 M NaCl, 0.01% (v/v) Triton X-100 and 50 
mM potassium phosphate buffer, pH 7.6) was pumped through the column at
a flow rate of 1 ml.min-1. Fractions (2 ml) were collected and their
absorbances measured at 280 nm.
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4 . 2 . 2  Time Course for Reconstitution of OGDC Activity
Initially, a time course was carried out to determine the optimal conditions 
required for maximal reconstitution of bovine heart OGDC activity after mixing the 
E1/E2 core with the native OGDC E3 (purified as in section 2.2.9,1). 
Reconstitution assays were performed as described in Materials and Methods 
(section 2.2.10.4). The zero time point was accomplished by adding the two 
components directly to the assay cuvette without pre-incubation. The extent of 
reconstitution was calculated as a percentage of original OGDC specific activity, 
determined before dissociation. As can be seen in Fig. 4.4, 60% of intact activity is 
already observed at zero time. This spontaneous re-assembly is an inherent 
property of multienzyme complexes. However, it was unclear as to why it took an 
additional 3-5 min for maximal re-assembly (70-80%) to occur. Recently, 
Sanderson et al. (1996b) provided an explanation for this effect by performing a 
time course of reconstitution of PDC activity after pre-incubation of the E2/X and 
E1/E3 components in 50 mM potassium phosphate buffer containing 2.6 mM 
cysteine-HCl. They reported that maximal levels of reconstitution (70-80%) of 
PDC activity was attained immediately and this high level was maintained over 40 
min (Fig. 4.5). The explanation offered for the elimination of the lag phase for 
maximal activity was that pre-incubation in buffer containing cysteine-HCl (a 
reducing agent) enabled a degree of re-activation of the separated components due 
to the reducing influence of sulphydryl agents. Therefore, the increase in activity 
over time shown in Fig. 4.4 does not represent further reassembly of the E1/E2 and 
the E3 components but a minor reactivation of the individual enzymes. A similar 
effect is often observed when purified OGDC is incubated in buffers containing 
DTT or (3-mercaptoethanol.
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Fig. 4.4: Time course of reconstitution of bovine heart E1/E2 core 
with native E3
E1/E2 (60 ng) from bovine heart OGDC was incubated with an excess of 
E3 (30 ]Lig) at 30°C. Aliquots (equivalent to 5 |ig E1/E2) were removed 
and assayed for OGDC activity (section 2.2.10.1) at prescribed time 
points. For the zero time point, components were added directly to the 
assay cuvette. Results represent the average of duplicate estimates 
differing by less than 5% and are presented as percent of original OGDC 
activity, measured before dissociation.
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Fig. 4.5: Time course of reconstitution of bovine heart PDC activity by 
re-assembly of E2/X and E1/E3 subcomplexes
Equal volumes of E2/X and E1/E3, diluted 1:10 in assay buffers A ( 0 —0 )  or A 
and B ( # - # )  (see Methods section 2.2.10.1 for buffers) to 0.1-0.2 mg.ml-l, were
preincubated together at 30°C in the cuvette containing buffers A and B minus 
substrate for the times indicated, prior to initiation of catalysis by the addition of 
pyruvate. The dissociated fractions exhibited negligible complex activity. Specific 
activity reconstituted was determined from duplicate assays and expressed as a % 
of the specific activity of the intact complex prior to dissociation.
Reproduced from Sanderson et al. (1996)
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4 .2 .3  R eco n stitu tio n  of OGDC A ctivity  by H om ologous and  
H eterologous E3 Enzym es
The aim of these experiments was to analyse the ability of the potato tuber 
E3 isoenzymes to reconstitute OGDC activity. The levels of reconstitution were 
compared with those obtained for native OGDC E3, bovine heart PDC E3, Candida 
utilis E3 (yeast) and porcine heart E3s. The E3 samples were all prepared as in 
section 2.2.9.7 and potato E3 isoforms as in 2.2.9.3.
The method of reconstitution was described in section 2.2.10.4 and results 
were presented as a percentage of original OGDC activity (Fig. 4.6). Native E3 
and bovine heart PDC E3 consistently gave a high level of reconstitution of activity 
(60-80%) over several experiments, confirming that E3s from both these complexes 
were completely interchangeable. In comparison, porcine heart E3 was only able to 
sustain intermediate levels (20%) of activity. This was considered highly unusual 
since it has high sequence identity with human liver E3 (96%). The porcine heart 
and yeast E3s, being commercial preparations may have been contaminated with an 
inhibitory component. However, these E3s, after purification by Mono Q ion 
exchange chromatography, still provided the same results. An interesting situation 
was discovered when reconstitution was attempted using bovine mucosal E3. 
Activities of only about 15% were sustainable with bovine mucosal E3 (data not 
shown) indicating that there may be tissue specific isoforms of the E3 component in 
mammalian systems. In each case, reconstitution activity reached saturation with 
1.5 |Ug of E3 to 5 pg of E1/E2 core. This correlated closely with the theoretical 
stoichiometry of E3 representing one fifth of the intact complex by weight and 
suggested high affinity of binding to the E1/E2 subcomplex.
Having demonstrated the ability to stimulate reconstitution of OGDC activity 
to varying levels employing E3s from various sources, the ability of the three 
individual potato isoforms to sustain OGDC activity was analysed. Unfortunately, 
the potato isoenzymes were unable to stimulate any intact activity of bovine heart 
OGDC, even with 100-fold excess enzyme (not shown in Fig. 4.6). The situation
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Fig. 4.6: Comparison of reconstitution of bovine heart OGDC activity by 
re assembly of native and heterologous E3s with the E1/E2 subcomplex.
Purified E1/E2 subcomplex of OGDC (Materials and Methods, section
2.2.9.2), was incubated with increasing amounts of E3 from bovine heart
OGDC (X™X), bovine heart PDC (■  -B ), porcine heart E3 ( A -  A ), yeast
E3 and the three potato tuber E3 isoforms ( # - #  ). Samples were incubated
for 12 min at 30°C with a fixed amount of bovine heart OGDC E1/E2 core
(7 fig). All samples were present in assay buffer A (minus NAD+). Intact
OGDC was assayed in duplicate (section 2.2.10.1) and reconstituted activity 
expressed as a % of original complex activity.
A competitive binding assay was performed with E1/E2 core (7 jig) and a 
fixed level of native bovine heart OGDC E3 (2 jig) in the presence of
increasing amounts of yeast E3 as indicated (O  -O ) and incubated for 12 min
at 30°C before assaying.
Reproduced from Sanderson et al. (1996b)
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was similar to that of yeast E3, which failed to reconstitute any OGDC activity. 
The complete lack of reconstitution obtained with these E3s was unexpected so it 
was essential to determine if this was caused by an inability of these E3s to 
associate with the OGDC core in the reconstitution assay.
4 . 2 , 4  E3 Binding Analysis
As the potato and yeast E3 failed to stimulate reconstitution with the E1/E2 
core, their binding capacity for the core was investigated. Binding to the 
mammalian core by the potato E3s had been expected as they had been purified 
initially in small amounts by binding to bovine heart OGDC E1/E2 subcomplex, 
immobilised to cyanogen bromide Sepharose 4B matrix. Assays were carried out,
whereby increasing amounts of yeast E3 were incubated with a fixed amount of 
E1/E2 subcomplex and bovine heart E3. The maximum activity of reconstitution
obtained with the core and the bovine heart E3 was rapidly decreased to zero 
activity with about 10 pg of yeast E3 (Fig. 4.6). At equimolar concentrations of the 
two E3s, activity was less than 40% of the original reconstituted activity suggesting 
a specific, high affinity interaction between yeast and bovine E3 for the E3 binding
'sites on the E1/E2 core. At a 4-fold excess of yeast E3 with respect to bovine E3,
there was total inhibition of reconstituted OGDC activity.
Similar experiments with the potato E3 found that they competed poorly
with the native E3 (Fig. 4.7), although there appeared to be a weak interaction of
the a 2 ocp and p2 isoenzymes with the core since there was a 40% decrease in 
’
original activity in the presence of 40 to 50-fold excess of these isoforms. 
Unfortunately, limitations in amounts of each isoform precluded a more detailed
investigation of their ability to interact with the mammalian E1/E2 OGDC
subcomplex. The possibility of the contaminating bands in the potato E3 
preparations interfering in binding interactions does exist, but it was not 
investigated further in this context. In summary, it appears that the potato 
mitochondrial « 2, a p  and P2 E3 isoforms interact weakly with the mammalian 
OGDC E1/E2 subcomplex. This is in contrast to yeast E3, which forms a tight
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Fig. 4.7: Percent decrease in reconstituted OGDC activity resulting 
from competition between the native E3 and potato tuber E3 isoforms
Increasing amounts ot the E3 isoforms from potato tubers were added to a 
fixed amount of E1/E2 core (5 p-g) from bovine heart OGDC and the lowest 
amount of native E3 required to give maximal, initial reconstitution (2 pg). 
Following a 12 min incubation at 30°C, OGDC activity was assayed as 
described in section 2.2.10.1. Results were presented as percent of original 
OGDC activity.
□ GL2 E3 (peak 1) ♦  a p  E3 (peak 2) o P2 E3 (peak 3)
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association with this assembly as judged by their relative abilities to act as 
competitive inhibitors with the homologous E3 enzyme.
4 . 2 . 5  Partial Purification of OGDC from Potato Tubers
The next stage was to test the potato isoforms with a homologous, potato 
OGDC core complex as reconstitution had failed to stimulate mammalian OGDC 
activity. Intact OGDC has never been purified, mainly because it is present at low 
levels in plant tissues and is thought to dissociate in dilute solution. Consequently, 
all reported investigations have concentrated on PDC from various plant sources. 
Pouls on and Wedding (1970) are credited with the only known report of partial 
OGDC purification from cauliflower florets where intact activity was achieved by 
reconstitution with porcine heart E3.
A crude isolation of OGDC was attempted from a potato tuber 
mitochondrial extract, following the work of A. Carmichael (Ph.D. Thesis, 
Glasgow University, 1994). Potato tuber mitochondria were isolated as described 
in Materials and Methods (section 2.2.9.5) and solubilised with 0.1% (v/v) Triton 
X-100. Total OGDC activities were very low compared with PDC activities (0.81 
pmol.min-l and 20.6 pmol.min'l, respectively). Poulson and Wedding (1970) had 
reported that NADH oxidase activity, which tended to mask OGDC activity in plant 
extracts, could be eliminated by freeze/thaw treatment of the mitochondria. This 
method of extraction was examined but found to have no effect on the final 
recorded activities.
The extract was applied to a Superdex 200 gel filtration column (bed
■
volume-100 ml). As illustrated in Fig. 4.8, PDC and OGDC activities were eluted 
in a single peak in the void volume; however, OGDC was barely detectable. E3 
activity was found in two peaks, at 46-50 ml (void volume fractions) and 70-80 ml.
The void volume E3 is clearly associated with the PDC and OGDC and the second 
peak is thought to represent E3 dissociated from PDC, OGDC and GDC. This 
conclusion was reached because GDC is known to exist in a dissociated state on
Ï
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Fig. 4.8: Elution profile from a Superdex 200 gel filtration column of 
PDC, OGDC and E3 activities from a potato mitochondrial extract
Potato tuber mitochondrial extract (3ml) was applied to a Superdex 200 gel 
filtration column (100 ml bed volume) and protein eluted with 50 mM 
imidazole, pH 6.8 containing 1 mM DTT. E3 , OGDC and PDC activities
were recorded as nkatals.ml-l. 
o E3 activity ^  PDC activity n OGDC activity
release from pea mitochondria (Bourguignon et a l, 1988; Walker & Oliver, 1986a); 
therefore, the L-protein would be expected to elute as ‘free’ enzyme.
It was possible that the Superdex gel filtration step was promoting the 
instability of the complexes due to excessive dilution of the extract. Accordingly, a 
smaller (25 ml) column was used, which led to poor resolution of the E3 peaks.
PDC and OGDC activities were still found in the same ratios as previously.
Reconstitution assays were carried out in the hope that the poor recovery of OGDC 
activity by gel filtration was due to the complete dissociation of the E3 component.
In this case the E1/E2 would still be present in the void volume fraction. Although 
PDC was also present in the sample, differential binding of the three E3 isoforms 
should be recognisable. However, all three potato E3 isoforms failed to stimulate 
OGDC and PDC activity when added to the void volume fraction.
4 .2 .6  P a r t i a l  P u r if ic a t io n  of O G D C  fro m  C a u lif lo w e r 
M itochondria
It was possible that potato tubers, being storage organs, naturally contained
■
less OGDC than other plant tissues. Hence, as the isolation procedure from potato 
tuber mitochondria had been unsuccessful, it was decided to use a modified method 
of mitochondrial purification by Poulson and Wedding (1970) from cauliflower 
florets. This is the only known report of the partial purification of OGDC from 
plants and, importantly for these experiments, intact activity had been obtained by 
reconstitution with porcine heart E3. The method is described in Materials and 
Methods (section 2.2.9.6). The procedure by which Poulson and Wedding had 
isolated the E1/E2 core of OGDC, by a series of ammonium sulphate precipitation, 
was not repeated since optimisation of the method was impossible in the time 
available. Instead, the isolated mitochondria were extracted with a 30 min 
incubation at 4°C in the presence of 0.1% (v/v) Triton X-100. The crude extract 
was assayed for enzyme activity and then reconstitution assays were performed 
with increasing concentrations of porcine heart E3 to try to stimulate OGDC and 
PDC activity. Fig. 4.9 presents the results of reconstitution with porcine heart E3.
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Fig. 4.9: Stimulation of cauliflower mitochondrial OGDC and 
PDC by reconstitution with increasing amounts of porcine 
heart E3
A fixed amount of mitochondrial extract was incubated at 30°C for 
20min with increasing quantities of pig heart E3. Assays for PDC 
and OGDC were carried out as in section 2.2.10.1. Insufficient 
mitochondrial material precluded duplicate assays.
Ü1 PDC activity E  OGDC activity
Levels of recordable OGDC activity were low but the ratio of OGDC to PDC 
activity (1:3) was readily measurable, in comparison with the potato tuber extract. 
Approx. 1.3-fold stimulation of OGDC and PDC activity is evident with excess 
porcine E3, indicating that the low levels of PDC and OGDC activity are unrelated 
to dissociation of the E3 component.
Confirmation of the presence of intact complexes was obtained by 
dissociating the E3 component from the core with high salt levels and then 
reconstituting intact activity with porcine heart E3. The extract was incubated in the 
presence of 1 M NaCl for 30 min at 4°C to remove the E3 components from the 
complexes. The extract was then centrifuged at 80 000 g for 16 h and the pellet, 
containing the E1/E2 core of OGDC and E2/X core of PDC, was resuspended in 20 
mM potassium phosphate buffer, pH 7.6. As illustrated in Fig. 4.10, salt treatment 
led to a 75% decrease in OGDC activity. Significantly, E3, at a level of 15 jig, 
produced a 3-fold stimulation in activity to 70-80% of original activity but 
surprisingly, reconstitution with the potato E3 isoenzymes did not promote any 
stimulation in activity (data not presented). Similar results were found when PDC 
was assayed in the same sample.
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Fig, 4.10: Reconstitution of OGDC activity from cauliflower mitochondria 
with increasing amounts of pig heart E3
Salt treated (1 M NaCl) mitochondrial extract was centrifuged at 80 000 g 
to pellet the E1/E2 core leaving the E3 component in the supernatant. Following 
dialysis to remove the salt, a fixed amount of E1/E2 core was incubated at 30°C for 20 
min with increasing amounts of pig heart E3. Reconstituted OGDC activity was 
plotted against increasing amounts of pig heart E3. Insufficient mitochondrial 
material precluded duplicate assays.
4.3 Discussion
'The reconstitution experiments with the E1/E2 core of bovine heart OGDC 
highlighted the contrasting abilities of a number of different E3 to stimulate OGDC 
activities. In spite of the extensive homologies between bovine mucosal, porcine 
heart and yeast E3s, these E3 preparations gave poor levels of reconstitution 
compared with native bovine heart OGDC and PDC E3s. The affinity of binding 
was high as maximal activity was obtained with stoichiometric levels of E3 but only 
15-20% restoration of OGDC activity was sustained by porcine heart and bovine 
mucosal E3. Surprisingly yeast E3 was unable to promote any reconstitution, 
although competition studies showed that there was a high affinity of association
between this E3 and the bovine heart E1/E2 core. In each case, the specific 
activities of the individual E3s were similar and their purity was confirmed by SDS- 
PAGE. Subtle differences in the interaction of heterologous E3s to the bovine heart 
OGDC core may explain the low levels of OGDC activity. Thus, imprecise binding 
orientations with heterologous E3s may prevent the optimal interaction of the
'flexible lipoyl domains of E2 with the active sites of E l and E3. The result with
'bovine mucosal E3 was unexpected because the view currently held by the majority 
of researchers is that a single E3 in mammalian species serves all the complexes and
:should, therefore, be interchangeable. A similar situation was later found with E3 
binding to the bovine heart PDC core (Sanderson et a l,  1996b) indicating that the 
results obtained with OGDC were not artefactual.
Complex specificity of the E3 isoforms from potatoes was not demonstrated 
by the reconstitution experiments using the E1/E2 core of bovine heart OGDC.
Reduction of OGDC activity through competition of the potato isoforms with the 
native E3 was low, even in the presence of a large excess of E3. These data 
suggest that binding of the plant E3 is quite different to that of the mammalian or 
yeast E3, with only low affinity interactions occurring with the bovine OGDC core.
This is consistent with the fact that potato E3s were known to bind to the
135
ïimmobilised E1/E2 subcomplex of OGDC, which could be employed in their
purification. However, the orientation and low affinity of binding are clearly
incompatible with an ability to support the activity of bovine heart OGDC. The
yeast E3 behaved in a similar way to the potato E3 isoforms as it was unable to
.promote detectable reconstitution; however, unlike the plant E3s, it exhibited a high 
affinity binding to the bovine heart core as evidenced by its ability to compete with 
the parent E3 enzyme (bovine heart E3).
Reconstitution experiments with the OGDC core from potatoes were 
impossible to conduct owing to difficulties in obtaining sufficient amounts of active 
complex from this source. Measurable recoveries of OGDC were obtained from 
cauliflower but were still approx. one third of PDC activities. The presence of low 
OGDC activities has been noticed by several researchers working with the plant 2- 
oxoacid dehydrogenase complexes and the reason for this is unclear since both 
PDC and OGDC are present at similar levels in mammalian cells. Again 
reconstitution with the potato E3 isoforms failed to occur with the E3-depleted 
cauliflower core, although it was shown to occur with porcine heart E3. The ability 
of porcine heart E3 to stimulate cauliflower OGDC activity is surprising in view of 
the lack of success with the potato E3 isoforms. The discovery of distinct 
mitochondrial E3 isoforms in some plants (potato and barley) and the presence of 
single E3s in other plants (pea and turnip) seems to place plants in two groups. 
Cauliflower appears to possess only one E3 for GDC and all the 2-oxoacid 
dehydrogenase complexes, which may have evolved differently from the potato 
isoforms. These observations may offer a possible explanation for the failure of 
specific potato E3 isoforms to promote reconstitution of the cauliflower OGDC.
Further work on the purification of OGDC from plants was not feasible in 
the time available but continuing work in this laboratory recently suggested complex 
specificity of the isoforms using PDC isolated from potato mitochondrial extracts 
(R. Cook, unpublished observations). The modified purification method 
maintained the initial mitochondrial extract in a concentrated state by the use of a
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small (10 ml) Sephadex G-200 gel filtration column which also separated the 
dissociated E3 component. Preliminary reconstitution studies showed that both the 
a p  and the p2 isoforms appeared to promote recovery of overall PDC activity to 
40-50% of original levels, but much lower levels of the P2 isoform were required, 
indicating that it bound to the PDC core with much higher affinity. The a 2 form, 
on the other hand failed to reconstitute PDC activity. The conclusion reached was 
that the p2 form was most likely to be the complex specific form of PDC. The 
specificity of p2 was extended to OGDC but levels of this complex, extracted by the 
modified method, were still found to be low. The roles of the a 2 and the aP form 
are less clear, but there is some evidence for tissue specific expression, with a 2 
predominating in leaves. It still needs to be elucidated whether it represents a GDC 
specific form as this complex is present at high levels in leaves, representing 30- 
50% of mitochondrial matrix proteins.
The direction of the project was altered at this stage, in view of the 
difficulties, highlighted in these chapters, in working with the plant 2-oxoacid 
dehydrogenase complexes. The isolation of the gene(s) encoding the a  and p 
polypeptides of the potato E3 isoenzymes was attempted since the N-terminal 
sequence of the two polypeptides was known (Fullerton et a l, 1996) and forms the 
subject of the following chapters. With regard to the complex specific nature of the 
E3 isoforms, the exact amino acid sequence would allow the determination of the 
relationship between the a  and p polypeptides and the sequence comparison with" 
other cloned E3s of known complex specificity. It would also permit their 
subsequent over-expression for further structure-function analysis.
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Chapter 5
Cloning the Potato Mitochondrial 
Dihydrolipoamide Dehydrogenase (E3) Gene(s)
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5.1 Introduction
Chapter 4 was concerned with reconstitution studies of the purified 
isoforms of potato mitochondrial dihydrolipoamide dehydrogenase (E3) with the 
E1/E2 cores of 2-oxoglutarate dehydrogenase (OGDC) from bovine heart and plant 
mitochondria. Attempts were made to assess possible complex specific roles of the 
mitochondrial 0C2, a p  and the p2 isoforms in potatoes. However, as this was not 
possible owing to the difficulties in assay, purification and reconstitution of the 
complexes, it was decided to approach the question by sequence comparison of the 
gene(s) encoding the a  and p subunits in order to determine their relationship with 
each other.
At the time of this work a number of prokaryotic and eukaryotic E3 genes 
had already been cloned and sequenced, yielding much information on domain 
organisation and amino acid identities with other pyridine nucleotide-disulphlde 
oxidoreductases (Carothers et al., 1989). Human erythrocyte glutathione reductase 
(GR) was the first enzyme of this family to be cloned and sequenced. Its domain 
structure and the role of specific amino acids in catalysis was elucidated from 
crystallographic data (Thieme et a l, 1981; Krauth-Siegel et al., 1982) and has been 
extremely valuable in predicting the domain organisation of various E3s, since there 
is considerable homology at the primary amino acid sequence level.
In E. coli a single gene {Ipd) has been cloned which encodes the E3 
component for PDC and OGDC (Stephens et al., 1983). It was found to be part of 
an operon containing the aceE and aceF genes for E l and E2 of PDC. The OGDC 
E l and E2 genes {sueA and sucB respectively) were subsequently found in a 
separate operon. All three genes of the PDC operon can be transcribed in a single 
transcriptional unit (Spencer & Guest, 1985) from a promoter located upstream 
from the first gene, aceE. However , the Ipd gene can be transcribed from its own 
promoter allowing excess E3 production to complement with OGDC. The Ipd gene 
of A. vinelandii and Pseudomonas fliiorescens is located downstream of the
139
succinyltransferase gene (E2 of OGDC) and not in the PDC operon (Benen et al., 
1989; Westphal & Kok, 1988).
The situation is complicated in other bacterial species. For example. 
Pseudomonas putida contains three different E3 enzymes encoded by separate 
genes. The lpd~val gene is part of a tightly linked operon encoding all the 
components of the BCDC (Sykes et al., 1987) and Ipd-glc, providing E3 for PDC, 
OGDC and GDC, is part of the OGDC cluster. A third gene (lpd-3) was found not 
to be part of a 2-oxoacid dehydrogenase operon (Burns et a l,  1989a). A simjlar 
arrangement exists in P. aeruginosa where the presence of two genetically distinct 
E3 enzymes has been proved (McCully et a l ,  1986), In the strict aerobe, 
Alcaligenes eutrophus, two distinct E3 enzymes were also detected; one was part of 
the PDC operon (pdhL) (Hein & Steinbuchel, 1994) and the other on the OGDC 
operon (odhL) (Hein & Steinbuchel, 1996). Remarkably, the pdhL product carries 
a lipoyl domain at the N-terminal region.
Less is known about the genetic aspects of E3 from eukaryotes. S. 
cerevisiae is similar to E. coli in having a single E3 stmctural gene (Ipdl) for PDC 
and OGDC (Ross et a l,  1988; Roy & Dawes, 1987). Otulakowski & Robinson 
(1987) concluded that the human gene encodes a single gene product representing 
L-protein of GDC and the E3 of the 2-oxoacid dehydrogenase complexes.
The only E3 to be cloned and sequenced in plants is that of L-protein, the 
dihydrolipoamide dehydrogenase component of GDC, from pea leaf mitochondria 
(Bourguignon et a l, 1992; Turner et a l,  1992). The cDNA encoded a 501 amino 
acid polypeptide including a 31 amino acid presequence. Mature L-protein was 
predicted to consist of 470 amino acids, giving a protein of M^ 49 721 (or 50 441 if 
the FAD cofactor is included). The sequence reported by Turner et a l  (1992), 
produced a C-terrainal extension to the open reading frame (ORF) of 28 residues 
resulting from an extra nucleotide at position 1535, but otherwise was identical to 
the sequence of Bourguignon et al. (1992). Re-sequencing confirmed that the extra 
nucleotide was an error and the cDNA sequences obtained by the two groups were
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derived from the same gene. There is strong evidence in pea for the presence of a 
single E3 gene involved in the 2-oxoacid dehydrogenase complexes and GDC 
(Bourguignon et al., 1996). The overall sequence similarity between the L-protein 
and human E3 is very high (70%); therefore, it was expected that the secondary and 
tertiary structure of L-protein would be similar to the human enzyme.
The wealth of sequence information has permitted comparisons of the 
domain organisation and tertiary structures of E3s from various organisms as 
discussed in Chapter 1 (1.3.4.1). All E3 enzymes whose sequences have been 
reported have the same domain structure as GR, as exemplified by the E3 
polypeptide from E. coli which was subdivided into an FAD-binding domain, an 
NAD+- binding domain, a central domain and an interface domain. Characteristic 
sequence motifs have been identified which are highly conserved within the 
domains of the family of pyridine nucleotide-disulphlde oxidoreductases (Carothers 
et al., 1989). These are the FAD-binding fold (residues 7-37), the region around 
the two redox-active cysteine residues found in the FAD-binding domain (cys-44 
and cys-49), the NAD(H) binding fold (residues 176-212) and the interface region 
(residues 430-462). The ‘fingerprint’ structural motif in the dinucleotide-binding 
fold of either FAD or NAD is manifested as a pa(3 fold.
In contrast to the single E3 purified from pea leaf mitochondria, three 
separate isoforms of E3 were isolated from potato tuber mitochondria by our group 
(Fullerton et al., 1996). As discussed in chapter 3, analysis by SDS-PAGE 
showed that the first isoform to elute from a FPLC Mono Q column was an alpha 
homodimer (a 2), the second an alpha/beta heterodimer (ap) and the third a beta 
homodimer (P2). Preliminary data suggest that they may have distinct kinetic and 
biochemical properties and heat stabilities and consequently it has been tentatively 
proposed that they represent complex specific forms of E3 (R. Cook, unpublished 
observations). However, the two polypeptides, a  and p are known to be very 
similar to each other because they cross-react strongly with yeast antisera, have 
identical N-terminal sequences and are veiy close in molecular mass (as estimated
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by electrospray mass spectrometry) differing by only approx. 116 Da.
Furthermore, the N-terminal sequence was identical to that reported for L-protein 
from pea mitochondria apart from one conservative substitution at residue 11.
Therefore, it was unknown whether they represented distinct gene products or were 
a result of alternate splicing or covalent modification.
The results presented in the next section concern the attempted cloning and 
sequencing of cDNAs encoding E3 from potatoes. The starting material was total 
RNA from potato leaves, the sole reason being ease of preparation in comparison to 
potato tuber RNA. It was valid to employ RNA purified from potato leaves since 
the three isoforms were also expressed in the mitochondria of this tissue (A.
Carmichael, Ph.D Thesis, Glasgow University, 1994), although it was known that 
the Œ2 homodimer predominated in this tissue as opposed to the f>2 homodimer in 
tubers. vS'. 
"
5 .2  Strategy for Cloning the E3 Gene
A PCR-based strategy was employed for the amplification of the cDNA 
generated from the mRNA of potato leaves. The availability of the N-terminal 
amino acid sequence allowed for gene specific primer design. Firstly, the exact 
nucleotide sequence of the 5 " end of the gene was determined to permit design of 
E3 gene specific primers for future amplification of the entire E3 cDNA. This was 
accomplished by amplifying the region of cDNA using highly degenerate primers 
based on the N-terminal amino acid sequence and cloning the product.
Once the nucleotide sequence at the extreme 5" end was known, specific 
nested primers were designed to amplify the entire gene in conjunction with a 
universal primer at the 3 " end of the cDNA. Initially Pfu, a proofreading DNA 
polymerase (Stratagene) was used to obtain faithful copies of the gene but problems 
were encountered with the cloning procedure using this product. Subsequently, a 
Taq amplified product was cloned and sequenced successfully. As a result of the 
cloning strategy, the Taq amplified cDNA lacked the 5 "-sequence encoding the
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ATG translation start site, the leader sequence and the first seventeen amino acids of 
the mature protein. Originally, it was intended to obtain this sequence by 5 " RACE 
(Rapid Amplification of 5" cDNA ends) of the first strand cDNA; however, as 
described in chapter 7, it was obtained by the isolation and sequencing of full- 
length potato leaf cDNA library clones.
5 .3  Results
5 . 3 . 1  RNA Preparation from Potato Leaves
The initial phase of this project involved preparation of good quality, 
undegraded total RNA for the synthesis of full length, double-str anded cDNA. An 
mRNA separation step from the total cellular RNA was not required for this 
purpose as an oligo-dT primer was used to prime the synthesis of the first-strand 
cDNA.
RNA was extracted from potato leaves {Solanum tuberosum, cv. Maris 
Piper) in the presence of guanidinium isothiocyanate, a powerful protein dénaturant 
which served to denature endogenous nucleases and deproteinate the RNA.
Dénaturation was enhanced by the addition of 2-mercaptoethanol to break 
intramolecular protein disulphide bonds. Phenol/chloroform extraction was used to 
remove the degraded protein and RNA was precipitated with salt and isopropanol.
The quantity of the RNA was assessed by measuring its absorbance at 260
:
nm (3.87 [ig.qTl) and its purity by measuring the A26O/A28O ratio. A value of 
1.74 was obtained which indicated pure RNA ( a ratio of 1.8-2.0 is generally 
appropriate for pure RNA). The preparation was judged as being relatively 
undegraded as discrete bands representing 28S and 18S rRNA (approx. 5 kb and 2 
kb respectively) were observed (Fig. 5.1). As expected, a heterogeneous smear of 
mRNAs ranging in size from 0.5 kb to over 10 kb was present. Ribosomal RNA 
is the most abundant species, representing 80-90% of total cellular RNA. In 
contrast mRNA represents only 1-5% of total cellular RNA.
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Fig. 5.1: Analysis of the RNA preparation from potato leaves
RNA was prepared from frozen potato leaves as described in 
Materials and Methods (section 2.2.28). Approx. 10 |lg of RNA 
were electrophoresed in duplicate on a 1 % (w/v) denaturing 
formaldehyde/agarose gel and stained with ethidium bromide 
following the method in 2.2.17.
5 . 3 . 2  First-Strand cDNA Synthesis
Synthesis of first-strand cDNA (as described in section 2.2.23.1) was
primed using the AofI-d(T)ig bifunctional primer corresponding to polyadenylated 
mRNA. It was termed ‘bifunctional’ because it was composed of a string of d(T) 
residues as well as an ‘anchor’ domain which contained a N otl and an EcoKl 
restriction site for cloning. The sequence of the primer was:
5 ’-d[AACTGGAAGAATTCGCGGCCGCAGGAATi8l-3 ’I I I__________ I
EcoRI N otl
Another primer {Notl-G), lacking the oligo d(T) portion, was made because 
the Nod-d(T)ig primer does not always function efficiently for subsequent PCR of 
the first-strand cDNA. The completed first-strand cDNA reaction of 33 |il was 
used directly for conversion to double-stranded cDNA and amplification by PCR as 
described in the next section.
5 . 3 . 3  PCR Amplification of the 5 -Region of the ORF of the 
Potato Mitochondrial E3 Gene
First-strand cDNA was amplified by PCR using degenerate primers 
designed from the known N-terminal sequence of potato mitochondrial E3 (Fig.
5.2). For cloning purposes an EcoRI site was added to the 5" end of primer A and 
a BamUl site to primer B. Primer sequences are shown in Table 5.1.
N - a s g s d e n d v v v i g g g p g g y v a a i k a a q l
5 ' ------------------------------------ > 3 '  3-' < ------------------------------------- 5 '
I P r i m e r  A | I P r i m e r B  |
Fig. 5.2: N-terminal sequence obtained for the potato 
mitochondrial a  and p polypeptides, showing positions of the
degenerate primers A and B.
. :
145
Table 5.1
Sequence of the forward and reverse primers used to am plify the 5" 
region of the potato mitochondrial E3 gene
Primer Sequence (5 "—>3 ")
Product
size Degeneracy
A G GAATTC GAC GAA AAC GAC GTN GT 
(forward) T G T T
SObp
64-fold
B CG GGATCC AGT TGN GCN GCT TTT AT
(reverse) C C 64-fold
a)N= A, T, G and C
b)Restriction sites underlined
5 . 3 . 3 . 1  Amplification of First-Strand cDNA
The first-strand cDNA product was used as a template to amplify double­
stranded cDNA corresponding to amino acids 5 to 28 of the N-terminal sequence. 
Primers A and B were present at 1000 pmol instead of 10 pmol in each 50 ql 
reaction as they were highly degenerate. The PCR mix is described in section 
2.2.22 and the cycling parameters are described in Fig. 5.3.
The products of PCR amplification with primers A and B are illustrated in 
Fig. 5.3, lane 3. The product at approx. 80 bp was assumed to be the product of 
interest as it corresponded to the expected size. Lanes 1 and 2 show the products 
generated with primer A or primer B respectively. This control, carried out to 
eliminate non-E3 specific products, found that neither primer amplified a 80 bp 
product on its own. There was a contamination in the negative template control 
(Lane 4); however, it was not considered to be a problem as the 80 bp product was 
well sepai’ated from it for future gel purification.
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80 bp 
product
M l  2 3 4 5
Fig. 5.3: Analysis of PCR products obtained by Taq polymerase 
amplification of first-strand cDNA
Potato leaf RNA served as a template for first-strand cDNA synthesis as 
described in Materials and Methods (section 2.2.23.1). The 5’-region of the 
first-strand cDNA (5 ql) was then converted to double-stranded cDNA and 
amplified by PCR (section 2.2.23.2) in the same reaction. DNA synthesis 
was primed using 1000 pmol of each degenerate primer, A and B, shown in 
Table 5.1, and in addition contained 1 mM MgCli. The cycling was as
follows: 1 X 5 min at 95°C, 30 x [30 s at 55°C, 30 s at 65°C and 30 s at 
95°C], 1 X 2 min at 65°C and 1 x 3 min at 72°C. Products were separated on 
a 12% (w/v) polyacrylamide gel
M: size marker 1: primer A only, 2: primer B only, 3: primers A+B,
4: negative DNA control, 5: Positive DNA control (pBluescript DNA and 
M13 forward and reverse primers from Pharmacia).
s.3 . 3 . 2 Cloning and sequencing the 80 Base Pair Fragment
The purified product was cloned directionally into the EcoBl and Bam Bl 
sites of pBluescript KS+ transformed into E. coli XLI Blue cells. Nine colonies 
out of fourteen colonies were found to contain an insert of the correct size (80 bp). 
Fig. 5.4 presents six of the recombinant plasmids (named pBkA, pBkB, pBkC, 
pBkD, pBkF and pBkG) after digestion with EcoRI and BamBl.
Automated sequencing (section 2.2.33) was carried out on the double­
stranded recombinant plasmid template to confirm that the correct PCR product had 
been cloned and to provide the exact nucleotide sequence for further primer design. 
Each of the four dyedeoxy terminators (ddNTPs) were tagged with a different 
fluorescent dye. Thus, the growing chain was simultaneously terminated and 
labelled with the dye corresponding to that base. Each dye emitted light at a 
different wavelength when excited with laser light. This had the advantage that four 
sequencing reactions could be performed in one tube and all four reactions could be 
detected and distinguished in a single gel lane.
The sequence of the clones corresponding to amino acids 5-28 of the mature 
E3 enzyme is shown in Fig. 5.5.
Primer A_________ _ _ _ S P l   N SPl__
g a t g a g a a t g a c g t g g t t g t t a t c g g t g g t g g t c c c g g c g g c t a t g t g g c g g c g a t t
c t a c t c t t a c t g c a c c a a c a a t a g c c a c c a c c a g g g c c g c c g a t a c a c c g c c g c t a a
A S G 5 D E N D V V V I G G G P G G Y V A A I
a a a g c c g c c c a a c t
t t t c g g c g g g t t g a  
K A A Q
Fig. 5.5: DNA sequence of clones pBkC, pBkD and pBkF 
representing amino acids 5-28 of the mature E3 protein
The first 4 amino acids from the N-teiminal sequence, not used for primer 
design, are shown in italics. Sequences chosen for production of unique 
nested primers, SPl and NSPl, are indicated.
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b p
# # #
400—
200-H
100— ^ UuU .80 bp product
_____________________________________________
M  pBkA pBkB pBkC pBkD pBkF pBkG
I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I
Clones containing 80 bp product 
Fig. 5.4: Analysis of clones containing the 80 bp insert
Recombinant pBluescript (KS+) plasmids containing the 80 bp product, 
(ligated into the EcoRl and BamHl site), were transformed into XLI Blue 
E. coli cells as described in section 2.2.27.1. Cells were grown on LB
(amp/tet) plates and positive colonies selected by inactivation of p-
galactosidase activity. Purified recombinant plasmid DNA (1 qg) was 
digested with EcoRl and BamHl and separated on a 12% (w/v) 
polyacrylamide gel.
M= size marker
5 . 3 . 4  N ested-PCR A m plification of the Full Length cDNA  
Encoding the Potato Mitochondrial E3
A nested-PCR approach was employed to permit the specific amplification 
of the E3 cDNA from the first-strand cDNA sample. This approach was necessary 
to identify the relevant cDNA from a number of PCR products. The method 
requires PCR amplification with one primer set followed by a subsequent PCR 
using a second primer set, internal to the amplified DNA. The primers were 
expected to be specific as they were designed from the sequenced 5 " end of the 
open reading frame of the gene, described in section 5.3.3.4.
5 . 3 . 4 . 1  Design of the Nested-PCR Primers
Two N-terminal sense primers, SPl and NSPl, were designed downstream 
of the original sequence corresponding to primer A to avoid the ambiguity of the 
codons specified in this region owing to the degeneracy of primer A (Fig. 5.5 and 
Table 5.2). The first primer set, used to amplify the E3 gene fiom the first-strand 
cDNA reaction, was SPl and the iVt>tl-d(T)i8 reverse primer and the second primer 
set was NSPl and the N ori-d(T)i8 antisense primer. Hence the PCR product 
obtained from the nested-PCR reaction was expected to start at the codon specifying 
amino acid 18 (glycine) of the mature E3 protein as indicated in Fig. 5.5.
Table 5.2
Sequence of the nested forward primers used to amplify the E3 
cDNA from first-strand cDNA
Approx. productPrimer Sequence (5"—>3") size (kb)
SPl CG GGATCC TGTTATCGGTGGTGGTCCC 1.8
N SPl G GAATTC GC GGCTATGTGGCGGC 1.8
a) Restriction sites underlined
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5 ,3 .4 .2  PCR Am plification of F irst-S tran d  cDNA
Amplification of DNA was catalysed with thermostable Pfu polymerase 
(Stratagene) as it had a 12-fold higher fidelity of DNA synthesis than Taq  
polymerase due to its 3" to 5" proof-reading exonuclease activity. High fidelity of 
synthesis was required as the product was to be cloned and the sequence of the 
gene obtained. Two sources of Pfu were available; one was the native enzyme 
from Pyrococcus furiosus  and the other was recombinant Pfu . PCR was 
performed with both enzymes in order to compare the products.
The ‘Hot Start’ technique (detailed in section 2.2.22) was employed for 
PCR with Pfu to reduce the possibility of competing side reactions such as the 
amplification of non-target sequences. Mis-priming mainly occurs during pre-PCR 
setup when all reactants have been mixed at room temperature. Therefore, the 
reaction was designed so that all reactants do not mix until they have reached a high 
enough temperature to suppress primer annealing to non-target sequences. In 
addition, the 3" to 5" exonuclease activity associated with Pfu DNA polymerase, 
will begin to degrade the template DNA in the absence of nucleotides. Thus, it was 
necessary to add the polymerase last to the reaction mix.
The cycling conditions, stated in Fig. 5.6, began with an initial 90 min 
extension to ensure that the second strand of DNA was fully extended. Lanes 1 and 
2 are the negative DNA controls with recombinant and native Pfu respectively. A 
smear of DNA, of unknown origin, was observed in these samples which was 
absent in the reactions amplifying the first-strand cDNA template (lanes 3 and 4). 
Surprisingly, a ladder of products was only observed with the native Pfu  
polymerase (lane 4). The size of cDNA product, estimated from the cloned pea 
mitochondrial E3, was expected to be above 1500 bp; therefore, the likely candidate 
was the 1.8 kb product. An increase in the annealing temperature from 60° C to 
63°C, 65°C and 68°C resulted in a loss of amplification of the 1.8 kb product but the 
inexplicable smear of DNA in the negative controls was always present.
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.8 kb 
product
Fig. 5.6: PCR amplification of first-strand cDNA with Pfu (native 
and recombinant) DNA polymerase
First-strand cDNA, generated from potato leaf RNA as described in 
section 2.2.23.1, was primed with the E3 gene specific primer, SPl (Table 
5.2) and the Notl-dT ig primer. The reactions contained 2.5 pi of first-
strand cDNA and 10 pmol primers (in a 50pl reaction). Cycling 
conditions were as follows: 1 x [4 min at 95°C, 10 min at 55°C and 90 
min at 75°C], 30 x [5 min at 60°C, 15 min at 75°C and 1 min at 95°C] and 
1 X 90 min at 75°C. One fifth of the reaction was separated on a 1% (w/v) 
agarose gel.
M: size marker, 1: negative DNA control with recombinant Pfu 
polymerase, 2: negative DNA control with native Pfu polymerase, 3: 
PCR amplification with recombinant Pfu polymerase, 4: PCR 
amplification with native Pfu polymerase.
5 .3 .4 .3  Nested-PCR Of The Amplified DNA Products
The sample previously amplified with the native Pfu polymerase (Fig, 5.6, 
lane 4) was re-amplified using the nested, forward primer, NSPl (Table 5.2) and 
the Notl-G  primer described in section 5.3.2. Once more, the activities of native 
and cloned Pfu were compared in case only one polymerase was able to amplify the 
target DNA. Only one product, at 1.8 kb was re-amplified (Fig. 5.7), confirming 
that it was likely to be specific for the E3 gene. Interestingly, this time the 
recombinant Pfu polymerase was effective, whereas the native Pfu polymerase had 
amplified the original product. Furthermore, the negative DNA control was 
completely clear.
Nested PCR on the previously amplified DNA (Fig. 5.6, lane 4) was also 
attempted with Tag polymerase as a comparison. Fig. 5.8 illustrates the separated 
products on a 1% (w/v) agarose gel. The PCR reaction, resolved in lane 3, re­
amplified the 1.8 kb product. Lanes 1 and 2 are the controls containing only the 
NSPl primer and the Notl-G  primer respectively. As expected no product was 
amplified with the Notl-G primer only; however, the NSPl primer alone generated 
products of the same size as the 1.8 kb product. This was thought to be due to 
caiTy over of the Noll~d(T)i^ antisense primer from the DNA template which would 
have primed DNA synthesis in conjunction with the NSPl primer. A few species 
of DNA with slightly different sizes could be distinguished on the gel because of 
the low concentration of product resulting from the presence of the limiting Notl- 
d (T )i8 contaminant. These were inconspicuous in lane 3 because of the high 
concentration of amplified DNA product. A possible explanation for this result was 
the occurrence of different polyadenylation sites for the E3 gene leading to 
heterogeneity in mRNA size. The d(T)ig portion of the primer also had the 
potential to bind non-specifically to sites along the poly A tail producing products of 
varying lengths depending on where it primed DNA synthesis. On the other hand, 
if the a  and (5 polypeptides were produced by different, but closely related genes 
then the two foims may have been simultaneously amplified.
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■1.8 kb
1 2 3
Fig. 5.7: Analysis of the potato leaf cDNA re-amplified by nested-PCR 
using native and recombinant Pfu polymerase
The DNA sample (1 pi), illustrated in Fig. 5.6 (lane 4), was re-amplified 
using the recombinant and native Pfu polymerases as described in section 
2.2.22. The reaction was primed using 10 pmol of the E3, nested gene 
specific primer (in a 50 pi reaction), NSPl (Table 5.2) and the Not\-G 
primer. Cycling conditions were as follows: 1 x 95°C for 3 min, 37 x [5 
min at 55°C, 15 min at 75°C and 1 min at 95°C] and 1 x 90 min at 75°C. 
Products were separated on a 1% (w/v) agarose gel.
M: size marker, 1 : PCR amplification with native P/m polymerase, 2: PCR 
amplification with recombinant Pfu polymerase, 3: negative DNA control.
1.8 kb
M 1 2 3 4
Fig. 5.8: Analysis of the potato leaf cDNA re-amplified by nested- 
PCR using Taq DNA polymerase
The DNA sample (1 pi), illustrated in Fig. 5.6 (lane 4), was re-amplified 
using Taq DNA polymerase. The reaction was primed with 10 pmol of 
the E3 nested gene specific primer, NSPl (Table 5.2) and the Not\-G 
primer and carried out in the presence of 1 mM MgCl]. Cycling
conditions were as follows: 1 x [3 min at 95°C], 35 x [3 min at 55°C, 3 
min at 65°C, 30 s at 95°C], and 1 x [6 min at 72°C]. One fifth of the 
products were separated on a 1% (w/v) agarose gel.
M: size marker, 1: NSPl primer only, 2: Not\-G primer only, 3: both 
primers, 4: negative DNA control.
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5 .3 .4 .4  Cloning the Nested PCR Product
The purified 1.8 kb products, amplified by both Pfu and Taq polymerase, 
are visualised in Fig. 5.9. Significantly, the figure shows quite clearly that both the 
Pfu and Taq polymerase products are the same size. The products were ligated into 
the PcoRI site of pBluescript (KS-f) following the protocol detailed in section 
2.2.26.
E. coli DH5a cells were transformed with each ligation mix. Thirty positive 
colonies were isolated from the plates containing cells transformed with the Taq 
construct and in comparison only seven colonies were produced with the Pfu
;construct. Visualisation of the purified recombinant plasmids (Fig. 5.10), after 
digestion with EcoPl, revealed that colonies transformed with the Taq construct 
contained inserts of interest. However, the seven colonies transformed with the 
Pfu construct were found not to contain any inserts. The presence of four different
sizes of insert was not surprising as the PCR with Taq and only the NSPl primer 
(Fig. 5.8) had already suggested a number of species differing in size. Subsequent 
sequencing and expression studies were required to determine whether this was due 
to different polyadenylation sites, non-specific priming of the NorI-d(T)i8 primer or 
different cDNA products.
The cloning strategy with the Pfu amplified product was repeated using 
Epicurian Coli SURE supercompetent cells (Stratagene). This recombination 
deficient host strain carries mutations in DNA repah* pathways directly involved in 
the rearrangement and deletion of DNA. Fifty colonies were isolated and analysis 
of the recombinant plasmid DNA, digested with E coR f revealed that part of the 
inserts had been deleted, leaving inserts ranging from 50 to 500 bp (Fig. 5.11). 
Owing to lack of time, further PCRs using Vent DNA polymerase (New England 
Biolabs, USA), another proof-reading enzyme, were not conducted. Analysis was 
continued with the clones containing the Taq amplified insert, although the fidelity 
of DNA polymerisation by Taq was a problem to be considered.
,:i|
M  1 2
Fig. 5.9: Gel purified PCR products amplified with Pfu or 
Taq DNA polymerase for cloning purposes
M: size marker, 1: Pfu PCR product, 3: Taq PCR product.
1 2 
Fig. 5.10: Analysis of clones obtained by transformation with the 
recombinant Taq and the Pfu PCR products
The PCR products, illustrated in Fig. 5.9, were ligated to the EcoRl site of 
pBluescript (KS+) vector and transformed into E. coli DFI5a cells as 
described in Materials and Methods (section 2.2.27.1). Cells were grown on 
LB (amp) plates and putative positive colonies were selected for a mini 
plasmid preparation (2.2.20). Plasmid DNA (1 pg) was digested with EcoRl 
to restrict out the inserts and separated on a 1% (w/v) agarose gel.
M: size marker, 1: putative positive Pfu clones, 2: putative positive Taq 
clones (showing only 12 of 30 obtained).
kb
M  TW R M #
kb
2.05- J  
1.50 J
m m m i t2.05 1.50
0.60. 1—0.60
0 . 10-1
M
1- 0.10
M
Fig. 5.11: Analysis of clones obtained by transformation of 
SURE E. coli cells with tbe recombinant Pfu PCR product
Twenty clones were Isolated for a mini plasmid preparation of 
which Ipg was digested with EcoRI to restrict out the insert. DNA 
was analysed on a 1% (w/v) agarose gel.
M= size marker
I5 .3 .4 .5  C onfirm ation of Identity by Partial Sequencing and 
Restriction M apping of the Clones Containing the Taq Am plified  
Insert
Eight of the clones containing the Taq amplified insert were chosen to
:
represent the range of insert sizes. They were named pTaql3, pTaql4, pTaqlS, 
pTaql6, pTaq22, pTaq23, pTaq25, and pTaq30. The inserts were sequenced from 
both ends using M l3 universal and M13 reverse primers. This partial sequencing 
was required to confirm the identity of the clones and to determine their orientation 
in the plasmid since cloning was non-directional. Automated sequencing was 
performed as described in section 2.2.33, providing 350-400 bases of sequence 
from each end.
The first 30 bases of the sense strand were ti'anslated and the sequence was 
consistent with amino acids 18 to 27 of the N-terrainal sequence of the E3 enzyme, 
shown in Fig. 5.5. The PCR with the M13 reverse primer provided sequence data 
from the 5' end of the sense strand for clones pTaql5, 25, and 30, therefore these 
clones had been inserted in the sense orientation. In contrast pTaql3, 14, 16, 22 
and 23 were found to be cloned in the antisense orientation as the M l3 reverse 
primer allowed the sequencing of the antisense strand from the polyA tails.
Confirmation of the identity of the clones by analysis of their 5" sequence 
was followed by their over-expression in bacteria, as will be described in chapter 6.
This control was carried out to ensure that Taq DNA polymerase had faithfully 
amplified the cDNA and to determine if any of the clones encoded the a  and (3 
polypeptides.
The clones were restriction digested with EcoRl (the cloning site) and one 
of the following enzymes: BarriRl, Pstl, SaR, HindTll and Kpnl in order to prepare 
a crude restriction map. The only enzymes found to cut within the insert were Pstl 
and Kpnl. Fig. 5.12 depicts an agarose gel of the pattern of digestion obtained for 
all eight clones with Ec(?Rl and Pstl or Kpnl. All the clones had two internal Kpnl 
sites generating three fragments. One fragment was relatively constant for all the
'■Ï'
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clones and was roughly 950 bp, whereas the smaller fragment varied in size 
between the clones (600 to 800 bp). The last fragment was too small to be 
visualised but was known to exist by sequencing the ends of the clones described 
above. pTaqlS and 30 were thought to be the same clone, as were pTaql4 and 23 
since they had the same digestion pattern. Therefore, there were six clones in total 
exhibiting obvious differences; they either had different polyadenylation start sites
or differences at the Kpnl sites. A representative restriction map of pTaq22 with
■EcoRI and Kpnl is presented in Fig. 5.13A and that of pTaql5 in Fig. 5.13B.
5 .3 .5  G e n e ra tio n  O f C lones F o r S equencing  By D irec ted  
D eletions
The DNA cloned into pBluescript (KS+) was too large to be sequenced
V-conveniently from a single primer binding site. An efficient way to sequence large 
DNA inserts was to generate a nested set of deletions using Exonuclease III (Exo 
III) in the target DNA, thereby moving the priming site closer to the sequence of 
interest. Therefore, deletions are from the end of the insert, closest to the priming 
site chosen for sequencing. Expression studies (Chapter 6) had demonstrated that 
pTaq22 and p T aq l6 encoded proteins with different Mr values, possibly 
corresponding to the a  polypeptide and the p polypeptide respectively; thus, these 
two clones were selected for sequencing. In these cases, the M13 universal primer 
site was used as it allowed the sequencing of the sense strands. This protocol, 
described in section 2.2.32 and schematically in Fig. 5.14, was favoured instead of 
primer walking because only one primer was required for sequencing and all the 
reactions could be analysed on a single sequencing gel.
The enzyme producing the 3" overhang, which is resistant to digestion by 
Exo in  thereby protecting the M l3 universal primer binding site, was Sad. The 5 ' 
overhang adjacent to the insert was generated by BamRl. The uniform rate of 
digestion of Exo III from the 5 " overhang allowed deletions of pre-determined 
lengths to be made by removing timed aliquots from the reaction. S1 nuclease was 
used to remove the remaining single-stranded tails, the low pH and the zinc cations
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pTaqlo ■f" M13 Universal priming site
5’ overhang
Digestion of plasmid 
DNA with S a d  and 
BamHl 3’ overhang
Exo ni 
remove timed 
aliquots
SI nuclease 
treatment
I Klenow, dNTPs DNA ligase
transform, plate, 
select colonies, 
sequence
Fig. 5.14: Schematic for the generation of nested-deletions of pTaql6
The general method was followed as described in section 2,2.32. Plasmid 
DNA (5 fig) was digested with BamRl (to generate 5’ overhang) and S a d  (to 
generate 3’ overhang) before being digested with Exo III. The outer strand of 
the insert represents the sense strand. Exo III deletions of pTaq22 were carried 
out in the same manner, using identical restriction enzymes.
in the SI nuclease buffer inhibiting further digestion by Exo III. After 
neutralisation and heat inactivation of the nuclease, the 3" to 5" activity of Klenow 
DNA polymerase was used to remove any remaining protruding 3' termini. Fig. 
5.15a presents an example of the nested deletions produced at 30 s intervals for 
T aq l6, performed in conjuction with Dr S. Pradhan. An excellent set of 
overlapping deletions were produced which were then hgated and transformed into 
DH5a cells. Each time point yielded a collection of subclones containing clustered 
deletions. Nine subclones from each time point were selected randomly for a small 
scale plasmid preparation and treated with a restriction enzyme to digest out the 
inserts. FvwII and contained two sites each within the pBluescript (KS+)
plasmid: one site for each enzyme was placed on either side of the multiple cloning 
site (refer to Fig. 1.1, Materials and Methods). B.y.yHII was used to cut out the 
insert because there were no sites within the insert itself. The inserts were sized on 
a 1% agarose gel along side a 100 bp marker (data not shown). A set of subclones, 
containing a decreasing ladder of inserts with deletions of approx. 100 bp extending 
further into the original insert, were chosen for plasmid preparations (Fig. 5.15b).
5 . 3 . 5 . 1  DNA Sequence the pTaq22 and pTaql6 Subclones
Plasmids from all the subclones were subjected to automated sequencing 
(section 2.2.33) using the M13 universal primer. The sequences representing 
pTaq22 and pTaql6 were aligned using the Gel Assemble programme and were 
found to be overlapping for the entire length of the gene. A putative consensus 
sequence of the sense strand was constructed for each clone which was found to 
start at the codon specifying amino acid 18 (glylS) and continued to the polyA tail. 
The antisense strand was sequenced by primer walking using primers designed 
from the consensus sequence (Table 5.3). The primers (20 bases in length) had 
annealing temperatures between 50-55°C. The final sequence of both clones and 
the positions of the forward and reverse sequencing primers is presented in Fig. 
5.16.
164
g  s  !I I
od
i  l> î> "  » ' I
I T
S S
0£C*KCd(Vuo0)-aCd0£s
s«cowso
crCdHa<usou
O
C/2oxcOV
X u3 0>C/5 .£:5 «Mm oLwi/i o"O.2f 3
• — _ 0  
X)
-o
c/2cQX<uc_o”ogsV373S
"S.
<u1
oXW
.EH
iI
ICLX)S
iM
ë_o
X3co
ririmriri
XI
■s
&
<u
fcûc-  y(5Û Ucd§
W).ssI
3&û3 IS
(UN
0
1
I
J?
m
bX)C
OXUQ
■SwIa
cdX
O
S  -C .2
•Sf H k  o,
(U
&
cd
I
cdK,
rxmriric.2oOJ
oX
'O
■S
cd§
B3II
"o
(d3Xi
15I
om
c.20>
30 CJ
1I
oa
&
(U
cd
enuid.)i
%XJIi
.ë
©
[
i
s©aI
1
IÔJD
î
f
W)©o13©g +os 1Ph 'o
en
3Iîao
tco
1
tJOI
i
env'lOi
f(DI
*O  M  SO 00
II
so CN oo r~ en o
oo oo en CNen lo oo
. îu  os s0  o1 s. .o 6 o
5  Ü
(N en
SOOO in
U
b
u
s  5i
u
I I I
X  N
o  en
UU
?  yi bt
y  8US i
b
VO
o
(U
The open reading frame of pTaq22 consisted of 1359 bp, encoding a 
polypeptide of 453 amino acid residues. The full length mature E3 protein was 
expected to be 470 amino acids with the inclusion of the first 17 amino acids from 
the N-terminus. The predicted Mj- values from the deduced amino acid sequences 
(including the first 17 amino acids) were 49 558 (pTaq22) and 46 060 (pTaql6). 
The Mr of the polypeptide from pTaql6 was surprisingly low in comparison with 
the known Mr of either the native a  or (3 polypeptides (49 446 ±12.28 and 49 562 
±6.83, respectively). This irregularity was resolved when the two putative 
consensus sequences were aligned and an in frame deletion of 96 bases 
(corresponding to 32 amino acids with an approx. Mr of 3500) was discovered in
T aq l6 at position 249 of the ORE (Fig. 5.16). To determine whether the deletion
'was a cloning artifact, the pTaq23 clone was sequenced by primer walking using 
the reverse primers designed above and forward primers also designed from the 
consensus sequence (Table 5.3). pTaq23 was chosen because it was known from 
expression studies, described in chapter 6, to encode an E3 polypeptide slightly 
larger than the pT aql6 product but smaller than the pTaq22 product. This had 
suggested that pTaq23 and pT aql6 may encode a protein similar in size to the j3 
polypeptide and pTaq22 may encode a protein similar in size to the a  polypeptide. 
Sequencing was initiated at the site of primer 1; therefore, the sequence of pTaq23 
presented in Fig. 5.16 begins at base 223 of the ORF. Sequence comparison 
showed that pTaq23 did not have the deletion found in pTaql6 and that its sequence 
was identical with that of pTaq22 and pT aql6 apart from the base differences 
indicated in Fig. 16. In order to calculate its mass (49 517.44) from the deduced
Aamino acid sequence, the assumption was made that the upstream sequence was 
identical with that of pT aql6. Additionally a deletion in this upstream sequence 
was unlikely in pTaq23 because the digest pattern with EcoKlIKpnl presented in 
Fig. 5.12, showed that its 950 bp band was similar in size to that of pTaq22.
In relating the three clones with each other, it was discovered that there were 
eight separate base changes in total causing amino acid differences, at the positions
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indicated in Fig. 5.16. However, these amino acid differences did not give rise to a 
mass difference between any of the clones of around 116 Da (found between the 
native potato a  and (3 polypeptides) and they appeared to be random, leading to the 
belief that some may represent mutations caused by the use of Taq polymerase. It 
was noted that the clones differed slightly in size due to the polyA start site; the 
polyA tail of pT aql6 appeared 60 bases after that of pTaq23 and 67 bases before 
the polyA tail of pTaq22. Nevertheless, the stop codon was in the same place for 
all the clones. There appear to be no frame shifts, deletions or insertions of one or 
more amino acids in the sequences.
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Fig. 5.16: DNA sequence comparison of the clones pTaq22, pTaq23 and 
pTaqI6.
The sequence of pTaq23 starts at base number 223. A changed base leading 
to an amino acid change is indicated by ' * '  and a changed base causing no 
amino acid change is indicated by The forward and reverse sequencing 
primers found in Table 5.3 are shown by half arrows. The stop codon is in 
bold and the poly A tails are underlined.
-mî
■M l3 Universal primer \  1
"  ^  ^  ^  GGCTATGTGGCGGCGATCAAAGCAGCA p T a q 2 2
GGCTATGTGGCGGCGATCAAAGCAGCA p T a q l 6 
G Y V A A I K A A
2 8  *
CAGcTTGGGCTTAAAACTCCATGTATCGAGAAACGTGGTACCCTCGGTGG p T a q 2 2  
CAGCT'TGGGCTTAAAACTACATGTATCGAGAAACGTGGTACCCTCGGTGG p T a q l 6 
Q L G L K T £ C I E K R G T L G G  
T
7 8
TACTTGCCTTAACGTTGGTTGTATTCCTTCTAAGGCACTTCTTCATTCGT p T a q 2 2  
TACTTGCCTTAACGTTGGTTGTATTCCTTCTAAGGCACTTCTTCATTCGT p T a q l 6 
T C L N V G C I P S K A L L H S S
328 Primer 2 \
TCTGTTGACACTGTCGAAGGTGGTAACTCTGTTGTTAAAGGCAAAAATAT p T a q 2 2  
TCTGTTGACACTGTCGAAGGTGGTAACTCTGTTGTTAAAGGCAAAAATAT p T a q 2 3
...................................................... GGTGGTAACTCTGTTGTTAAAGGCAAAAATAT p T a q l 6
S V D T V E G G N S V V K G K N I
428
ATGAGAAGAAAATTGTGTCATCCACCGGAGCATTAGCTTTGACTGAAATT p T a q 2 2  
ATGAGAAGAAAATTGTGTCATCCACCGGAGCATTAGCTTTGACTGAAATT p T a q 2 3  
ATGAGAAGAAAATTGTGTCATCCACCGGAGCATTAGCTTTGACTGAAATT p T a q l 6 
E K K I V S S T G A L A L T E I
1 2 8
CCCACATGTTTCATGAAGCGCAACATTCATTTGCCAATCATGGTGTGAAG p T a q 2 2  
CCCACATGTTTCATGAAGCGCAACATTCATTTGCCAATCATGGTGTGAAG p T a q l 6 
H M F H E A Q H S F A N H G V K
17 8 Primer 1 \  *
TTTTCTTCTGTCGAAGTTGATCTCCCTGCCATGATGGGACAAAAAGATAA p T a q 2 2
GATAA p T a q 2 3
TTTTCTTCTGTCGAAGTTGATCTCCCTGCCATGATGGGACGAAAAGATAA p T a q l 6 
F S S V E V D L P A M M G Û K D K
R
2 2 8
AGCCGTGTCTAACTTAACACGAGGTATAGAGGGTCTATTCAAGAAAAACA p T a q 2 2  
AGCCGTGTCTAACTTAACACGAGGTATAGAGGGTCTATTCAAGAAAAACA p T a q 2 3
AGCCGTGTCTAACTTAACACGA....................................................................................... p T a q l 6
A V S N L T R G I E G L F K K N K
2 7 8
AAGTAAACTATGTGAAGGGATATGGTAAATTCCTCTCCCCTTCTGAAATT p T a q 2 2 
AAGTAAACTATGTGAAGGGATATGGTAAATTCCTCTCCCCTTCTGAAATT p T a q 2  3
............................................................................................................................................................. p T a q l 6
V N Y V K G Y G K F L S P S E I
3 
■
3 7 8
TATTATTGCAACTGGCTCTGATGTCAAAGGTCTACCTGGCATAACCATTG p T a q 2 2  
TATTATTGCAACTGGCTCTGATGTCAAAGGTCTACCTGGCATAACCATTG p T a q 2 3  
TGTTATTGCAACTGGCTCTGATGTCAAAGGTCTACCTGGCATAACCATTG p T a q l 6 
i l A T G S D V K G L P G I T I D
V '
1
478
CCAAAAAGATTAGTTGTTATTGGTGCTGGCTATATAGGCCTTGAGATGGG p T a q 2 2  
CCAAAAAGATTAGTTGTTATTGGTGCTGGCTATATAGGCCTTGAGATGGG p T a q 2 3 
CCAAAAAGATTAGTTGTTATTGGTGCTGGCTATATAGGCCTTGAGATGGG p T a q l 6 
P K R L V V I G A G Y I G L E M G
Primer 3 A5 2 8  _ _ _ _ _
ATCTGTCTGGGGTCGCCTCGGCTCAGAGGTGACTGTTGTTGAATTTGCAT p T a q 2 2  
ATCTGTCTGGGGTCGCCTCGGCTCAGAGGTGACTGTTGTTGAATTTGCAT p T a q 2 3 
ATCTGTCTGGGGTCGCCTCGGCTCAGAGGTGACTGTTGTTGAATTTGCAT p T a q l 6 
S V W G R L G S  E V T V V E F A S
Primer Z
5 7 8
CTGATATTGTTCCAACCATGGATGGTGAAGTTCGCAAGCAATTTCAACGT p T a q 2 2  
CTGATATTGTTCCAACCATGGATGGTGAAGTTCGCAAGCAATTTCAACGT p T a q 2  3 
CTGATATTGTTCCAACCATGGATGGTGAAGTTCGCAAGCAATTTCAACGT p T a q l 6 
D I V P  T M D G E V R K Q F Q R
6 2 8
GCTCTTGAGAAGCAAAAGATGAAATTCATGCTAAACACTAAGGTGGTGTC p T a q 2 2  
GCTCTTGAGAAGCAAAAGATGAAATTCATGCTAAACACTAAGGTGGTGTC p T a q 2  3 
GCTCTTGAGAAGCAAAAGATGAAATTCATGCTAAACACTAAGGTGGTGTC p T a q l 6 
A L E K Q K M K F M L N T K V V S
6 7 8
AGTTGATGCTACAGGTGATGGTGTGAAATTGACCCTTGAACCTTCAGCTG p T a q 2 2  
AGTTGATGCTACAGGTGATGGTGTGAAATTGACCCTTGAACCTTCAGCTG p T a q 2 3  
AGTTGATGCTACAGGTGATGGTGTGAAATTGACCCTTGAACCTTCAGCTG p T a q l 6 
V D A T G D G V K L T L E P  S A G
7 2 8
GTGGTGATCAAACTATTCTCGAGGCTGATGTTGTTCTCGTCTCTGCTGGA p T a q 2 2  
GTGGTGATCAAACTATTCTCGAGGCTGATGTTGTTCTCGTCTCTGCTGGA p T a q 2  3 
GTGGTGATCAAACTATTCTCGAGGCTGATGTTGTTCTCGTCTCTGCTGGA p T a q l 6 
G D Q T I L E A D V V L  V S A G
:
7 7 8
AGAGTACCATTCACTTCAGGACTTGGATTGGACACGATAGGAGTTGAAAC p T a q 2 2  
AGAGTACCATTCACTTCAGGACTTGGATTGGACACGATAGGAGTTGAAAC p T a q 2  3 
AGAGTACCATTCACTTCAGGACTTGGATTGGACACGATAGGAGTTGAAAC p T a q l 6 
R V P F T S G L G L D T I G V E T
Ï
82 8 Primer 4 \
TGACAAGGCTGGTAGAATCTTGGTCAATGAACGTTTTGCCACTAACGTCC p T a q 2 2  
TGACAAGGCTGGTAGAATCTTGGTCAATGAACGTTTTGCCACTAACGTCC p T a q 2  3 
TGACAAGGCTGGTAGAATCTTGGTCAATGAACGTTTTGCCACTAACGTCC p T a q l 6 
D K A G R I L V N E R F A T N V P
8 7 8  +
CAGGGGTACATGCAATTGGTGATGTCATTCCTGGACCAATGCTGGCTCAC p T a q 2 2  
CAGGGGTACATGCAATTGGTGATGTCATTCCTGGACCAATGTTGGCTCAC p T a q 2  3 
CAGGGGTACATGCAATTGGTGATGTCATTCCTGGACCAATGTTGGCTCAC p T a q l 6 
G V H A I G D V I P G P M L A H
928
AAGGCAGAGGAGGATGGCGTTGCTTGCGTAGAGTTCATTGCAGGTAAGGA p T a q 2 2  
AAGGCAGAGGAGGATGGCGTTGCTTGCGTAGAGTTCATTGCAGGTAAGGA p T a q 2 3 
AAGGCAGAGGAGGATGGCGTTGCTTGCGTAGAGTTCATTGCAGGTAAGGA p T a q l 6 
K A E E D G V A C V E F I A G K E
-3
9 7 8
GGGTCATGTAGACTATGATATGGTACCTGGTGTTGTTTACACCCACCCGG p T a q 2 2  
GGGTCATGTAGACTATGATATGGTACCTGGTGTTGTTTACACCCACCCGG p T a q 2  3 
GGGTCATGTAGACTATGATATGGTACCTGGTGTTGTTTACACCCACCCGG p T a q l 6 
G H V D Y D M V P G V V Y T H P E
I
1028 ! * 
AGGTGGCTTATGTTGGGAAAACCGAGGAACAGGTAAAGTCACTCGGAGTT p T a q 2 2  
AAGTGGCTTATGTTGGGAAAACCGAGGAACAGGTAAAGTCACTCGGAATT p T a q 2 3 
AAGTGGCTTATGTTGGGAAAACCGAGGAACAGGTAAAGTCACTCGGAATT p T a q l 6
V A Y V G K T E E  Q V K S L G M
V ” Primer X i
1078 Primer 5 \
GATTATCGTGTTGGCAAATTCCCCTTCCTAGCTAACAGTAGAGCCAAGGC p T a q 2 2  
GATTATCGTGTTGGCAAATTCCCCTTCCTAGCTAACAGTAGAGCCAAGGC p T a q 2 3  
GATTATCGTGTTGGCAAATTCCCCTTCCTAGCTAACAGTAGAGCCAAGGC p T a q l 6 
D Y R V G K F P F L A N S R A K A
1 1 2 8  +  +  
AATTGATGATGCTGAGGAAATTGTCAAGGTAATTGCTGAGAAAGAGAGCG p T a q 2 2  
AATTGATGATGCTGAGGGAATTGTCAAGGTAATTGCTGAGAAAGAGAGTG p T a q 2 3  
AATTGATGATGCTGAGGGAATTGTCAAGGTAATTGCTGAGAAAGAGAGTG p T a q l 6 
I D D A E G I V K V I A E K E S D
1 1 7 8  + * +
ACAAGATATTGGGTGTCCATATTATGTCACCTAACGCAGGGGAGCTTATT p T a q 2 2  
ACAAGATATTGGGCGCCCATATTATGTCACCTAATGCAGGGGAGCTTATT p T a q 2  3 
ACAAGATATTGGGCGTCCATATTATGTCACCTAATGCAGGGGAGCTTATT p T a q l 6 
K I L G Y H I M S P N A G E L I
A
1 2 2 8  +
CACGAAGCTGTCCTGGCATTGCAGTACGGAGCATCAAGTGAGGACATTGC p T a q 2 2  
CACGAAGCTGTACTGGCATTGCAGTACGGAGCATCAAGTGAGGACATTGC p T a q 2 3  
CACGAAGCTGTACTGGCATTGCAGTACGGAGCATCAAGTGAGGACATTGC p T a q l 6 
H E A V L A L Q Y G A S S E D I A
1 2 7 8  *
TCGTACTTGTCATGCACATCCAACAATGAGTGAGGCACTCGAAGAAGCAG p T a q 2 2 
TCGTACTTGTCATGCACATCCAACAATGAGTGAGGCACTCAAAGAAGCAG p T a q 2  3 
TCGTACTTGTCATGCACATCCAACAATGAGTGAGGCACTCAAAGAAGCAG p T a q l 6 
R T C H A H P T M S E A L £ I E A A
K
1 3 2 8  *
CCATGGCCACTTATGACAAGCCCATCCACATGTAGGCTTGTGTTATATCC p T a q 2  2 
CCATGGCCACTTATGACAAGCCCATCCACACGTAGGCTTGTGTTATATCC p T a q 2 3  
CCATGGCCACTTATGACAAGCCCATCCACATGTAGGCTTGTGTTATATCC p T a q l 6  ,1
M A T Y D K P I H M  ’^ Primer W
T
1 3 7 8
TCGATAGCCTCATTTTTCTTATTCCGTTGAGAATCTTGAACGCITAGAAT p T a q 2 2 
TCAATAGCCTCATTTTTCATnTnCCGTTGAAAATCTTGAATGCTTAnAAT p T a q 2 3  
TCGATAGCCTCATTTtTCATATTCCGtTGAGAATCTTGAATGCTTAGAAT p T a q l 6
1 4 2  8 Prim er 6  \
AGGCTTTTTGTTGCTGCCGTTACTCAAGCAGCCCATATTCCTCTTnATTC p T a q 2 2  
AGGCTTTTTGTTGCTGCCGTTACTCAAACAGCCCATATTCCCCTTTATtC p T a q 2  3 
AGGCTTTTTGTTGCTGCCGTTACTCAAGCAGCCCATATTCCCCTTTATTC p T a q l 6
1 4 7 8
AGGACTCCAAATACACTATATGAATGTTTATCTTCTGCATTTTTCCATAA p T a q 2 2  
aGGACTCCAAATACATTATATGAATGTTTATCATCTGCATTTTTCCATAA p T a q 2 3  
A G G A C T C C A A A T A C A T T A T A T G A A T G T T tA T C A tC T G C A T ttttC C A tA A  p T a q l 6
1 5 2 8
TAAAGATGAGATGTAACCTGCTTTAAACCCTGCAGAAGTTAACTGCCTG p T a q 2 2  
TAAAGATGAGATGTAACCTGCTTTAAACCCTGCAGAAGTTAACTGCCTG p T a q l 6
1 6 2 8
TTGGCATGTATCCCTAAATTCTATATTTATCTTGTTTGATTTGGTAGATC p T a q 2 2 
1 6 7 8
GGAGTCGATTTGGTGAAAAAAAAAAAAAAAAAA p T a q 2 2  _ _ _ _ _ _ _ _
M13 Reverse primer
1 5 7 8
GCACTAAsATGGTGCTAGACATTACAAAACTTCCCATTTACTTTGCTTTT p T a q 2 2  
GCACTAAGATGGTGCTAGACATTACAAAAAAAAAAAAAAAAAAA p T a q l 6
■Il
5.4  Discussion
PCR amplification of cDNA derived from RNA was the method used for 
cloning the potato mitochondrial E3 gene for the reason that the possible presence 
of two transcripts of the gene, encoding the a  and (3 polypeptides, may be isolated 
more efficiently than screening a library.
The clones, pTaql3, pTaql4, pTaqlS, pT aql6, pTaq22, pTaq23, pTaq25 
and pTaq 30 were identified as containing E3 cDNA by comparison of their 
deduced amino acid sequence with the N-terminal sequence information obtained 
from the purified potato E3 protein. However, as a result of the cloning strategy 
the cDNA sequence started at the bases encoding amino acid eighteen (glycine).
Clones pTaq22, pT aql6 and pTaq23 were selected for sequencing after 
expression studies (chapter 6) showed that they expressed E3 proteins which could 
possibly be related to the a  and p polypeptides. In chapter 6, pTaq22 appeared to 
express a polypeptide with lower mobility as assessed by SDS-PAGE, indicating 
that it could represent the a  polypeptide. However, the theoretical Mr, 49 558 
(calculated from the deduced amino acid sequence), was closer to the native Mj- of 
the p polypeptide, which appears as the higher mobility subunit on SDS-PAGE. 
pTaq23 and pTaql6 appeared to express a polypeptide with higher mobility than the 
pTaq22 product by SDS-PAGE in chapter 6, which could possibly correspond to 
the p polypeptide. In the case of pT aql6, the low Mr of the deduced amino acid 
sequence and the higher mobility of the polypeptide was explained by an internal 
deletion of 96 bp, encoding 32 amino acids. Although the deletion was in frame, it 
was probably artifactual since the mass of the polypeptide, estimated from the 
deduced amino acid sequence, was too distant from the native a  and p 
polypeptides. The activity of Taq DNA polymerase would be expected to mis- 
incorporate or add a base and not to delete large sequences from a PCR product. 
Therefore, it is suggested that the sequence may have been deleted by a 
recombination event in D H 5a during cloning. However, the existence of
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secondary structures in the DNA, causing Taq polymerase to skip parts of the DNA 
can not be ruled out. Since only three of the clones were sequenced, it was not 
known if a deletion, similar to pT aql6, existed in any of the other clones. The 
theoretical Mr of the deduced amino acid sequence of pTaq23 was 41Da smaller 
than the Mr of the pTaq22 (being 49 517.44) protein due to four amino acid 
substitutions between them.
The double restriction digests with EcoBlJKpnl generated two bands: the 
top one was approximately 950 bp and the lower one varied in size (Fig. 5.12). 
Full length sequencing of both strands of the cDNAs found that the variation in the 
lower band was owing to heterogeneity at the polyA site. The top band of pTaql6 
was slightly smaller in size at 850 bp, coinciding with the deletion of 96 bp. 
Sequencing pTaq23, which had expressed a protein slightly larger that pTaql6, 
showed that it did not have this deletion. The reason for the slightly larger top band 
in pTaq25 (Fig. 5.12) remained a mystery as it was not sequenced.
A comparison of the deduced amino acid sequences presented in the 
Appendix, Fig. B, revealed that there were no gross differences in amino acids 
between the clones, the translation stop site was in an identical position and there 
were no frame shifts. With the data available, it was difficult to conclude that the 
clones represented the separate a  and p cDNAs. It appeared that only the cDNA 
encoding the p polypeptide had been cloned. However, two amino acid residues 
per clone (three in pTaql6) were different from the consensus. These differences 
in amino acids were at dissimilar positions and provided no obvious distinction 
between pTaq22 and the clones, pT aq l6 and23. Additionally, at five other 
positions in the sequence (919, 1145, 1176, 1191 and 1239, in Fig. 5.16) there 
were differences in bases which caused no change in the amino acid. It seemed that 
the differences were random and may be attributed to the use of Taq DNA 
polymerase due to the relatively high error rate of this enzyme. Base substitutions 
occur about one per 9000 bp and frameshifts occur about one per 40 000 bp. The 
mutation rates are highly template-specific and are caused by the lack of a 3 "-5"
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products, which were expected to be the same as the Pfu amplified products, had 
been cloned successfully. The seven false positives, shown in Fig. 5.10, may have
■
exonuclease (proofreading) activity. One error in 9000 bp seems insignificant but 
after 30 cycles of PCR it leads to an error in every 300 bp of product. As single 
products were cloned this error rate may be encountered in the sequencing.
However, it was difficult to judge which amino acid differences were real and not
'due to Taq DNA polymerase.
An attempt had been made to reduce the chances of including mutations in 
the sequence by the use of the proof-reading Pfu DNA polymerase. It was unclear 
as to why the Pfu amplified product was “unclonable”. In general, many failures 
are attributed to the fact that some foreign inserts form non-standard secondary and 
tertiary structures, which are then deleted by the host. Two frequently occurring 
unstable structures in eukaryotic DNA are cruciforms (caused by inverted repeats) 
and Z-DNA (formed witliin alternating purine-pyrimidine stretches). Homologous 
recombination between the genome of the host and the recombinant plasmid is also 
a possibility. However, these explanations are unlikely as the Taq amplified DNA
arisen by a small deletion in the Lac Z gene as a result of excision of the inserted 'à
DNA at some stage during colony growth (Brown, 1992).
Expression of the cloned gene in E. coli, as described in the following 
chapter, was carried out in an attempt to determine if the clones represented only 
one type of polypeptide, a  or (3. Moreover, active E3 protein would suggest that 
the PCR derived clones were faithful copies of the E3 gene. Since the 5 " upstream 
sequence (encoding the leader sequence and the first seventeen amino acids) was 
unavailable from the PCR derived cDNA, a potato leaf cDNA library was later 
screened to isolate full length cDNA clones (chapter 7). The added advantage of 
this was that the sequence of the PCR derived clones could be compared with that 
of the clones isolated from the library and they could be used for future expression 
studies if expression of the Taq clones proved to be unsuccessful.
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Chapter 6
Heterologous Expression of the Potato Mitochondrial 
Dihydrolipoamide Dehydrogenase Gene(s) in E s c h e r i c h i a
c o l i
111
6.1 Introduction
Owing to the enor rate of Taq polymerase, it was decided to determine 
whether the eight Taq clones, isolated in chapter 5, encode a functional lipoamide 
dehydrogenase (E3) by attempting its expression in E. coli. However, it was 
recognised that the absence of the nucleotide sequence encoding the first seventeen 
amino acids of the mature protein from the cloned Taq inserts, as a result of the 
cloning strategy, may also have posed problems in the binding of the FAD cofactor 
or the folding of the E3 protein or both. The domain structure of E3 was elucidated 
when a tertiary structure for E. coli E3 was determined by fitting its primary amino 
acid sequence into the known tertiary structure of glutathione reductase (Rice et aL, 
1984). The FAD-binding domain is composed of residues 1-145 and is 
characterised by a pap structural fold involving residues 8-35, of which 5 residues 
are known to make contact with the FAD. For this reason the successful binding of 
FAD to the truncated protein during over-expression was in some doubt. Although 
the consequences of the absence of this sequence were unknown, an additional 
advantage of the heterologous expression work was to determine whether 
polypeptides of differing mass were expressed by any of the clones which could be 
related to either the a  or p polypeptides of E3. Furthermore, successful over­
expression of the potato H3 in E. coli would provide a plentiful supply of the 
enzyme, which is not available from potato tubers.
The pET system (Novagen) was chosen to subclone and express the Taq 
inserts, encoding the E3 gene, in E. coli. Genes are under the control of strong 
bacteriophage T7 transcription and translation signals: expression is induced by 
providing a source of T7 RNA polymerase in the host cell. pET28a, b and c are 
translation vectors, for the cloning of genes without the ribosome binding site (rbs) 
and ATG start codon or for eukaryotic genes in general as they do not carry the 
compatible rbs for expression in prokaryotes. The vectors carry the efficient rbs 
from the phage T7 major capsid protein and sequences adjacent to the cloning site
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6 .2  Results
for the histidine ‘Tag’ for purification of the protein on a nickel affinity column.
This stretch of 6 histidine residues can be cleaved off at a later stage by thrombin.
The three forms of the vector, ‘a’, ‘b ’ and ‘c ’ denote the reading frame relative to 
the BamHl cloning site (see Fig. 1.1, Materials and Methods).
At first, genes are cloned using DH5a, a host strain that does not contain 
the T7 RNA polymerase. As a result, they are transcriptionally silent, eliminating 
plasmid instability owing to the production of proteins potentially toxic to the host 
cell. Once established in a non-expression host, the plasmids are then transferred 
into expression hosts - E. coli BL21(DE3) cells - containing a chromosomal copy 
of the T7 RNA polymerase gene under the control of the lacUV5 promoter which is 
induced by the addition of IPTG (0.4mM). The added advantage of these strains is 
that they have been engineered to lack the Ion protease and the omp T outer 
membrane protease. Thus, target proteins are expected be more stable than in host 
strains containing these proteases. An additional strain - BL21(DE3)pLysS - can be 
used if expression of the heterologous protein takes place at an accelerated rate and
-is detrimental to the cell or to correct folding of the protein. The pLysS plasmid 
encodes T7 lysozyme which forms a specific complex with T7 RNA polymerase, 
reducing the rate of transcription (Moffat & Studier, 1987).
6 . 2 , 1  Subcloning the T a q  Inserts into pET28c Expression  
Vectors
The general procedure for subcloning into the BanM l and Hindill sites of 
the expression vector, pET28c from pBluescript was described in section 2.2.34.1. 
pET28c expresses from the ATC triplet of the GGATCC B ainBl recognition 
sequence and was chosen because expression of the E3 gene would be in the 
correct reading frame i.e. from the first glycine residue of the cloned gene as 
described in Fig. 6.1.
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With reference to chapter 5, the Taq amplified inserts representing the E3 
gene (clones pTaql3, 14,16, 22 and 23) had been inserted into pBluescript KS+ in 
the antisense direction; therefore, excising the insert from the plasmid with BamBl 
and H indill would allow their insertion into pET28c in the sense orientation. 
However, the Taq amplified inserts in pTaql5, 25 and 30 were cloned in the sense 
orientation of pBluescript already and subcloning with BamlTl and H in d ill 
orientated them in the antisense direction in the expression vector. As a result, 
expression of these genes should either be absent or should produce nonsense 
protein. These three constructs were used as a negative control of expression. An 
additional negative control for expression was the insert from pTaq22 subcloned 
into pET28a. As this insert would have been cloned in the wrong reading frame, 
protein expression should not occur or if it did, nonsense protein would be 
expressed.
Fig. 6.2 is an analytical gel showing the inserts subcloned into pET28c and 
propagated in DH5a E. coli cells. They were of the correct size expected for the 
respective cloned Taq insert. These new clones were named pTaqE16, 22, 23, 25 
30, 13, 14 and 15
6 .2 .2  Time Course of Expression from  the pET28c Clones
The transfer of the recombinant expression vectors from the cloning host to 
the expression host strain was described in section 2.2.34.2. The expression hosts 
used were BL21(DE3) and BL21(DE3)plysS. The latter strain possesses an 
additional plasmid, pLysS, which encodes for T7 RNA polymerase lysozyme. As 
described in the introduction to this chapter, T7 lysozyme provides a stringent level 
of control for rapid over-expression of proteins by complexing with a certain 
amount of the T7 RNA polymerase produced on induction.
The time course of protein expression, after induction of the lacUVS 
promoter with 0.4 mM IPTG, was performed following the method detailed in 
section 2.2.34.3. It was important to induce protein expression in mid log phase 
(Agoo of between 0.3-0.5) as this would ensure that there were still plenty of
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Fig. 6.2: Analysis of the Taq amplified inserts subcloned from 
pBluescript into the pET28c expression vector
The Taq amplified inserts were subcloned from pBluescript (KS+) clones 
(section2.2.34.1) into the BamW\ and HindlW sites of pET28c. Positive 
clones containing each of the inserts were isolated and purified plasmid 
DNA (1 pg) was digested with BamWl and HindlW. Fragments were 
separated on a 1% (w/v) agarose gel.
M: size marker, 1: pTaqE16, 2: pTaqE22, 3; pTaqE23 4; pTaqE25, 
5: pTaqE30, 6: pTaqE13, 7:pTaqE14, 8: pTaqE15
nutrients in the media to support continued growth of the cells. Samples (1 ml) 
were collected 0 ,1 ,2  and 3 h after induction and separated by 10% SDS-PAGE as 
described in section 2.2.5.
The results (Table 6.1) were very encouraging as it was found that the 
clones pTaqE13, 14, 16, 22 and 23 were all found to express protein at both 30°C 
and 37°C in one of the strains - BL21(DE3). The complete lack of expression in E. 
coli BL21(DE3)plysS was surprising because T7 lysozyme is only expected reduce 
the rate of expression and not inhibit it. As expected, clones pTaqElS, 30 and 25 
did not express protein because, as mentioned earlier, they had been cloned in the 
wrong orientation. There were two additional negative controls for expression. 
The first was expression of insert cloned in the wrong reading frame i.e. in pET28a 
and the second was induction of untransformed E. coli BL21(DE3). Neither was 
found to express the heterologous protein (data not shown).
Table 6.1
Results from the induction of expression of the Taq clones
Clone
Expression in 
BL21(DE3)
Expression in 
BL21(DB3)plysS
pTaqE13 yes no
pTaqE14 yes no
pTaqE16 yes no
pTaqE22 yes no
pTaqE23 yes no
pTaqE15 no no
pTaqE25 no no
pTaqE30 no no
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Fig. 6.3 shows the results of expression of only two of the clones at 37°C. '
High level of over-expression of clone pTaqE13 in BL21(DE3) can be seen over 
the 4 h; in contrast no expression was obtained in the BL21(DE3)plysS strain. The 
recombinant plasmid is slightly Teaky’ as some expression is evident before 
induction (at 0 h). The lack of expression in either of the host cells is shown for 
clone pTaqE15.
Fig. 6.4A and 6.4B present 10% (w/v) SDS-polyacrylamide gels analysing 
the expression at 37°C of clones pTaqE13, 14, 16, 23 and comparing the 
expression of pTaqE22 and 23. Interestingly, proteins having slightly differing 
mobilities on SDS-PAGE were expressed. In order to show the apparent 
differences in mobilities of the expressed proteins, four times less sample was 
loaded as compared with the gel in Fig. 6.3. The plasmids, pTaqE13, pTaqE14 
and pTaqE22 were found to express a protein having a lower mobility than the 
protein expressed from pTaqE16 and pTaqE23 by SDS-PAGE. It was thought at 
first that they may represent the a  and p forms; however, sequencing of pTaq22 
and pTaq23 had shown that they had very similar cDNAs and the unusually small 
polypeptide expressed by pTaqE16 was explained by a deletion of 96 bp leading to 
the absence of 32 amino acids from the mature protein. The protein encoded by 
pTaqE14 does appear to be intermediate in size between the protein of pTaql3 and 
pTaq23. The Mr of the expressed proteins will be 2.7 kDa more than the native 
proteins purified from potatoes, contributed by the plasmid from the ATG initiating 
residue to the Bam R l cloning site (ref. Fig. 6.1). However, since the native E3 
proteins were not analysed alongside the expressed proteins, this increase in mass 
would not be discernible on the gel.
The identity of the expressed proteins as E3 was confirmed by Western 
blotting the proteins expressed from all clones and immunological detection by ECL 
(section 2.2.7). Yeast antiserum was used to probe the blots as it was known to 
cross react with potato tuber mitochondrial E3. A one in five thousand dilution of
the antibody was made and incubated with blots of gels showing the time course of
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expression for all the clones. The results of the ECL detection of protein 
expression from plasmids pTaqElS, 14 and 16 are presented in Fig. 6.5. Both 
forms of the protein cross reacted with the antisera very specifically. The blot 
shows the Teaky’ nature of pTaqElS since E3 is detectable before induction at zero 
time. Furthermore, no background was observed and there was no cross reaction 
with E. coli E3 as judged by probing the cell extracts of the untransformed host 
cells (data not shown).
6 ,2 .3  P u r i f ic a t io n  o f th e  E x p re s s e d  D ih y d ro lip o a m id e  
D ehydrogenase from  BL21(DE3) Cells
Having established expression of E3 in E. coli, the next step was to purify 
the enzyme in an active form. Initial experiments concentrated on trying to assay 
over-expressed protein in a crude extract before attempting purification on nickel 
affinity columns using the six histidine tag on the N-terminal end of the enzyme 
which binds to the divalent nickel cations.
Lysate preparation from 100 ml cultures of the expressing BL21(DE3) was 
described in section 2.2.34.3 of Materials and Methods. The control sample was 
untransformed BL21(DE3) which was cultured and induced in the same way as the 
experimental samples. After three passages through a French press, the control 
sample emerged as a transparent, straw coloured liquid. In contrast, the lysates 
from the expressing samples were opaque containing fine white particulate matter. 
Not surprisingly, centrifugation at 12 000 g for 20 min resulted in the white 
insoluble matter pelleting down leaving a clear supernatant. E3 activity was 
assayed before and after centrifugation as in section 2.2.10.2 but no activity was 
found above background E, coli E3 activity. Evidently, E3 was being expressed in 
an insoluble form, accumulating in inclusion bodies. The pelleted samples were 
solubilised in Laemmli sample buffer and resolved on a 10% (w/v) SDS- 
polyacrylamide gel which showed, in lanes 2 and 3 of Fig. 6.6, that the E3 was 
indeed in the insoluble fraction. Furthermore, all concentrated preparations of E3 
tend to be a bright yellow colour due to the presence of the FAD cofactor.
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pTaqE13 pTaqE14 pTaqE16
Fig. 6.5: Immunological identification of the protein expressed from 
clones pTaqE13, pTaqE14 and pTaqE16
A time course of expression was carried out as described in section 2.2.34.3. 
Samples (1 ml,) collected at the time points of 0, 1,2 and 3 h after induction 
with 0.4 mM IPTG, were pelleted and resuspended in laemmli buffer 
(lOpl/0.1 absorbance unit). The samples were separated by 10% (w/v) 
SDS-PAGE and transferred to Hybond C membrane. ECL detection of the 
protein was performed with yeast E3 anti-serum ( 1/5000 dilution) as 
described in Materials and Methods, section 2.2.7.
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Therefore, since the precipitated material was uncharacteristically white, it was 
possible that there was no binding of the FAD cofactor.
A number of conditions for growth of the expressing strains were tested 
using the pTaqE22 clone, in an attempt to increase the solubility of the expressed 
E3. It is a well known phenomenon that reduction in the temperature of growth can 
lead to 30-90% of the heterologous protein accumulating in active, soluble form -
(Hockney, 1994). Expression of E3 at 30°C had already been shown (section
6.2.2) to occur at similar levels as 37°C, but again the protein was insoluble and 
inactive.
It was conceivable that E3 was being expressed too rapidly and was 
aggregating in the bacterial cells over the 4 h of induction period. In view of this, 
samples for analysis on a 10% (w/v) SDS-PAGE gel were collected 15 and 30 min 
after induction, after which time cells were harvested for protein purification. As 
can be seen in Fig. 6.7, a high level of expression had already occuned after 30 
min at both 30°C and 37°C and this is certainly too rapid to permit correct protein 
folding. A five times lower concentration of IPTG (0.8 mM) caused no detectable 
reduction in the rate of expression. In both cases E3 was insoluble and therefore 
inactive. The protein was still insoluble even when the cells were extracted in the 
presence of 50% glycerol using the French press.
As the rate of expression was so fast it was possible that the cells could not 
produce enough FAD for the vast amounts of E3. Finally, expression was carried 
out in the presence of riboflavin, the precursor required for FAD production.
Riboflavin was known to be quite insoluble in aqueous solution that it was 
necessary to add the solid riboflavin directly to 50ml of sterile LB media at a 
concentration of approx. 0.05-0.1 mM. The media was re-sterilised by passing it 
through a 0.22 pm filter and the culture flasks were foil wrapped as riboflavin is 
sensitive to light. Again, this attempt failed to produce active, soluble E3 (data not 
shown).
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6.3 Discussion
Over-exprès s ion of the E3 enzyme in E. coli was successful in that it 
showed that cDNAs encoding E3 had been cloned by the specific amplification of 
RNA derived cDNA. It appeared that each clone was encoding products with 
different mobilities on SDS-PAGE which may have been be related to the a  and p 
polypeptides. However, subsequent amino acid sequence information deduced 
from the DNA sequence for pTaql6, pTaq22 and pTaq23 (Chapter 5) found that 
there were no gross differences between the clones which could account for the 
expression of the separate polypeptides. Importantly, the open reading frame of 
pTaq22 and pTaq23 were the same length. Calculation of the Mr values from 
deduced amino acid sequence of the clones pTaq22, pTaq23 and pTaql6 in chapter 
5 also dispelled the idea that the expressed proteins may represent both the a  and P 
E3 polypeptides. The Mr of the protein encoded by pTaq22 was found to be closer 
to that of the p polypeptide which had been obtained by electrospray mass 
spectrometry. The 96 base deletion, discovered on sequencing pTaqE16 in chapter 
5, made an observable difference to the subunit Mr of the expressed protein as the 
polypeptide expressed from this plasmid was slightly smaller than the polypeptide 
expressed by pTaqE23. The predicted Mr of this protein would have been 49 589 if 
the deletion was not present; a value close to the Mr of the native p polypeptide (49 
562, determined by Es-Ms). Similarly the predicted Mr of the protein encoded by 
pTaq23 was closer to the Mr of the P polypeptide.
Sequence information of three of the Taq clones pointed to only one type of 
cDNA having been cloned from RNA of potato leaves and hence only one type of 
E3 being expressed (P2 ). The question of why the expressed proteins displayed 
slightly different sizes still remained to be answered. Proteolysis within E. coli is a 
possibility depending on the conformation of the insoluble protein.
Unfortunately, this work was inconclusive in terms of confirming the 
authenticity of the Taq polymerase derived clones because the over-expressed 
proteins were inactive. In addition, the expressed products could not be identified
Î
as specifically a  or p subunits without a comparison of their kinetic profiles with 
those of the native isoforms. Reducing the temperature of gi’owth of the cultures 
from 37°C to 30°C and lysing the cells in the presence of 50% glycerol did not 
improve the solubility of the expressed protein leading to the production of active 
enzyme. The complete lack of expression in BL21(DE3)pLysS was surprising, 
although it is possible that the T7 lysozyme was controlling T7 DNA polymerase 
too efficiently.
Other prokaryotic E3s have been successfully over-expressed in E. coli 
(Benen et ah, 1989; Westphal & Kok, 1988) but this is the first known attempt to 
express a eukaryotic E3 in a prokaryotic system. Many proteins are known to 
accumulate in the form of insoluble, biologically inactive inclusion bodies and in 
most cases the problem stems from the fact that the protein being expressed is 
eukaryotic in origin. Prokaryotes used as hosts for heterologous expression, like 
E. coli do not provide the appropriate environment for many eukaryotic proteins. 
They are unable to cany out many of the co- or post-translational modifications 
required by eukaryotic proteins e.g. glycosylation. In addition, eukaryotic proteins 
may not be able to fold correctly because the rate of protein synthesis is far more 
rapid in prokaryotes and they lack the specific chaperones.
It was suggested in the introduction to this chapter that the absence of the 
first 17 amino acids from the N-terminal end of the mature protein may be the main 
contributing reason for the resulting insoluble protein. As discussed in chapter 1, 
the E3 polypeptides from all sources are highly conserved and can be divided into 
four functional domains: the FAD-binding domain, the NAD(H)-binding domain, 
the central domain and the interface domain (Carothers et ah, 1989). Sequence 
analysis of the pea and potato mitochondrial E3 indicated that the important sites for 
enzyme activity are strongly conserved (Bourguignon et ah, 1992). It was 
expected therefore, that their secondary and tertiary structures would be the same as 
other E3s.
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A structural comparison will be made with E. coli E3 which has 40% 
identity with the pea E3. The FAD cofactor is deeply buried within the FAD-
s
binding domain and in E. coli E3 this encompasses residues 1 to 145. The 
conserved structural motif for FAD-binding is the p a p  fold which is found 
between residues 8 to 35 and within this group, the residues L eu ll, Alal3, Glyl4,
Ala 16, and Glyl7 are known to make contacts with the FAD cofactor. There are an 
additional nineteen main chain residues with polar or non-polar side-chains, found 
right along the polypeptide, making contacts with the FAD cofactor (Rice et aL,
1984). Clearly, there are important contacts made with the FAD cofactor in the first 
twenty residues which would be missing in the over-expressed E3 proteins. As
FAD is an integral part of E3, its inability to bind to the protein could lead to 
incorrect folding and structure formation. In support of this, recent work has 
shown that FAD is a necessary component in the re-folding of functionally active 
E3, previously unfolded in the presence of guanidine-HCl (N. Beaumont, Glasgow 
University: personal communication).
In conclusion, possible reasons for the expression of inactive E3 in the E. 
coli host strain are: 1) errors in the sequence of the clones containing & Taq  
amplified insert; 2) the absence of the N-terminal region of the E3 protein; 3) 
expression in a non-compatible system; 4) the presence of the positively charged 
histidine tag at the N-terminus of the proteins which could affect correct folding. 
Expression of the full length E3 clones isolated from the potato leaf cDNA library in 
the following chapter would provide a confirmation of any of these possibilities as 
they would be expected to be faithful copies of the E3 gene. A number of methods 
are available to overcome expression of insoluble protein. For example, Teaky’ 
plasmids can be left to express protein over a long period of time i.e 20 h without 
induction and a temperature of 30-35°C would help to reduce the log phase of 
growth so that nutrients are not depleted too quickly. It is also important to try 
different expression vectors with different host strains before resorting to use of a 
eukaryotic expression system.
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Chapter 7
Screening a Potato Leaf cDNA Library for Mitochondrial 
Dihydrolipoamide Dehydrogenase Genes
195
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7.1  Introduction
In chapter 5 the isolation of clones encoding dihydrolipoamide 
dehydrogenase (E3) by PCR amplification of cDNA, derived from potato leaf RNA 
was described. The clones expressed E3 subunits of slightly different sizes; 
however, there was no conclusive evidence to identify them as the separate a  and j3 
polypeptides. The disadvantage of using Taq DNA polymerase to amplify products 
for cloning was its lack of proof-reading ability. Therefore, the error frequency of 
Taq may have been responsible for introducing sufficient mutations in the cDNA to 
yield inactive protein products forming inclusion bodies. In addition, the Taq 
amplified clones were truncated at the 5 ' end. Finally, a potato cDNA library was 
screened for full length E3 gene(s) in order to be able to make valid conclusions 
concerning the precise sequence. Unfortunately, the only library available was a 
potato leaf library whereas a tuber library would have been more appropriate. 
However, it was known that both a  and P polypeptides were expressed in leaf 
tissue although it was found that the (%2 isoform was predominant in this tissue 
compared with tubers where the p2 isoform predominated (A.Carmichael, Ph.D 
thesis, Glasgow University, 1994). Thus, the only difficulty envisaged was 
isolating the gene encoding the p isoform from the leaf library, if indeed there is a 
separate gene. It was hoped that the isolated clones would include the 5 ' upstream 
sequence information not present in the Taq clones.
The potato leaf library was made in Lambda ZAP II by Dr. H. Hesse at the 
Max Planck Institute for Plant Molecular Physiology, Germany. Lambda ZAP II is 
an insertion type vector for uni-directional cloning into the EcoRl and Xhol sites 
(Chapter 2, Fig. 2.4). It harbours a complete copy of the phagemid vector, 
pBluescript SK-, which contains the multiple cloning site. pBluescript is flanked 
on one side by the initiator region and on the other by the terminator region of f  1 
filamentous phage origin of replication where DNA synthesis initiates and 
terminates, respectively. The presence of these regions allows for the in vivo
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excision of the pBluescript (-)strand which re-circularises, eliminating the need for 
laborious subcloning procedures. The proteins necessary for initiation and 
termination of replication, re-circularisation of the (-)-strand phagemid and 
packaging as filamentous phage are provided by simultaneously infecting the E. coli 
host with lambda helper phage.
Screening of the library was performed in three stages. Nearly 500 000 
phage were probed in the first screen to isolate areas on the plates (roughly 1 cm^) 
corresponding to a positive signal. Each area would contain negative clones as well 
as the positive clone resulting from the presence of overlapping plaques as plating 
was at high density. Therefore, the subsequent rounds of screening were aimed at 
purifying the positive clones by plating the phage from the primary screen at far 
lower densities to obtain separate plaques.
7 .2  Results
7 . 2 . 1  Titre of the Potato Leaf cDNA Library
The first step in the screening protocol was to obtain the titre of the library, 
i.e. the number of plaque forming units per ml of the library. This was achieved by 
counting the number of plaques produced by a known dilution of the library stock 
(section 2.2.30.1). The average titre was 5.8 x 10^ pfu.ml'l of the cDNA library.
7 .2 .2  Probe Preparation
The E3 clones obtained in chapter 5 provided a homologous probe for 
screening the potato leaf cDNA library. Restriction digests of the pTaq22 clone 
presented in that chapter had shown that a double digest with EcoRI and Kpnl 
produced two bands, one of 750 bp and the other of 950 bp (Chapter 5, Fig. 5.12), 
The 950 bp band, found to be close to the 5 " end of the gene, was used as the probe 
for the library. The advantage of this was that any clones hybridising with it would 
be most likely to harbour inserts containing the initiating codon of the E3 gene and 
would therefore provide the leader and N-terminal sequence missing from the Taq
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clones. The likelihood of false negatives was also reduced as the fragment was 
completely gene specific, containing no vector sequences.
The purified 950 bp product, shown in Fig. 7.1, was estimated to be 75 
n g .q l 'l  using the Hoefer minifluorimeter (section 2.2.24.2). The probe was 
labelled using the Megaprime DNA Labelling kit from Amersham (2.2.29.1) based 
on the use of random sequence nonamers to prime DNA synthesis on denatured 
template DNA at numerous sites along its length. Unlabelled dCTP was substituted 
by a radiolabelled equivalent [a-^^PjdCTP (3000 C i.m m opl) which was 
incorporated into newly synthesised DNA. The Klenow fragment of DNA 
polymerase I was used to synthesise DNA and the absence of the 5 "-3 " exonuclease 
activity associated with DNA polymerase I ensured that the labelled nucleotide was 
not removed as a monophosphate. The protocol was so efficient that only 25 ng of 
double-stranded template DNA were required to produce probes with a high 
specific activity.
7 .2 .3  Screening the Potato cDNA L ibrary  for the E3 Gene
For the primary screen approximately 500 000 phage were plated at a 
density of 60 000 pfu per plate. Plaque lifts were carried out exactly as described in 
section 2.2.30.2 using the positively charged nylon membrane, Hybond N+.
The membranes were incubated overnight with the heat-denatured probe at 
65°C, followed by washing of the membranes at high stringency (section
2.2.29.2). Fig. 7.2A presents one autoradiographed membrane showing a single 
positive signal (and two putative positives) obtained from a plate containing 60 000 
pfu. Probing with the 950 kb fragment appears to be very specific as there is no 
background hybridisation. A total of 25 positive signals were identified (spread 
over eight plates) from their position on the autoradiograph and cored from the 
plates as agai* plugs for elution and storage of the phage in 1 ml of SM buffer and 
50 pi of chloroform (section 2.2.30.3).
Ten of the positively hybridising plaques were re-screened in the second 
stage. The aim was to screen approximately 100-200 plaques per sample. This
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DNA
probe
Fig. 7.1: DNA probe (900 bp) prepared from a Ecol^KpnV  digest of 
pTaq22
The plasmid, pTaq22 (25 pg) was digested with the named restriction 
enzymes and the 900 bp digested fragment gel purified using the method 
described in section 2.2.18. The final purified product was analysed on a 
1% (w/v) agarose gel.
M= size marker
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number is low enough for individual plaques to be distinguished. A large number 
of the plaques were expected to hybridise with the probe as each sample from the 
primary screen was enriched for its particular positive clone. The primary screen 
samples were titred as before and diluted thirty times to achieve the plating density 
required. Fig. 7.2B is an example of the positive signals obtained with one of the 
samples after hybridisation to the membranes and autoradiography. The positive 
signals are very clearly defined and the absence of smearing of the plate surface 
owing to condensation or the plaque lifts is also evident as there are no streak marks 
across the film. Two or three positively hybridising plaques from each plate were 
cored from the agar and stored in 1 ml of SM buffer and 50 |il of chloroform. 
Although the plaques were separate from each other it was difficult to remove a 
single hybridising plaque and the estimate is that two negative plaques were also 
removed with the one positive plaque.
One positive sample from each plate of the secondary screen was re­
screened for a final time. This time it was important to ensure that the plaques were 
well separated so that single plaques could be isolated. This was achieved by 
plating the phage at a density of 50-70 plaques per plate, using the same procedures 
as above. Fig. 7.2C shows the positive signals obtained from one of the plates; 
about a half of the plaques on the plates were positive. A couple of positive plaques 
were cored from each plate for storage in 1 ml of SM buffer and 50 [il of 
chlorofoim. Each selected plaque was expected to contain a single type of clone.
Eight of the purified clones from the tertiary screen were chosen for PCR 
analysis as described in the next section. For this purpose these samples were 
amplified using the protocol described in section 2.2.30.4 to provide a phage stock. 
The average titre of the stocks was increased from 1 x 10^ to 6 x 10^ pfu.mpl by 
this procedure.
7 . 2 . 4  PCR Analysis of the Isolated Library Clones
A quick test to ensure that the eight Lambda clones from above were 
carrying the E3 cDNA was to amplify the insert DNA of the clones with the
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degenerate primers used in chapter 5 (Table 5.1). They were designed from N- 
terminal amino acid sequence of the E3 polypeptide from potato tuber mitochondria 
to amplify an 80 bp fragment from the 5' end of the E3 gene for cloning purposes. 
The cycle parameters and the products obtained are presented in Fig. 7.3. The 
degenerate primers successfully enabled the amplification of an 80 bp product from 
all the clones apart from clone pB7-l. Priming was very specific as only one 
product was obtained. The experiment indicated that the E3 gene had been cloned 
and that the clones, most probably, contained the extreme 5 ' end of the gene as the 
80 bp fragment corresponds to amino acids 5 to 28 of the mature E3 protein.
PCR was used again to determine if the upstream sequence encoding the 
leader sequence and the first seventeen amino acids of E3 were present in the 
clones. This sequence was important for the full length sequence of the E3 gene as
it had been absent from the Taq clones. Foreign DNA is cloned directionally into 
the multiple cloning site of pB lue script SK- which is pait of the Lambda ZAP II 
vector. The 5 ' end of the gene is inserted in the EcoRl site and the 3" end into the 
Xhol site. The T3 primer site is adjacent to the EcoRI site; therefore it is possible to 
use the T3 sense primer in conjunction with an antisense, gene specific primer 
(AGSP) to amplify the region in between the two primers. The antisense, gene 
specific primer was designed from the sequence already available from the Taq 
amplified clones in chapter 5, (shown below in Table 7.2). The position of AGSP, 
is indicated in Fig. A (appendix) and was 120 bases downstream from the 5" end of 
the Taq clones. A product of around 450 bases was obtained from five of the 
clones (Fig. 7.4), a size which agreed well with the estimate of 350-500 bases from 
the pea E3 sequence (Bourguignon et al., 1992). It was unclear why other non­
specific products were amplified from the clones pB6-2, 3-1 and 7-1 since a control 
reaction containing the T3 primer only was not carried out.
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Fig. 7.3: PCR analysis of the 5’ region of the library clones using the 
degenerate primers designed from the N-terminal region of the E3 enzyme
The degenerate primers (1000 pmol per 50 pi reaction) shown in Table 5.1 were 
used to prime DNA synthesis from Lambda ZAP II target DNA (0.05pg) purified 
using the method described in section 2.2.30.4. Amplification with Taq 
polymerase was carried out in the presence of 1 mM MgCh as described in 
section 2.2.22. The cycles were as follows: 1 x 5 min at 95°C, 30 x [30 s at 
55°C, 30 s at 65°C and 3 s at 95°C], 1 x 2 min at 65°C and 1 x 3  min at 72°C.
One fifth of the sample was analysed on a 12% (w/v) polyacrylamide gel.
M: size marker, 1: negative DNA control, 2:pB 6-l, 3: pB7-l, 4: pB9-2, 5: 
pB3-l, 6:pB9-3, 7: pBlO-1, 8:pB8-l, 9:pB6-2
b p
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Fig. 7.4: PCR amplification of the 5’ region of the library clones - priming 
with T3 and an E3 gene specific primer (AGSP)
The amplification of the Lambda ZAP II DNA (0.05 pg), purified as in section 
2.2.30.4, with Taq polymerase was carried out in duplicate, in the presence of 1 
mM MgCl2. The cycling conditions were as follows: 1 x 5 min at 95°C, 35 x [ 1
min at 50°C, 2 min at 60°C, 30 s at 95°C] and 1x10  min at 72°C. The Lambda 
ZAP II clones were analysed on a 12% (w/v) polyacrylamide gel and are named 
below their respective lanes (not in the same order as Fig. 7.3).
M= size marker
T able 7,2
Primer sequences used for the amplification of the 5 ' upstream  
sequences of the isolated library clones.
Number of
Primer Sequence (5 "-3") Bases
AGSP ATTCTAGA TGAAGAAGTGCCTTAGAAGG 28
T3 ATTAACCCTCACTAAAGGGA 20
7 . 2 . 5  In Vivo E xcision of the pBIuescript Phagem id from  
Lambda ZAP II
The use of Lambda ZAP II as a cloning vector eliminated the need for 
subcloning the inserts into plasmid vectors. As explained in the introduction, the 
vector contains the pBIuescript SK- phagemid and in E. coll it can be excised by fl 
or M13 based helper phage. The protocol was followed as described in section 
2.2.31. The success of the in vivo excision was apparent as many colonies 
appeared on the plates which were expected to contain the double-stranded 
pBIuescript plasmid with the cloned insert. pBIuescript was able to be propagated 
as a plasmid, as well as a phagemid, as it carried the colEl origin of replication. 
The helper phage were not ampicillin resistant and contained an amber mutation 
which meant that they were unable to co-infect SOLR cells (non-suppressing 
strain).
Two colonies from each plate were isolated and used directly for PCR 
analysis to confirm that they still contained the E3 gene. Each colony was 
suspended in 100 pi of sterile water and 5 pi used for PCR amplification with the 
degenerate primers designed in chapter 5 (Table 5.1). The reaction mix and cycling 
conditions were described in Fig. 7.3 for the amplification of the 80 bp fragment 
from the 5" end of the E3 gene. The Triton X-100 in the Taq polymerase buffer
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was sufficient to solubilise the SOLR cells. The same 80 bp product as in Fig. 7.3 
was amplified from all the excised clones verifying the identity of the inserts.
7 . 2 . 6  Restriction Digest Analysis
Owing to the incomplete sequence information available so far it was 
impossible to know if the a  and P polypeptides were encoded by one gene or two 
very similar genes. It was already known that the a  form predominated in potato 
leaf mitochondria and hence the a  gene was more likely to be isolated from the 
library. In order to narrow down the number of clones for sequencing, restriction 
mapping was necessary to ascertain whether all the cloned inserts represented the 
same gene. Of course, two very closely related genes would not necessarily be 
differentiated by this method.
Restriction maps of six clones were prepared using a series of restriction 
enzymes. All the clones were found to have the same restriction map apart from 
clone pB3-l. On closer inspection it was found that this clone also had the same 
map but had been inserted into the vector in the antisense orientation. This result 
was unexpected as the clones had been isolated from a unidirectional library. Fig 
7.5 a and 7.5b present the final restriction maps.
The two fragments of 700 and 950 bp obtained upon Kpnl digestion of the 
clones were identical with those of the Kpnl digested Taq clones (Chapter 5, Fig. 
5.12). In addition, the existence of different polyadenylation start sites was 
indicated because the Kpnl/Xhol fragment near the 3 ' end of the gene was slightly 
larger in clones pB9-3 and pB 8-l. The restriction maps provided important 
reference points for the subsequent sequence analysis, but the existence of two 
different cDNAs was still unclear.
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Fig. 7.5a: Restriction map of clones pB9-3, pBlO-1, pB9-2, pB6-l and 
pB8-l
Direction of transcription of the lacZ gene is indicated.
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Fig. 7.5b: Restriction map of clone pB3-l
Direction of transcription of the lacZ gene is indicted.
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7 . 2 . 7  Sequence Analysis of the Potato Leaf cDNA Clones
Three clones were selected for automated sequencing; pB3-l, pB9-3 and 
pBlO-1. Fig 7.6 shows the plasmid preparations used for the sequencing reactions 
after Kpnl digestion. Primer walking was peiformed using the forward and reverse
-
primers (Chapter 5, Table 5.3) designed for sequencing the Taq clones: pTaql6, 
pTaq22 and pTaq23. The primers had been designed from the sequence of the 
sense-strand of pTaq22 obtained by sequencing the Exo III deletion clones in
chapter 5.
The nucleotide sequence of the cDNA from pB3-l and the deduced amino 
acid sequence of the protein is shown in Fig. 7.7. The ATG triplet designated as the 
translation start site was confirmed by the similarity of the surrounding sequence 
(ACAAATGGC) with the favoured sequence (AACAATGGC) flanking the 
consensus functional pi ant-initiator codon (Liitcke et al., 1987). This is the only 
upstream ATG codon in the sequence. The synthesis of potato mitochondrial E3 
will therefore begin with methionyl-alanine as do most plant proteins. The open 
reading frame encodes a protein with 504 amino acid residues. The identity of the 
encoded protein was confirmed by comparison with the N-terminal sequence of the 
purified potato E3. The N-terminus corresponds to Ala35, indicating that the 
protein is synthesised with a 34-amino acid leader sequence. Thus, the mature E3 
consists of 470 amino acids, giving a protein of Mr 49 561. This is exactly the 
same as the mass of the p polypeptide obtained by electrospray mass spectrometry. 
The proposed polyA signal (AATAAA) is indicated on Fig. 7.7. The positions of 
the restriction sites shown agrees with the restriction map shown in Fig. 7.5B. The 
leader sequence exhibits a typical enrichment for alanine (9%), leucine (15%), 
arginine (12%), threonine (15%) and serine (20%) and contains no negatively 
charged residues. The sequence of pB9-3 was exactly the same as pB3-l, apart 
from a two base deletion at position 766 (indicated by ‘XX’ on Fig. 7.7). This 
deletion was expected to be a cloning artefact because translation of the sequence
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Fig. 7.6: Analysis of the purified plasmids pB3-l, pB9-3 and pBlO-1 used 
for sequencing the E3 gene from potato
The purified plasmids ( 1 pg) were digested with EcoKl and Kpnl and the 
fragments analysed on a 1% (w/v) agarose gel.
M= size marker
I'I
I:î
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Fig. 7.7: Nucleotide sequence of potato E3 and its deduced amino 
acid sequence
The bases and amino acids are numbered separately. The N-terminal 
sequence is underlined and vector sequences are in bold. The position of 
the two base deletion in clone pB9-3 is marked with an ‘X’ and the 
active-site cysteins are marked with ‘§’. The proposed poly A signal is 
indicated by
",
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GGCACGAGCAACAACTCA 18
ACAGTTCACATCGAATCACCAAAATTGACCAAAAAACCTACCGGAAAGTTCACCGGAATA 7 8
Leader sequence
CACGATTCCGATAACTGACCTTTACAAATGGCGATTTCTACCTTAGCTAGACGAAAGGCT 13 8
M À I S T L A R R K A  11
ACCACGTTTCTGTCATCCAGACTCCTTTACAGCACTTCCAAGTATTCGTTCTCTTTAACC 19 8 
T T F L S S R L L Y S T S K Y S F S L T  3 1
r-»E3
I B am H l
AGAGGTTTCGCTTCAGGATCCGATGAGAACGACGTCGTTGTTATCGGTGGTGGTCCCGGA 2 58  
R G F A S G S D E N D V V V I G G G P G  51
GGCTATGTGGCGGCGATCAAAGCAGCACAGCTTGGGCTTAAAACTACATGTATCGAGAAA 3 1 8  
G Y V A A I K A A O L G  L K T T C I E K  7 1
K p n l  § §
CGTGGTACCCTCGGTGGTACTTGCCTTAACGTTGGTTGTATTCCTTCTAAGGCACTTCTT 37  8 
R G T L G G T C L N V G C I P S K A L L  9 1
CATTCGTCCCACATGTTTCATGAAGCGCAACATTCATTTGCCAATCATGGTGTGAAGTTT 4 3 8  
H S S H M F H E A Q H S F A N H G V K F  1 1 1
TCTTCTGTCGAAGTwGATCTCCCTGCCATGATGGGACAAAAAGATAAAGCCGTGTCTAAC 49  8 
S S V E V D L P A M M G Q K D K A V S N  1 3 1
TTAACACGAGGTATAGAGGGTCTATTCAAGAAAAACAAAGTAAACTATGTGAAGGGATAT 5 58  
L T R G I E G L F K K N K V N Y V K G Y  1 5 1
GGTAAATTCCTCTCCCCTTCTGAAATTTCTGTTGACACTGTCGAAGGTGGTAACTCTGTT 6 1 8  
G K F L S P S E I S V D T V E G G N S V  1 7 1
GTTAAAGGCAAAAATATTATTATTGCAACTGGCTCTGATGTCAAAGGTCTACCTGGCATA 67 8 
V K G K N I I I A T G S D V K G L P G I  1 9 1
ACCATTGATGAGAAGAAAATTGTGTCATCCACCGGAGCATTAGCTTTGACTGAAATTCCA 7 3 8 
T I D E K K I V S S T G A L A L T E I P  2 1 1
XX
AAAAGATTAGTTGTTATTGGTGCTGGCTATATAGGCCTTGAGATGGGATCTGTCTGGGGT 7 98  
K R L V V I G A G Y I G L E M G S V W G  2 3 1
CGCCTCGGCTCAGAGGTGACTGTTGTTGAATTTGCATCTGATATTGTTCCAACCATGGAT 8 5 8  
R L G S E V T V V E F A S D I V P T M D  2 5 1
GGTGAAGTTCGCAAGCAATTTÇAACGTGCTCTTGAGAAGCAAAAGATGAAATTCATGCTA 9 1 8  
G E V R K Q F Q R A L E K Q K M K F M L  2 7 1
AACACTAAGGTGGTGTCAGTTGATGCTACAGGTGATGGTGTGAAATTGACCCTTGAACCT 97  8 
N T K V V S V D A T G D G V K L T L E P  2 9 1
X h o l
TCAGCTGGTGGTGATCAAACTATTCTCGAGGCTGATGTTGTTCTCGTCTCTGCTGGAAGA 1 0 3  8 
S A G G D Q T I L E A D V V L V S A G R  3 1 1
GTACCATTCACTTCAGGACTTGGATTGGACACGATAGGAGTTGAAACTGACAAGGCTGGT 10  9 8 
V P F T S G L G L D T I G V E T D K A G  3 3 1
AGAATCTTGGTCAATGAACGTTTTGCCACTAACGTCCCAGGGGTACATGCAATTGGTGAT 1 1 5  8 
R I L V N E R F A T N V P G V H A I G D  3 5 1
GTCATTCCTGGACCAATGCTGGCTCACAAGGCAGAGGAGGATGGCGTTGCTTGTGTAGAG 1 2 1 8  
V I P G P M L A H K A E E D G V A C V E  3 7 1
ATGTTTATCTTCTGCATTTTTCCATAÀTAAAGATGAGATGTAACCTGCTTTAAAAAAAAA 1 8 1 8
♦ ♦ ♦ ♦ ♦
P s t l  B am H l
AAAAAAAA7VAACCTCGTGCCGAATCCTGCAGCCCGGGGGATCCACTAGTTCT
K p n l
TTCATTGCAGGTAAGGAGGGTCATGTAGACTATGATATGGTACCTGGTGTCGTTTACACC 1 2 7  8 
F I A G K E G H V D Y D M V P G V V Y T  3 9 1
CACCCGGAAGTGGCTTATGTTGGGAAAACCGAGGAACAGGTAAAGTCACTCGGAGTTGAT 13 3 8 
H P E V A Y V G K T E E Q V K S L G V D  4 1 1
TATCGTGTTGGCAAATTCCCCTTCCTAGCAAACAGTAGAGCCAAGGCAATTGATGATGCT 13 9 8  
Y R V G K F P F L A N S R A K A I D D A  4 3 1
GAGGGAATTGTCAAGGTAATTGCTGAGAAAGAGAGTGACAAGATATTGGGCGTCCATATT 1 4 5 8  
E G I V K V I A E K E S D K I L G V H X  4 51
ATGTCACCTAATGCAGGGGAGCTTATTCACGAAGCTGTACTGGCATTGCAGTACGGAGCA 1 5 1 8  
M S P N A G E L I H E A V L A L Q Y G A  4 7 1
TCAAGTGAGGACATTGCTCGTACTTGTCATGCACATCCAACAATGAGTGAGGCACTCAAA 1 5 7  8 
S S E D I A R T C H A H P T M S E A L K  4 9 1
GAAGCAGCCATGGCCACTTATGACAAGCCCATCCACATGTAGGCCTGTGTTATATCCTCG 1 6 3  8 
E A A M A T Y D K P I H M *  5 0 4 i
ATAGCCTCATTTTTCTTATTCCGTTGAGAATCTTGAACGCTTAGAATAGGCTTTTTGTTG 1 6 9 8  
CTGCCGTTACTCAAGCAGCCcA'I ATTCCCCTTAATTCAGGACTCCAAATACACTATATGA 17 58
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following it produced many stop codons. Incomplete sequence information was 
obtained for pB 10-1 and it was not analysed further.
A comparison of all the DNA sequences is presented in Fig. A (Appendix) 
which also includes the sequence of the PCR derived clones from chapter 5. The 
sequences of pTaq22, pTaq23 and pTaql6 were missing upstream sequence 
encoding the N-terminal and leader sequences due to the cloning procedures 
employed. Nevertheless, all the sequences are identical with each other, except at 
the bases indicated. Some base changes caused amino acid differences as indicated 
in bold in Fig.B (Appendix). A comparison of the clones reveals that all the 
differences, except one (at residue 19), are in the PCR derived clones. The 
deduced amino acid sequence of all the clones (Fig. B, Appendix) found that the 
stop codon is in exactly the same position (at base number 1618 in Fig. A, 
Appendix). The upstream sequences of pTaql6 and pTaq22 are expected to be the 
same as the two library clones because they encompass the N-terminal sequence 
derived from protein sequencing. However, as explained in chapter 5, the 
sequence of pTaq23 begins later than the other Taq amplified clones merely because 
the sequencing strategy for this clone was started further downstream. There could 
be some differences in the upstream sequence of pTaq23 but this was not 
investigated further.
7 .3  Discussion
Confidence in the identity of the clones isolated from the potato leaf cDNA 
library comes from the fact that the predicted N-terminal sequence matches the 
sequence derived from protein sequencing. The cDNA clone for potato E3 revealed 
a 1512-nucleotide open reading frame encoding a 504 residue protein. The first 34 
residues were found to bear some of the hallmarks of a mitochondrial leader 
sequence (a positive hydrophobic-polar design).
Surprisingly, the predicted Mr of the clone pB3-l, 49 561, was found to 
correspond exactly with the Mr of the P polypeptide as determind by electrospray
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mass spectrometry. Preliminary protein studies had shown that the p2 isoform was 
the minor species in pea leaf mitochondria, with the a2  form predominating. 
Hence, there would have been a higher probability of cloning the a  gene if there 
were two sepai-ate genes encoding the a  and p polypeptides. The reasons for
cloning the apparently minor species remains unclear at this stage. Preliminary
A
copy number analysis had been inconclusive in determining whether the E3 gene 
was in single copy; therefore, it was impossible to conclude that another gene 
encoding the a  polypeptide did not exist in the cDNA library. Furthermore, 
although the Taq amplified clones did not match the sequence of pB3-l exactly they 
were thought to represent the gene for the p polypeptide. Initially, the assumption 
made in selecting Taq amplified clones for sequencing was that pTaql6 and pTaq23 
may encode the P polypeptide and pTaq22 may encode the a  polypeptide. 
However, there were no obvious differences in amino acid residues consistent only 
with pTaq22. The predicted values (including the 5" amino acid sequence 
absent from the clones) were 49 558 (pTaq22), 49 517 (pTaq23) indicating identity 
with the p polypeptide and 46 060 for the protein encoded by pTaql6; none of them 
showing a difference in Mr of 116 found between the native a  and P polypeptides. 
Characteristically for mitochondrial E3s, the Mr of the P polypeptide obtained by 
electro spray mass spectrometry is lower than the value of 56 000 based on its 
mobility in SDS-PAGE.
The putative element signalling polyadenylation (AATAAA) in higher 
eukaryotes was found at the 3' end of the clones (Fig. A, Appendix), twenty bases 
from the polyA tail of pB3-l. However, since the poly A tail of pTaq23 began 
immediately at this sequence and those of pB9-3, pTaql6, pTaq22 and pTaq23 
began a various points later in the sequence it was not known if there were other 
related signals before and after the proposed sequence. Multiple polyA signals are 
quite common in plant genes as it appears that the standard polyadenylation signal is 
not as strong as it is in other eukaryotic genes. J-
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There are various possibilities at the genetic level for the generation of the a  
and p polypeptides, having a mobility difference visible on SDS-PAGE and a Mr 
difference of 116. A deletion of three bases causing the loss of one amino acid or 
the cleavage of the first or terminal amino acid during post-translational processing 
could generate the a  polypeptide since it is smaller by 116 Da. Neither of these 
were found to occur and cleavage of the first last amino acids would not have 
generated proteins with the small mass difference since their Mr values would be 71 
(alanine) and 149 (methionine), respectively. A post-translational modifcation 
involving an addition would not be possible since the gene for the larger
polypeptide had been cloned. Finally, the a  polypeptide could be a physiologically 
insignificant form generated by an unusual type of allelic variation which allowed 
the separation of the two polypeptides.
It is feasible that there are two separate genes having a number of 
conservative substitutions in amino acids which coincidentally leads to polypeptides 
having a small difference in mass. The validity of this hypothesis is apparent when 
comparing the amino acid sequence of the potato and pea mitochondrial E3 which 
have 85% identity in sequence, giving rise to a difference in Mr of only 168. Copy 
number analysis is required to prove the presence of a second gene. Furthermore, 
the presence of a second transcript originating from a single gene by RNA splicing, 
could be investigated by analysis of mRNA by Northern blots.
The overall sequence similarities at the amino acid level between E3 from 
potato and E3s from eukaryotic sources is very high (Table 7.3). It has 92.8% 
similarity with pea E3 and 72-73% with yeast, human and pig E3s. Although 
potato E3 is found to be less similar to prokaryotic E3s, the values are still high 
(60-70%). Therefore, the potato enzyme in not expected to be very different from
these E3s in secondary and tertiary structure. The primary amino acid sequence 
comparisons between the potato clone pB3-l and several other E3s (Fig. 7.8) 
showed that important sites for enzyme activity are highly conserved. In fact, the 
amino acid sequence surrounding the two redox-active cysteines (residues 75-91
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located in the FAD-binding domain) is identical in all the E3s of eukaryotic origin. 
Likewise, two regions in the mature potato E3 protein are very similar to the 
‘fingerprint’ structural motif in the adenine-binding domain of either FAD (residues 
42-63) or NAD (residues 214-241) of many enzymes, including the 
dihydrolipoamide dehydrogenases. The presence of several clustered regions of 
high sequence similarity suggests that all these proteins have evolved from a 
common ancestor.
..ft
Table 7.2
Percent identity and similarity of several E3s with potato E3
Source of E3
Percentage
identity
Percentage
similarity
Accession
Number Reference
Pea ( Pisum sativum) 85.2 92.8 X63464 Bourguignon 
et a l  (1992)
Trypanosoma brucei 56.2 75.2 X70646 Else et al. 
(1993)
Human 54.6 73.0 J03490 Otuiakowski 
& Robinson. 
(1987)
Pig 54.6 73.6 J03489 Otuiakowski 
& Robinson. 
(1987)
Yeast 55.7 72.2 J03645 Browning et 
a/. (1988)
Pseudomonas putida (lpd3)
54.4 73.3 X55704
S74684
Palmer et al. 
(1991)
Azotobacter vinelandii 48.1 68.0 P I8925 Westphal & 
de Kok. 
(1988)
Klebsiella pneumoniae 
(AcoD*)
40.2 61.1 U30887 Peng et al. 
(1996)
Staphylococcus aureus 44.1 63.8 X58434 Elemila.
(1991)
Bacillus
stearothermophilus 47.9 64.9 X53560 Borges et al. (1990)
E. coli K12 43.0 62.6 P00391 Stephens et 
oZ. (1983)
* Klebsiella pneumoniae Acetoin dehydrogenase system {acoD gene for E3)
Fig. 7.8: Primary amino acid sequence comparison of potato E3 (clone pB3-l) 
and E3s from other sources
The comparison was created using the pileup program of the GCG sequence 
analysis package. The boxed regions show the conserved amino acid domains. 
Abbreviations for the source of the E3 sequence: pB3-I,potato; Tryp,Trypanosoma 
brucei; ŸSGud,Pseudomonas putida; Azo, Azotobacter vinelandii; Aco-\y,Klebsiella 
pneumoniae; Staph, Staphylococcus aureus; Bac, Bacillus stearothermophilus; Coli, 
Escherichia coli.
§=redox active cysteines
*= amino acids conserved in higher Eukaryotes
+= amino acids conserved in all E3s
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Chapter 8 
Discussion and Future Research
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8.1 Dihydrolipoamide Dehydrogenase (E3) from Potato 
Tuber Mitochondria
8 . 1 . 1  Purification and Mr Analysis of Potato Mitochondrial E3
The novel isolation of multiple E3 isoforms from a plant source {Solarium 
tuberosum  c.v. Maris piper potatoes) was first reported by this laboratory 
(Fullerton et al, 1996) where otp and P2 activities (eluted from Mono Q ion
:exchange column as peaks 1, 2 and 3, respectively) were shown to arise from the
s.',various combinations of the 58 000 (a) and the 56 000 (p) subunits. The existence 
of the heterodimeric a p  form was surprising since E3 has been reported to exist 
only as a homodimer in all organisms studied to date. Recently, similar isoforms 
were discovered in mitochondria from barley leaves, although several other plants 
such as horseradish {Amoracia rusticana), turnip (Brassica campesteris) and pea
i(Pisum sativum) have only a single form of mitochondrial E3 (M. Conner, Ph.D 
Thesis, Glasgow University, 1997). The expression of isoforms in potatoes was 
not a result of the tetraploid nature of the genes since a dihaploid strain of Solatium 
tuberosum and a diploid strain of Solarium phoreta also expressed three isoforms of 
E3.
Although the isoforms had been purified to homogeneity, their final yields 
were poor making further characterisation difficult. The original purification 
protocol was redesigned to scale up the procedure by removing an affinity 
chromatography step and replacing it with an ion exchange step (DEAE-52 
chromatography) having greater capacity. The scale-up, was successful in 
obtaining approx. 20-fold more units of E3 activity (16 units by the original 
protocol to 320 units by the new protocol). However, since the extract was 
obtained from a crude pellet and not pure mitochondria the scale-up procedure 
increased the final yield of the three isoforms at the cost of slightly reduced purity.
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Increased yield of the E3 isoforms permitted the determination of precise Mj- 
values of the a  and (3 polypeptides by electrospray mass spectrometry (Es-Ms). 
The Mr for the a  polypeptide (49 446 ±12.28) and the p polypeptide (49 562 
±6.83) were found to be lower than the masses deduced by SDS-PAGE (58 000 
and 56 000, respectively). This discrepancy is characteristic of mitochondrial E3s 
and the Mr values obtained by Es-Ms were in a similar range to other mitochondrial 
E3s reported to date. However, it was observed that the polypeptide having the 
larger mass by SDS-PAGE (a) is actually the smaller form by electrospray mass 
spectrometry.
8 . 1 . 2  Complex Specificity of the Mitochondrial E3 isoforms
The discovery of E3 isoforms in potato mitochondria had suggested that 
their physiological significance may be related to complex specificity. This would 
be an unusual situation since the single mitochondrial E3 from pea has been shown 
to be a common component for both PDC, OGDC and GDC (Bourguignon et a l, 
1992; Turner et al., 1992; Bourguignon et a l, 1996). In general, a single E3 is 
thought to complement the activities of the PDC, OGDC, BCDC and GDC in 
higher eukaryotes, although there are increasing examples of complex specific 
forms in prokaryotes.
In support of a complex specific role, tissue specific expression of the three 
potato E3 isoforms was reported by A. Carmichael (Ph.D Thesis, Glasgow 
University, 1994). The %  form was observed to be expressed at higher levels in 
potato leaf mitochondria (at a ratio of 9 a|3:2 p2 and a p  and p2 were the major
form in tubers (a ratio of 1 a2:3 ap:5 p2). This result suggests that the a 2 isoform 
may be specific for GDC, which constitutes 30-50% of total leaf mitochondrial 
protein. Additionally, some preliminary kinetic characterisation carried out in the 
laboratory had shown that the three isoforms differ considerably in their enzymatic 
properties. For example, striking differences were found in the for NAD+ 
(120p,M [a 2], 200ji.M [ap] and 500qM [p2]). They were also found to have 
varying heat stabilities, with the a  form being more stable, and varying salt
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sensitivities (R. Cook, unpublished observations, Glasgow University). It is not 
clear whether the enzymatic properties of the isoforms were dependent on the 
conditions of assay used i.e. different assay temperature and buffers, since 
previous results had suggested that the kinetic differences were not as pronounced 
(R. Fullerton, Ph.D Thesis, Glasgow University, 1996) as those found more 
recently.
Subsequently, complex specificity was investigated by reconstitution of 
potato OGDC and PDC activities (after being stripped of their E3 components) with 
the potato E3 isoforms. This approach proved to be more difficult than at first 
envisaged owing to the difficulties in purifying plant OGDC. Thus, there was no 
direct evidence for the preferential use of any of the isoforms by OGDC.
Although difficulties were encountered with detection and purification of the 
plant complexes, interesting differences in the selective binding of E3s from a 
variety of sources with the E1/E2 core of mammalian OGDC (bovine heart) were 
shown. Although the potato E3s were unable to promote any OGDC activity, weak 
binding was shown by competition experiments. Surprisingly, reconstitution by a 
variety of E3s highlighted subtle differences in catalytic and/or binding orientations
.
between bovine heart E1/E2 and E3 from different species. Bovine mucosal and 
porcine heart were found to give poor reconstitution (15-20%) with bovine heait 
OGDC core and yeast E3 did not promote any complex activity. However, they 
were all found to have a high affinity of binding. E3 is a highly conserved enzyme 
with approx. 96% sequence identity between human liver and porcine heart E3; 
therefore, these E3s had been expected to promote the activity of OGDC to the same 
levels as native bovine heart E3. Similar experiments carried out by Sanderson et 
a i  (1996b) had shown that these results were not artefactual since the same pattern 
of reconstitution was obtained with bovine heart PDC core complex.
Recent preliminary data on reconstitution of plant PDC has suggested some 
complex specificity of the p2 isoform for PDC (R. Cook, unpublished 
observations, Glasgow University). This would seem to agree with the suggestion
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#that the (%2 form is putatively specific for GDC as it is expressed in high levels in 
leaf tissue. A recent development has been the discovery of a distinct chloroplastic 
E3 from pea leaves (Conner, et al. 1996). It is thought that this E3 is a component
of the PDC found in chloroplasts which is distinct from mitochondrial PDC. The
Mr of the plastidic E3 was found to be 52 614 by Es-Ms, approx. 3000 Da larger 
than the pea mitochondrial E3.
8 .2  Cloning the Potato Mitochondrial E3 gene(s)
Since conclusions could not be made about the role of the three E3 by 
reconstitution studies, the relationship between the a  and p polypeptides was 
investigated by the cloning their genes. This is only the second mitochondrial E3 to 
be cloned from a plant source.
8 . 2 . 1  Cloning by PC R  Am plification of E3 cDNA
A PCR-based strategy was used for the amplification of cDNA generated 
from potato leaf RNA in the event of two separate transcripts encoding E3. 
Generating a PCR product for the purposes of sequencing requires the use of a 
proof-reading polymerase (Pfu) but tlie amplified product was unable to be cloned. 
The cloning of a Taq amplified product of the same size as the Pfu product led to 
the isolation of eight clones containing E3 cDNA inserts of varying size. The 
inserts were expected to encode E3 from amino acid 18 of the mature protein as a 
result of the cloning strategy. Expression of the cDNAs in E. coli showed that they 
also encoded proteins of different size. However, the proteins were inactive and 
insoluble either because they were truncated at the N-terminus causing FAD- 
binding sites to be lost or they had crucial mutations caused by the use of Taq DNA 
polymerase.
The sequence of pTaq22 consisted of an open reading frame of 1359 bp, 
encoding a polypeptide of 453 amino acids, which with the inclusion of the first 17 
amino acids at the N-terminus would be 470 amino acids in total. The Mr was
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found to correspond approx. to the (5 polypeptide (49 558). The amino acid 
sequence of pTaq23 was identical with pTaq22 apart from four amino acid 
substitutions. It was expected that the two clones represented the j3 polypeptide 
and expression of proteins of differing size was merely due to non-conservative 
amino acid substitutions. The sequence of pTaql6 was also identical with pTaq22 
except for a deletion of 96 bp which was thought to be a cloning artefact.
8 . 2 . 2  Isolation of E3 clones from a Potato leaf cDNA Library
A 5' restriction fragment of the pTaq22 cDNA was used as a probe for 
screening the cDNA library for full length E3 clones. A total of six clones were 
isolated and all were found to have the same restriction maps. Clones selected for 
sequencing, pB3-l and pB9-3, had an open reading frame of 1512 bp, encoding a 
protein with 504 residues. The mature protein was 470 residues with a leader 
sequence of 34 residues. The theoretical Mr of the deduced protein was 49 561, 
being identical to the mass of the P polypeptide by Es-Ms. pB9-3 had a two base 
deletion, but this was expected to be a cloning artefact. Partial sequence of another 
clone, pBlO-1 was obtained and was expected to be identical with pB3-l and pB9- 
3. The sequence of these clones were identical to the sequence of the clones 
containing the Taq amplified insert, except at a few positions. The base differences 
in the Tag clones were attributed to mutations caused by Tag polymerase.
The sequence information and calculated Mr values of all the clones 
indicated that the p polypeptide had been cloned. If there was a second gene 
encoding the a  polypeptide it was unclear why it had not been identified by cloning 
from purified mitochondrial RNA and from the library. Preliminary data presented 
by R. Cook suggested that the three isoforms had very distinct kinetic properties 
which would suggest that a  and p are products of two different genes. The a  
polypeptide may posses a significant number of amino acid substitutions which 
coincidentally has a similar to the p polypeptide. This is evident with pea 
mitochondrial E3 with the potato E3 which have 10% non-similar amino acids in 
comparison with each other and a Mr difference of only 168. However, other
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criteria shows that the two polypeptides were very similar i.e. they both cross­
reacted strongly to yeast antiserum, they were found to have identical N-terminal 
sequences and are very close in mass (a difference of only approx. 116 by Es-Ms). 
This would imply that alternate splicing of RNA or a deletion was responsible for a 
second, closely related polypeptide. The possibility of a post-translational 
modification for the generation of the a  polypeptide was eliminated because it was 
shown that the gene encoding the polypeptide with the larger predicted Mr value had 
been cloned. Moreover, the deletion of the first or last amino acid of the mature 
protein would not generate an a  polypeptide with the known Mr.
The existence of leaf specific mitochondrial isoforms can be discounted 
because the clone isolated from a leaf cDNA library had an identical Mr value to the 
P polypeptide of tuber mitochondria origin. The potato E3 sequence was found to 
have very high sequence similarities with other eukaryotic and prokaryotic E3s; 
62% (E. coli), 73% (human) and 93% (pea). This reflects the highly conserved 
nature of the E3 enzyme. The highest identities were in the conserved functional 
domains of the polypeptide. An unrooted evolutionary tree of several E3s was 
constructed, based on amino acid sequence (Fig. 8.1). The open circle is the 
presumed origin of all the sequences and the numbers are ‘PAM-distances’, giving 
the % amino acid deviation from the last common root. The eukaryotic genes are 
clustered to the bottom left of the tree, with the plant E3s forming a separate branch. 
The tree shows that LPD-3 from Pseudomonas putida is found in between yeast 
and Trypanosoma brucei E3. Sequence and evolutionary analysis by Palmer et al. 
(1991) had shown that this E3 was more similar to eukaryotic E3s than the other 
E3s from P. putida, LPD-val and LPD-glc which were closely related to the 
prokaryotic E3s. The authors suggest that the lpd2) gene may be close to the 
ancestral gene for eukaryotic E3.
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Fig. 8.1: Unrooted evolutionary tree of potato E3 in relation to other E3s, 
based on amino acid sequence.
The numbers indicate the relative evolutionary distances from the next 
common root (percent amino acid mutation) and were calculated using the 
Darwin system (AllAll: related peptide software) at the Computational 
Biochemistry Research Group server (ETHZ, Switzerland). The open circle 
indicates the theoretical origin of the tree.
8 .3  Future Research
The exact relationship between the two polypeptides, a  and j3, forming the 
three isofoi*ms of potato E3 has, as yet, not been established. Therefore, future 
work will concentrate on identifying the nature of a second possible gene encoding 
the a  polypeptide. In this context, copy number analysis of the E3 gene in genomic 
potato DNA is a crucial first step. Extensive kinetic characterisation is required to 
clear the current confusion in this area. Additionally, comparisons of Km, Vmax 
and heat stabilities would help to determine if the a  and P polypeptide are very 
closely related or not. This would then lead to the screening of a potato leaf or a 
potato tuber cDNA library if available.
Cloning of the newly discovered pea chloroplast E3 is underway and will
provide an interesting comparison of structure-function relationships between the
potato and pea mitochondrial E3s. For example, in characterising the selective
binding of the chloroplast specific E3 to plastidic PDC. Cloning and sequencing of
these plant genes is particularly important for the future production of transgenic I
!plants. This would aid the assessment of the role played by plastidic PDC in fatty |I
acid metabolism by its selective inhibition.
Northern blots would provide important information on the developmental 
regulation and tissue specific expression of the potato E3 isoforms. Of interest 
would be following the expression of the a 2 forni with expression of GDC,
The over-expression of the clone, pB3-l, isolated from the potato leaf 
cDNA library is eagerly anticipated which would provide plentiful supply of the p2 
isoform. Initially this full length clone would be expressed in bacteria before 
attempting eukaryotic expression systems. This would be followed by 
crystallisation of the p2 form for future structural determination at high resolution.
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Appendix
Fig. A: DNA sequence comparison of the clones pB3“l ,  pB9-3 and the 
PCR derived clones pTaq22, pTaq23 and pTaql6,
The sequence information of pTaq23 starts at base number 482. A changed 
base leading to an amino acid change is indicated b y '* '  and a changed base 
causing no amino acid change is indicated by The forward and reverse 
sequencing primers found in Chapter 5, Table 5.3 are shown by half arrows. 
The position of primer, ‘AGSP’, designed to amplify the 5’ upstream 
sequences of the clones is shown. The stop codon is in bold, poly A tails are 
underlined and the polyadenylation signal is shown by
GGCACG AGCAACAACT CAACAGTTCA CATCGAATCA p B 3 - l  
CGGCAC GAnAGACTC. TTCAACAACT CAACAGTTCA CATCGAATCA p B 9 -3
37 CCAAAATTGA CC.AAAAAAC 
CCAAAATTGA CCAAAAAAAC
87 CCGATAACTG ACCTTTACAA 
CCGTTAACTG ACCTCTACAA 
+
1 3 7  GCTACCACGT TTCTGTCATC 
GCTACAACGT TTCTGTCATC
187  GTTCTCTTTA ACCAGAGGTT 
GTTCTCTTTA ACCAGAgGTT
CTACCGGAAA GTTCACCGGA 
CAACCGGAAA GTTCACCGGA
I— ► Leader sequence
ATGGCGATTT CTACCTTAGC 
ATGGCGATTT CAACCTTAGC
*  P r i m e r  P ____________
CAGACTCCTT TACAGCACTT 
CAGATTCCTT TACAGCACTT
■►E3 sequence:cEcTCGCTTCAGG ATCCGATGAG 
TCGCTTCAGG ATCCGATGAG
ATACACGATT
ATACACGATT
TAGACGAAAG
TAGACGAAAG
CCAAGTATTC
CCAAGTATTC
AACGACGTCG
AACGACGTCG
p B 3 - l
p B 9 -3
p B 3 - l
p B 9 -3
p B 3 - l
p B 9 -3
p B 3 - l
p B 9 -3
2 3 7  TTGTTATCGG 
TTGTTATCGG
TGGTGGTCCC GGAGGCTATG TGGCGGCGAT CAAAGCAGCA p B 3 - l  
TGGTGGTCCC GGAGGCTATG TGGCGGCGAT CAAAGCAGCA p B 9 -3  
GGCTATG TGGCGGCGAT CAAAGCAGCA p T aq 22  
GGCTATG TGGCGGCGAT CAAAGCAGCA p T a q l6
2 8 7  CAGCTTGGGC TTAAAACTAC ATGTATCGAG AAACGTGGTA CCCTCGGTGG p B 3 - l
CAGCTTGGGC TTAAAACTAC ATGTATCGAG AAACGTGGTA CCCTCGGTGG p B 9 -3
CAGcTTGGGC TTAAAACTCC ATGTATCGAG AAACGTGGTA CCCTCGGTGG p T aq22
CAGCTTGGGC TTAAAACTAC ATGTATCGAG AAACGTGGTA CCCTCGGTGG p T a q l6
3 3 7
387
437
487
TACTTGCCTT
TACTTGCCTT
TACTTGCCTT
TACTTGCCTT
CCCACATGTT
CCCACATGTT
CCCACATGTT
CCCACATGTT
AACGTTGGTT
AACGTTGGTT
AACGTTGGTT
AACGTTGGTT
TCATGAAGCG 
TCATGAAGCG 
TCATGAAGCG 
TCATGAAGCG 
P r i m e r  1
GTATTCCTTC 
GTATTCCTTC 
GTATTCCTTC 
GTATTCCTTC \ -----
TAAGGCACTT
TAAGGCACTT
TAAGGCACTT
TAAGGCACTT
CAACATTCAT 
CAACATTCAT 
CAACATTCAT 
CAACATTCAT 
 2S.
TTTTCTTCTG
TTTTCTTCTG
TTTTCTTCTG
TCGAAGTwGA
TCGAAGTwGA
TCGAAGTTGA
TCTCCCTGCC
TCTCCCTGCC
TCTCCCTGCC
TTTTCTTCTG TCGAAGTTGA TCTCCCTGCC
AGCCGTGTCT
AGCCGTGTCT
AGCCGTGTCT
AGCCGTGTCT
AGCCGTGTCT
AACTTAACAC
AACTTAACAC
AACTTAACAC
AACTTAACAC
AACTTAACAC
GAGGTATAGA 
GAGGTATAGA 
GAGGTATAGA 
GAGGTATAGA 
G .......................
AUSP
TTGCCAATCA
TTGCCAATCA
TTGcCAATCA
TTGCCAATCA
ATGATGGGAC
ATGATGGGAC
ATGATGGGAC
ATGATGGGAC
+
GGGTCTATTC
GGGTTTATTC
GGGTCTATTC
GGGTCTATTC
CTTCATTCGT p B 3 - l  
CTTCATTCGT p B 9 -3  
CTTCATTCGT p T aq 22  
CTTCATTCGT p T a q l6
TGGTGTGAAG
TGGTGTGAAG
TGGTGTGAaG
TGGTGTGAAG
*
AAAAAGATAA
AAAAAGATAA
AAAAAGATAA
GATAA
GAAAAGATAA
p B 3 - l
p B 9 -3
p T aq 22
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
AAGAAAAACA p B 3 - l  
AAGAAAAACA p B 9 -3  
AAGAAAAACA p T aq22  
AAGAAAAACA p T aq 23  
.......................... p T a q l6
53 7
587
AAGTAAACTA TGTGAAGGGA TATGGTA^\AT 
AAGTAAACTA TGTGAAGGGA TATGGTAAAT 
AAGTAAACTA TGTGAAGGGA TATGGTAAAT 
AAGTAAACTA TGTGAAGGGA TATGGTAAAT
TCCTCTCCCC TTCTGAAATT p B 3 - l  
TCCTCTCCCC TTCTGAAATT p B 9 -3  
TCCTCTCCCC TTCTGAAATT p T aq 22  
TCCTCTCCCC TTCTGAAATT p T aq 23  
......................................................... p T a q ie
P r i m e r  2
TCTGTTGACA CTGTCGAAGG TGGTAACTCT 
TCTGTTGACA CTGTCGAAGG TGGTAACTCT 
TCTGTTGACA CTGTCGAAGG TGGTAACTCT 
TCTGTTGACA CTGTCGAAGG TGGTAACTCT 
................................................. AGG TGGTAACTCT
GTTGTTAAAG
GTTGTTAAAG
GTTGTTAAAG
GTTGTTAAAG
GTTGTTAAAG
GCAAAAATAT
GCAAAAATAT
GCAAAAATAT
GCAAAAATAT
GCAAAAATAT
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
637  TATTATTGCA ACTGGCTCTG ATGTCAAAGG TCTACCTGGC ATAACCATTG p B 3 - l
TATTATTGCA ACTGGTTCTG ATGTCAAAGG TCTACCTGGC ATAACCATTG p B 9 -3
TATTATTGCA ACTGGCTCTG ATGTCAAAGG TCTACCTGGC ATAACCATTG p T aq 22
TATTATTGCA ACTGGCTCTG ATGTCAAAGG TCTACCTGGC ATAACCATTG p T aq 23
TGTTATTGCA ACTGGCTCTG ATGTCAAAGG TCTACCTGGC ATAACCATTG p T a q l6
687 ATGAGAAGAA AATTGTGTCA TCCACCGGAG CATTAGCTTT GACTGAAATT p B 3 - l
ATGAGAAGAA AATTGTGTCA TCCACCGGAG CATTAGCTTT GACTGAAATT p B 9 -3
ATGAGAAGAA AATTGTGTCA TCCACCGGAG CATTAGCTTT GACTGAAATT p T aq 22
ATGAGAAGAA AATTGTGTCA TCCACCGGAG CATTAGCTTT GACTGAAATT p T aq 23
ATGAGAAGAA AATTGTGTCA TCCACCGGAG CATTAGCTTT GACTGAAATT p T a q l6
737
78 7
837
CCAAAAAGAT
CCAAAAAGAT
CCAAAAAGAT
CCAAAAAGAT
CCAAAAAGAT
ATCTGTCTGG
ATCTGTCTGG
ATCTGTCTGG
ATCTGTCTGG
ATCTGTCTGG
CTGATATTGT
CTGATATTGT
CTGATATTGT
CTGATATTGT
CTGATATTGT
TAGTTGTTAT
TAGTTGTTAT
TAGTTGTTAT
TAGTTGTTAT
TAGTTGTTAT
GGTCGCCTCG
GGTCGCCTCG
GGTCGCCTCG
GGTCGCCTCG
GGTCGCCTCG
TCCAACCATG
TCCAACCATG
TCCAACCATG
TCCAACCATG
TCCAACCATG
TGGTGCTGGC TATATAGGCC 
TGGTGCTGGC xxTATAGGCC 
TGGTGCTGGC TATATAGGCC 
TGGTGCTGGC TATATAGGCC 
TGGTGCTGGC TATATAGGCC 
_______________ P r i m e r  3 ____________
GCTCAGAGGT
GCTCAGAGGT
GCTCAGAGGT
GCTCAGAGGT
GCTCAGAGGT-------
GATGGTGAAG
GATGGTGAAG
GATGGTGAAG
GATGGTGAAG
GATGGTGAAG
GACTGTTGTT
GACTGTTGTT
GACTGTTGTT
GACTGTTGTT
GACTGTTGTT
TTGAGATGGG
TTGAGATGGG
TTGAGATGGG
TTGAGATGGG
TTGAGATGGG
GAATTTGCAT
GAATTTGCAT
GAATTTGCAT
GAATTTGCAT
GAATTTGCAT
P r i m e r  Z  
TTCGCAAGCA 
TTCGCAAGCA 
TTCGCAAGCA 
TTCGCAAGCA 
TTCGCAAGCA
ATTTCAACGT
ATTTCAACGT
ATTTCAACGT
ATTTCAACGT
ATTTCAACGT
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
8 87 GCTCTTGAGA AGCAAAAGAT GAAATTCATG CTAAACACTA AGGTGGTGTC p B 3 - l
GCTCTTGAGA AGCAAAAGAT GAAATTCATG CTAAACACTA AGGTGGTGTC p B 9 -3
GCTCTTGAGA AGCAAAAGAT GAAATTCATG CTAAACACTA AGGTGGTGTC p T aq 22
GCTCTTGAGA AGCAAAAGAT GAAATTCATG CTAAACACTA AGGTGGTGTC p T aq 23
GCTCTTGAGA AGCAAAAGAT GAAATTCATG CTAAACACTA AGGTGGTGTC p T a q l6
937 AGTTGATGCT ACAGGTGATG GTGTGAAATT GACCCTTGAA CCTTCAGCTG p B 3 - l
AGTTGATGCT ACAGGTGATG GTGTGAAATT GACCCTTGAA CCTTCAGCTG p B 9 -3
AGTTGATGCT ACAGGTGATG GTGTGAAATT GACCCTTGAA CCTTCAGCTG p T aq 22
AGTTGATGCT ACAGGTGATG GTGTGAAATT GACCCTTGAA CCTTCAGCTG p T aq 23
AGTTGATGCT ACAGGTGATG GTGTGAAATT GACCCTTGAA CCTTCAGCTG p T a q l6
987 GTGGTGATCA AACTATTCTC 
GTGGTGATCA AACTATTCTC 
GTGGTGATCA AACTATTCTC 
GTGGTGATCA AACTATTCTC 
GTGGTGATCA AACTATTCTC
1 0 3 7  AGAGTACCAT TCACTTCAGG 
AGAGTACCAT TCACTTCAGG 
AGAGTACCAT TCACTTCAGG 
AGAGTACCAT TCACTTCAGG 
AGAGTACCAT TCACTTCAGG
F Ÿ T m e r 4 _____________\
1 0 8 7  TGACAAGGCT GGTAGAATCT 
TGACAAGGCT GGTAGAATCT 
TGACAAGGCT GGTAGAATCT 
TGACAAGGCT GGTAGAATCT 
TGACAAGGCT GGTAGAATCT
GAGGCTGATG
GAGGCTGATG
GAGGCTGATG
GAGGCTGATG
GAGGCTGATG
ACTTGGATTG
ACTTGGATTG
ACTTGGATTG
ACTTGGATTG
ACTTGGATTG
TGGTCAATGA
TGGTCAATGA
TGGTCAATGA
TGGTCAATGA
TGGTCAATGA
TTGTTCTCGT
TTGTTCTCGT
TTGTTCTCGT
TTGTTCTCGT
TTGTTCTCGTV
GACACGATAG
GACACGATAG
GACACGATAG
GACACGATAG
GACACGATAG
ACGTTTTGCC
ACGTTTTGCC
ACGTTTTGCC
ACGTTTTGCC
ACGTTTTGCC
CTCTGCTGGA 
CTCTGCTGGA 
CTCTGCTGGA 
CTCTGCTGGA 
CTCTGCTGGA 
Primer Y _
GAGTTGAAAC
GAGTTGAAAC
GAGTTGAAAC
GAGTTGAAAC
GAGTTGAAAC
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l 6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l 6
ACTAACGTCC p B 3 - l  
ACTAACGTCC p B 9 -3  
ACTAACGTCC p T aq 22  
ACTAACGTCC p T a q 2 3  
ACTAACGTCC p T a q l6
1 1 3 7  CAGGGGTACA 
CAGGGGTACA 
CAGGGGTACA 
CAGGGGTACA 
CAGGGGTACA
1 1 8 7  AAGGCAGAGG 
AAGGCAGAGG 
AAGGCAGAGG 
AAGGCAGAGG 
AAGGCAGAGG
1 2 3 7  GGGTCATGTA 
GGGTCATGTA 
GGGTCATGTA 
GGGTCATGTA 
GGGTCATGTA
12 87 AAGTGGCTTA 
AAGTGGCTTA 
AGGTGGCTTA 
AAGTGGCTTA 
AAGTGGCTTA
1 3 3 7  GATTATCGTG 
GATTATCGTG 
GATTATCGTG 
GATTATCGTG 
GATTATCGTG
13 87 AATTGATGAT 
AATTGATGAT 
AATTGATGAT 
AATTGATGAT 
AATTGATGAT
1 4 3 7  ACAAGATATT 
ACAAGATATT 
ACAAGATATT 
ACAAGATATT 
ACAAGATATT
1 4 8 7  CACGAAGCTG 
CACGAAGCTG 
CACGAAGCTG 
CACGAAGCTG 
CACGAAGCTG
1 5 3 7 TCGTACTTGT
TCGTACTTGT
TCGTACTTGT
TCGTACTTGT
TCGTACTTGT
TGCAATTGGT
TGCAATTGGT
TGCAATTGGT
TGCAATTGGT
TGCAATTGGT
AGGATGGCGT
AGGATGGCGT
AGGATGGCGT
AGGATGGCGT
AGGATGGCGT
GACTATGATA
GACTATGATA
GACTATGATA
GACTATGATA
GACTATGATA
TGTTGGGAAA
TGTTGGGAAA
TGTTGGGAAA
TGTTGGGAAA
TGTTGGGAAA
TTGGCAAATT
TTGGCAAATT
TTGGCAAATT
TTGGCAAATT
TTGGCAAATT
+
GCTGAGGGAA 
GCTGAGGGAA 
GCTGAGGAAA 
GCTGAGGGAA 
GCTGAGGGAA 
+ * 
GGGCGTCCAT 
GGGTGTCCAT 
GGGTGTCCAT 
GGGCGCCCAT 
GGGCGTCCAT 
+
TACTGGCATT
TCCTGGCATT
TCCTGGCATT
TACTGGCATT
TACTGGCATT
CATGCACATC
CATGCACATC
CATGCACATC
CATGCACATC
CATGCACATC
GATGTCATTC
GATGTCATTC
GATGTCATTC
GATGTCATTC
GATGTCATTC
+
TGCTTGTGTA
TGCTTGCGTA
TGCTTGCGTA
TGCTTGCGTA
TGCTTGCGTA
TGGTACCTGG
TGGTACCTGG
TGGTACCTGG
TGGTACCTGG
TGGTACCTGG
ACCGAGGAAC
ACCGAGGAAC
ACCGAGGAAC
ACCGAGGAAC
ACCGAGGAAC------
CTGGACCAAT
CTGGACCAAT
CTGGACCAAT
CTGGACCAAT
CTGGACCAAT
GAGTTCATTG
GAGTTCATTG
GAGTTCATTG
GAGTTCATTG
GAGTTCATTG
+
TGTCGTTTAC
TGTTGTTTAC
TGTTGTTTAC
TGTTGTTTAC
TGTTGTTTAC
AGGTAAAGTC
AGGTAAAGTC
AGGTAAAGTC
AGGTAAAGTC
AGGTAAAGTC
GCTGGCTCAC
GTTGGCTCAC
GCTGGCTCAC
GTTGGCTCAC
GTTGGCTCAC
CAGGTAAGGA
CAGGTAAGGA
CAGGTAAGGA
CAGGTAAGGA
CAGGTAAGGA
ACCCACCCGG
ACCCACCCGG
ACCCACCCGG
ACCCACCCGG
ACCCACCCGG★
ACTCGGAGTT
ACTCGGAGTT
ACTCGGAGTT
ACTCGGAATT
ACTCGGAATT
P r i m e r  X  
+ P r i m e r  5 ACCCCTTCCTA
CCCCTTCCTA
CCCCTTCCTA
CCCCTTCCTA
CCCCTTCCTA
TTGTCAAGGT
TTGTCAAGGT
TTGTCAAGGT
TTGTCAAGGT
TTGTCAAGGT
ATTATGTCAC
ATTATGTCAC
ATTATGTCAC
ATTATGTCAC
ATTATGTCAC
GCAGTACGGA
GCAGTACGGA
GCAGTACGGA
GCAGTACGGA
GCAGTACGGA
CAACAATGAG
CAACAATGAG
CAACAATGAG
CAACAATGAG
CAACAATGAG
GCAAACAGTA
GCTAACAGTA
GCTAACAGTA
GCTAACAGTA
GCTAACAGTA
AATTGCTGAG
AATTGCTGAG
AATTGCTGAG
AATTGCTGAG
AATTGCTGAG
+
CTAATGCAGG
CTAACGCAGG
CTAACGCAGG
CTAATGCAGG
CTAATGCAGG
GCATCAAGTG
GCATCAAGTG
GCATCAAGTG
GCATCAAGTG
GCATCAAGTG
TGAGGCACTC
TGAGGCACTC
TGAGGCACTC
TGAGGCACTC
TGAGGCACTC
GAGCCAAGGC
GAGCCAAGGC
GAGCCAAGGC
GAGCCAAGGC
GAGCCAAGGC
+
AAAGAGAGTG
AAAGAGAGCG
AAAGAGAGCG
AAAGAGAGTG
AAAGAGAGTG
GGAGCTTATT
GGAGCTTATT
GGAGCTTATT
GGAGCTTATT
GGAGCTTATT
AGGACATTGC 
AGGACATTGC 
AGGACATTGC 
AGGACATTGC 
AGGACATTGC 
* + 
AAAGAAGCAG 
AAAGAAGCTG 
GAAGAAGCAG 
AAAGAAGCAG 
AAAGAAGCAG
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
p B 3 - l  
p B 9 -3  
p T aq 22  
p T aq2 3 
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q l6
p B 3 - l
p B 9 -3
p T aq 22
p T aq 23
p T a q ie
15 87 CCATGGCCAC 
CCATGGCCAC 
CCATGGCCAC 
CCATGGCCAC 
CCATGGCCAC
TTATGACAAG
TTATGACAAG
TTATGACAAG
TTATGACAAG
TTATGACAAG
CCCATCCACA
CCCATCCACA
CCCATCCACA
CCCATCCACA
CCCATCCACA
TGTAGGCCTG
TGTAGGCCTG
TGTAGGCTTG
CGTAGGCTTG
TGTAGGCTTG
TGTTATATCC p B 3 - l  
TGTTATATCC p B 9 -3  
TGTTATATCC p T aq 22  
TGTTATATCC p T aq 23  
TGTTATATCC p T a q l6  
\  P r i m e r  W
.■'I
1 6 3 7  TCGATAGCCT 
TCGATAGCCT 
TCGATAgCCT  
TCAATAGCCT 
TCGATAGCCT
CATTTTTCTT  
CATTTTTCTT  
CATTTTTCTT  
CATTTTTCAT  
CATTTTTCAT  
P rim er 6
ATTCCGTTGA
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p T a q 2 2
p T a q 2 3
p T a q l S
p B 3 - l
p B 9 " 3
p T a q 2 2
p T a q 2 3
p T a q i e
ATGTAACCTG CTTTAAAAAA AAAAAAAAAAA p B 3 ~ l  
ATGTAACCTG CTTTAAACCC TGCAGAAAGT TAACTGCCTA p B 9 ~ 3  
ATGTAACCTG CTTTAAACCC TGCAGAA GT TAACTGCCTG p T a q 2 2  
AAAAA p T a q 2 3
TAAAGATGAG ATGTAACCTG CTTTAAACCC TGCAGAA GT TAACTGCCTG p T a q l 6
1 8  3 7  GCACTAAGAT GGTGCTAGAC ATTACAAAAC TTCCCATTTA CTTTGCTTTT p B 9 -3
GCACTAAGAT GGTGCTAGAC ATTACAAAAC TTCCCATTTA CTTTGCTTTT p T a q 2 2
GCACTAAGAT GGTGCTAGAC ATTACAAAAA AAAAAAAAAA AAAAt T  p T a q l 6
1 8  8 7  TTGGCATGTA TCCCTAAATT CTATATTTAT CTTGTTTGAT TTGGTAAAAA p B 9 ” 3 
TTGGCATGTA TCCCTAAATT CTATATTTAT CTTGTTTGAT TTGGTAGATC p T a q 2 2
1 9 3 7 ACTC p B 9 ~ 3
AGTCGATTTGG p T a q 2 2
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Fig. B: Amino acid comparison of the library clones, pB3-l and pB9-3 
with the Tag amplified clones pTaq22, pTaq23 and pTaql6
§§= redox active cysteines.
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5 1 § § 1 0 0
p B 3 “ l GGYVAAIKAA QLGLKTTCIE KRGTLGGTCL N V G C IPSK AL LHSSHMFHEA
p B 9 - 3 GGYVAAIKAA Q LGLKTTCIE KRGTLGGTCL N V G C IPSK AL LHSSHMFHEA
p T a q 2 2 GYVAAIKAA Q LGLKTECIE KRGTLGGTCL NV G C IPSK AL LHSSHMFHEA
p T a q 2 3
p T a q l 6 GYVAAIKAA Q LGLKTTCIE KRGTLGGTCL NV G C IPSK AL LHSSHMFHEA
1 0 1 1 5 0
p B 3 - l QHSFANHGVK F SSV E V D L PA MMGQKDKAVS NLTRG IEG LF KKNKVNYVKG
p B 9 - 3 QHSFANHGVK F SSV E V D L PA MMGQKDKAVS NLTRGIEG LF KKNKVNYVKG
p T a q 2 2 QHSFANHGVK FSSV E V D L PA MMGQKDKAVS NLTRGIEG LF KKNKVNYVKG
p T a q 2 3 KDKAVS NLTRG IEG LF KKNKVNYVKG
p T a q lG QHSFANHGVK FSSV E V D L PA MMGEKDKAVS N L T R ................
1 5 1 2 0 0
p B 3 - l Y G K F L SP SE I SVDTVEGGNS V V K G K N IIIA TGSDVKGLPG IT ID E K K IV S
p B 9 - 3 Y G K F L SP SE I SVDTVEGGNS V V K G K N IIIA TGSDVKGLPG IT ID E K K IV S
p T a q 2 2 Y G K F L SP SE I SVDTVEGGNS V V K G K N IIIA TGSDVKGLPG IT ID E K K IV S
p T a q 2 3 Y G K F L SP SE I SVDTVEGGNS V V K G K N IIIA TGSDVKGLPG IT ID E K K IV S
p T a q l 6 ................ GGNS V V K G K N IIIA TGSDVKGLPG IT ID E K K IV S
2 0 1 2 5 0
p B 3 - l STG AL ALTEI P K R L W IG A G YIGLEMGSVW G R L G SE V T W EFA SD IV PT M
p B 9 - 3 STG AL ALTEI P K R L W IG A G XIGLEMGSVW G R L G SE V T W EFA SD IV PTM
p T a q 2 2 STG AL ALTEI P K R L W IG A G YIGLEMGSVW G R L G SE V T W EFA SD IV PT M
p T a q 2 3 STG AL ALTEI P K R L W IG A G YIGLEMGSVW G R L G SE V T W EFA SD IV PTM
p T a q l 6 STG AL ALTEI P K R L W IG A G YIGLEMGSVW G R L G SE V T W EFA SD IV PTM
2 5 1 3 0 0
p B 3 ” l DGEVRKQFQR ALEKQKMKFM L N T K W SV D A TGDGVKLTLE PSAG G DQ TIL
p B 9 ~ 3 DGEVRKQFQR ALEKQKMKFM L N T K W SV D A TGDGVKLTLE PSAG G DQ TIL
p T a q 2 2 DGEVRKQFQR ALEKQKMKFM L N T K W SV D A TGDGVKLTLE PSAG G DQ TIL
p T a q 2 3 DGEVRKQFQR ALEKQKMKFM L N T K W SV D A TGDGVKLTLE PSAG G DQ TIL
p T a q l 6 DGEVRKQFQR ALEKQKMKFM L N T K W SV D A TGDGVKLTLE PSAG G DQ TIL
3 0 1 3 5 0
p B 3  — 1 EADVVLVSAG RVPFTSGLGL DTIGVETDKA GRILVNERFA TNVPGVHAIG
p B 9 - 3 E A D W L V SA G RVPFTSGLGL DTIGVETDKA G RILVNERFA TNVPGVHAIG
p T a q 2 2 EADVVLVSAG RVPFTSGLGL DTIGVETDKA G RILVNERFA TNVPGVHAIG
p T a q 2 3 EADVVLVSAG RVPFTSGLGL DTIGVETDKA G RILV NERFA TNVPGVHAIG
p T a q l 6 EADVVLVSAG RVPFTSGLGL DTIGVETDKA G RILVNERFA TNVPGVHAIG
3 5 1 4 0 0
p B 3 - l DVIPGPMLAH KAEEDGVACV EFIAGKEGHV DYDM VPGW Y THPEVAYVGK
p B 9 ~ 3 DVIPGPMLAH KAEEDGVACV EFIAGKEGHV DYDM VPGW Y THPEVAYVGK
p T a q 2 2 DVIPGPMLAH KAEEDGVACV EFIAGKEGHV DYDMVPGW Y THPEVAYVGK
p T a q 2 3 DVIPGPMLAH KAEEDGVACV EFIAGKEGHV DYDMVPGW Y THPEVAYVGK
p T a q l 6 DVIPGPMLAH KAEEDGVACV EFIAGKEGHV DYDM VPGW Y THPEVAYVGK
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